ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-9013405,RHOD GTPase cycle,3/43,54/10899,0.0012333584660213098,0.263045731667039,0.24882191777011908,STBD1/AKAP12/SLC4A7,3
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,2/43,17/10899,0.001991547235490519,0.263045731667039,0.24882191777011908,MET/SLC2A3,2
R-HSA-204005,COPII-mediated vesicle transport,3/43,68/10899,0.0023982365508545566,0.263045731667039,0.24882191777011908,MCFD2/SEC24A/USO1,3
R-HSA-425407,SLC-mediated transmembrane transport,5/43,250/10899,0.00288269294977577,0.263045731667039,0.24882191777011908,SLC4A7/SLC35D1/SLC2A3/SLC33A1/SLC39A14,5
R-HSA-5673001,RAF/MAP kinase cascade,5/43,280/10899,0.004677215532972914,0.2646154860405784,0.2503067899677281,RASA2/MET/ITGB3/PSMD5/DUSP5,5
R-HSA-5684996,MAPK1/MAPK3 signaling,5/43,286/10899,0.005114498679330144,0.2646154860405784,0.2503067899677281,RASA2/MET/ITGB3/PSMD5/DUSP5,5
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",2/43,29/10899,0.005769732691726581,0.2646154860405784,0.2503067899677281,SEC24A/HSPA5,2
R-HSA-170834,Signaling by TGF-beta Receptor Complex,3/43,93/10899,0.005799791474861992,0.2646154860405784,0.2503067899677281,PPP1R15A/ITGB3/WWTR1,3
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,6/43,433/10899,0.006653904468767841,0.26985279234447357,0.2552608965796318,ESR2/MET/ITGB3/PSMD5/PPFIBP1/PRKAR1A,6
R-HSA-5694530,Cargo concentration in the ER,2/43,33/10899,0.007429022738199136,0.27115932994426845,0.25649678506624385,MCFD2/SEC24A,2
R-HSA-5683057,MAPK family signaling cascades,5/43,325/10899,0.008692918653703724,0.27806286365679284,0.2630270202723232,RASA2/MET/ITGB3/PSMD5/DUSP5,5
R-HSA-3928662,EPHB-mediated forward signaling,2/43,42/10899,0.011845962420908636,0.27806286365679284,0.2630270202723232,ACTR3/EFNB2,2
R-HSA-9035034,RHOF GTPase cycle,2/43,42/10899,0.011845962420908636,0.27806286365679284,0.2630270202723232,AKAP12/SLC4A7,2
R-HSA-8878166,Transcriptional regulation by RUNX2,3/43,121/10899,0.011926205709070487,0.27806286365679284,0.2630270202723232,HIVEP3/PSMD5/WWTR1,3
R-HSA-9006936,Signaling by TGFB family members,3/43,122/10899,0.012193681956465856,0.27806286365679284,0.2630270202723232,PPP1R15A/ITGB3/WWTR1,3
R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",2/43,43/10899,0.012392963371817669,0.27806286365679284,0.2630270202723232,SLC35D1/SLC33A1,2
R-HSA-1566948,Elastic fibre formation,2/43,44/10899,0.012950873101823229,0.27806286365679284,0.2630270202723232,LOXL1/ITGB3,2
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,2/43,46/10899,0.01409905781569239,0.28589756126265126,0.2704380680436903,PPP1R15A/ITGB3,2
R-HSA-383280,Nuclear Receptor transcription pathway,2/43,52/10899,0.017796126459538784,0.34187295567008713,0.3233866747218129,NRBF2/ESR2,2
R-HSA-9700206,Signaling by ALK in cancer,2/43,55/10899,0.01978236993616306,0.34383642984283413,0.3252439768953125,PPFIBP1/PRKAR1A,2
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,2/43,55/10899,0.01978236993616306,0.34383642984283413,0.3252439768953125,PPFIBP1/PRKAR1A,2
R-HSA-199977,ER to Golgi Anterograde Transport,3/43,154/10899,0.022603660590393416,0.37501527797698164,0.35473687433727463,MCFD2/SEC24A/USO1,3
R-HSA-8986944,Transcriptional Regulation by MECP2,2/43,62/10899,0.02475804823986862,0.3907893073309341,0.3696579460837675,MET/SLC2A3,2
R-HSA-5658442,Regulation of RAS by GAPs,2/43,68/10899,0.029385830795499338,0.3907893073309341,0.3696579460837675,RASA2/PSMD5,2
R-HSA-9006925,Intracellular signaling by second messengers,4/43,309/10899,0.03286377445142639,0.3907893073309341,0.3696579460837675,ESR2/MET/PSMD5/PRKAR1A,4
R-HSA-8939902,Regulation of RUNX2 expression and activity,2/43,73/10899,0.0334849989090256,0.3907893073309341,0.3696579460837675,HIVEP3/PSMD5,2
R-HSA-948021,Transport to the Golgi and subsequent modification,3/43,185/10899,0.03615899612279524,0.3907893073309341,0.3696579460837675,MCFD2/SEC24A/USO1,3
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/43,78/10899,0.037794457481802365,0.3907893073309341,0.3696579460837675,ESR2/MET,2
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,1/43,10/10899,0.03877576031895391,0.3907893073309341,0.3696579460837675,HSPA5,1
R-HSA-425381,Bicarbonate transporters,1/43,10/10899,0.03877576031895391,0.3907893073309341,0.3696579460837675,SLC4A7,1
R-HSA-442380,Zinc influx into cells by the SLC39 gene family,1/43,10/10899,0.03877576031895391,0.3907893073309341,0.3696579460837675,SLC39A14,1
R-HSA-8875656,MET receptor recycling,1/43,10/10899,0.03877576031895391,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-8851805,MET activates RAS signaling,1/43,11/10899,0.04257157649181531,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-8875555,MET activates RAP1 and RAC1,1/43,11/10899,0.04257157649181531,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-210990,PECAM1 interactions,1/43,12/10899,0.046352750464156545,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,1/43,12/10899,0.046352750464156545,0.3907893073309341,0.3696579460837675,HSPA5,1
R-HSA-9700645,ALK mutants bind TKIs,1/43,12/10899,0.046352750464156545,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-2682334,EPH-Ephrin signaling,2/43,92/10899,0.05090078608973299,0.3907893073309341,0.3696579460837675,ACTR3/EFNB2,2
R-HSA-162658,Golgi Cisternae Pericentriolar Stack Reorganization,1/43,14/10899,0.05387139217239412,0.3907893073309341,0.3696579460837675,USO1,1
R-HSA-3322077,Glycogen synthesis,1/43,14/10899,0.05387139217239412,0.3907893073309341,0.3696579460837675,GBE1,1
R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/43,14/10899,0.05387139217239412,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-5578768,Physiological factors,1/43,14/10899,0.05387139217239412,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,1/43,14/10899,0.05387139217239412,0.3907893073309341,0.3696579460837675,PERP,1
R-HSA-8878159,Transcriptional regulation by RUNX3,2/43,96/10899,0.05490727366636427,0.3907893073309341,0.3696579460837675,PSMD5/WWTR1,2
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-71336,Pentose phosphate pathway,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,PRPS2,1
R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,1/43,15/10899,0.05760896958503392,0.3907893073309341,0.3696579460837675,PPP1R15A,1
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,2/43,102/10899,0.061118832807084904,0.3907893073309341,0.3696579460837675,BIRC3/PSMD5,2
R-HSA-3229121,Glycogen storage diseases,1/43,16/10899,0.061332124152091105,0.3907893073309341,0.3696579460837675,GBE1,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/43,104/10899,0.06324107575385898,0.3907893073309341,0.3696579460837675,ESR2/MET,2
R-HSA-164378,PKA activation in glucagon signalling,1/43,17/10899,0.0650409102093783,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-435354,Zinc transporters,1/43,17/10899,0.0650409102093783,0.3907893073309341,0.3696579460837675,SLC39A14,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",2/43,106/10899,0.06538832456800292,0.3907893073309341,0.3696579460837675,ESR2/MET,2
R-HSA-2243919,Crosslinking of collagen fibrils,1/43,18/10899,0.068735381892984,0.3907893073309341,0.3696579460837675,LOXL1,1
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1/43,18/10899,0.068735381892984,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-3928664,Ephrin signaling,1/43,19/10899,0.07241559313998336,0.3907893073309341,0.3696579460837675,EFNB2,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,2/43,113/10899,0.07309339127789136,0.3907893073309341,0.3696579460837675,ESR2/MET,2
R-HSA-5610787,Hedgehog 'off' state,2/43,113/10899,0.07309339127789136,0.3907893073309341,0.3696579460837675,PSMD5/PRKAR1A,2
R-HSA-163615,PKA activation,1/43,20/10899,0.07608159768915457,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",1/43,20/10899,0.07608159768915457,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-2028269,Signaling by Hippo,1/43,20/10899,0.07608159768915457,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/43,20/10899,0.07608159768915457,0.3907893073309341,0.3696579460837675,PPFIBP1,1
R-HSA-8876384,Listeria monocytogenes entry into host cells,1/43,20/10899,0.07608159768915457,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-189200,Cellular hexose transport,1/43,21/10899,0.07973344908168778,0.3907893073309341,0.3696579460837675,SLC2A3,1
R-HSA-445144,Signal transduction by L1,1/43,21/10899,0.07973344908168778,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-5620916,VxPx cargo-targeting to cilium,1/43,21/10899,0.07973344908168778,0.3907893073309341,0.3696579460837675,PKD2,1
R-HSA-6807004,Negative regulation of MET activity,1/43,21/10899,0.07973344908168778,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-9008059,Interleukin-37 signaling,1/43,21/10899,0.07973344908168778,0.3907893073309341,0.3696579460837675,PTPN14,1
R-HSA-111931,PKA-mediated phosphorylation of CREB,1/43,22/10899,0.08337120066189407,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-112409,RAF-independent MAPK1/3 activation,1/43,23/10899,0.08699490557791312,0.3907893073309341,0.3696579460837675,DUSP5,1
R-HSA-1257604,PIP3 activates AKT signaling,3/43,267/10899,0.08771626178517818,0.3907893073309341,0.3696579460837675,ESR2/MET/PSMD5,3
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,2/43,126/10899,0.08812815608280783,0.3907893073309341,0.3696579460837675,SEC24A/IFNAR1,2
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,1/43,24/10899,0.09060461678241394,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-114608,Platelet degranulation ,2/43,129/10899,0.09172094285740609,0.3907893073309341,0.3696579460837675,ITGB3/HSPA5,2
R-HSA-156588,Glucuronidation,1/43,25/10899,0.09420038703329714,0.3907893073309341,0.3696579460837675,SLC35D1,1
R-HSA-400685,Sema4D in semaphorin signaling,1/43,25/10899,0.09420038703329714,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-937041,IKK complex recruitment mediated by RIP1,1/43,25/10899,0.09420038703329714,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-180024,DARPP-32 events,1/43,26/10899,0.09778226889439445,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,1/43,26/10899,0.09778226889439445,0.3907893073309341,0.3696579460837675,PPP1R15A,1
R-HSA-425410,Metal ion SLC transporters,1/43,26/10899,0.09778226889439445,0.3907893073309341,0.3696579460837675,SLC39A14,1
R-HSA-5223345,Miscellaneous transport and binding events,1/43,26/10899,0.09778226889439445,0.3907893073309341,0.3696579460837675,LRRC8E,1
R-HSA-912694,Regulation of IFNA/IFNB signaling,1/43,26/10899,0.09778226889439445,0.3907893073309341,0.3696579460837675,IFNAR1,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,2/43,134/10899,0.09780382130724907,0.3907893073309341,0.3696579460837675,ITGB3/HSPA5,2
R-HSA-3000170,Syndecan interactions,1/43,27/10899,0.10135031473616185,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-354192,Integrin signaling,1/43,27/10899,0.10135031473616185,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-77387,Insulin receptor recycling,1/43,27/10899,0.10135031473616185,0.3907893073309341,0.3696579460837675,ATP6V1A,1
R-HSA-8982491,Glycogen metabolism,1/43,27/10899,0.10135031473616185,0.3907893073309341,0.3696579460837675,GBE1,1
R-HSA-1483191,Synthesis of PC,1/43,28/10899,0.10490457673637732,0.3907893073309341,0.3696579460837675,PCYT1A,1
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/43,28/10899,0.10490457673637732,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-5213460,RIPK1-mediated regulated necrosis,1/43,29/10899,0.1084451068808292,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-5675482,Regulation of necroptotic cell death,1/43,29/10899,0.1084451068808292,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,1/43,30/10899,0.11197195696400541,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/43,30/10899,0.11197195696400541,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-8874081,MET activates PTK2 signaling,1/43,30/10899,0.11197195696400541,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-70268,Pyruvate metabolism,1/43,31/10899,0.11548517858978036,0.3907893073309341,0.3696579460837675,LDHA,1
R-HSA-917977,Transferrin endocytosis and recycling,1/43,31/10899,0.11548517858978036,0.3907893073309341,0.3696579460837675,ATP6V1A,1
R-HSA-5358351,Signaling by Hedgehog,2/43,149/10899,0.11670371064882357,0.3907893073309341,0.3696579460837675,PSMD5/PRKAR1A,2
R-HSA-446203,Asparagine N-linked glycosylation,3/43,304/10899,0.11753228202636723,0.3907893073309341,0.3696579460837675,MCFD2/SEC24A/USO1,3
R-HSA-381042,PERK regulates gene expression,1/43,32/10899,0.11898482317209935,0.3907893073309341,0.3696579460837675,HSPA5,1
R-HSA-8941326,RUNX2 regulates bone development,1/43,32/10899,0.11898482317209935,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-446652,Interleukin-1 family signaling,2/43,153/10899,0.12189333292167963,0.3907893073309341,0.3696579460837675,PTPN14/PSMD5,2
R-HSA-163359,Glucagon signaling in metabolic regulation,1/43,33/10899,0.12247094193565844,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,1/43,34/10899,0.12594358591658683,0.3907893073309341,0.3696579460837675,SLC35D1,1
R-HSA-5663084,Diseases of carbohydrate metabolism,1/43,34/10899,0.12594358591658683,0.3907893073309341,0.3696579460837675,GBE1,1
R-HSA-1222556,ROS and RNS production in phagocytes,1/43,36/10899,0.1328486527362781,0.3907893073309341,0.3696579460837675,ATP6V1A,1
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/43,36/10899,0.1328486527362781,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-390522,Striated Muscle Contraction,1/43,36/10899,0.1328486527362781,0.3907893073309341,0.3696579460837675,TPM1,1
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,1/43,36/10899,0.1328486527362781,0.3907893073309341,0.3696579460837675,ACTR3,1
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,1/43,36/10899,0.1328486527362781,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-111933,Calmodulin induced events,1/43,37/10899,0.13628117671053364,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-111997,CaM pathway,1/43,37/10899,0.13628117671053364,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-168638,NOD1/2 Signaling Pathway,1/43,37/10899,0.13628117671053364,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-2129379,Molecules associated with elastic fibres,1/43,37/10899,0.13628117671053364,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-9658195,Leishmania infection,2/43,164/10899,0.136450321204515,0.3907893073309341,0.3696579460837675,ACTR3/PRKAR1A,2
R-HSA-9013407,RHOH GTPase cycle,1/43,38/10899,0.1397004281744858,0.3907893073309341,0.3696579460837675,SLC4A7,1
R-HSA-111996,Ca-dependent events,1/43,39/10899,0.14310645723152438,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-76009,Platelet Aggregation (Plug Formation),1/43,39/10899,0.14310645723152438,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-5357905,Regulation of TNFR1 signaling,1/43,40/10899,0.14649931380049708,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-5674135,MAP2K and MAPK activation,1/43,40/10899,0.14649931380049708,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/43,40/10899,0.14649931380049708,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-8875878,MET promotes cell motility,1/43,41/10899,0.14987904761637139,0.3907893073309341,0.3696579460837675,MET,1
R-HSA-5619115,Disorders of transmembrane transporters,2/43,176/10899,0.15275285124286986,0.3907893073309341,0.3696579460837675,SLC33A1/PSMD5,2
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1/43,42/10899,0.15324570823089478,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-1489509,DAG and IP3 signaling,1/43,43/10899,0.156599345013254,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,1/43,43/10899,0.156599345013254,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/43,43/10899,0.156599345013254,0.3907893073309341,0.3696579460837675,DUSP5,1
R-HSA-9656223,Signaling by RAF1 mutants,1/43,43/10899,0.156599345013254,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,1/43,43/10899,0.156599345013254,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,1/43,44/10899,0.1599400071507291,0.3907893073309341,0.3696579460837675,PERP,1
R-HSA-6811438,Intra-Golgi traffic,1/43,44/10899,0.1599400071507291,0.3907893073309341,0.3696579460837675,GOLGA5,1
R-HSA-2172127,DAP12 interactions,1/43,45/10899,0.16326774364934915,0.3907893073309341,0.3696579460837675,CLEC5A,1
R-HSA-3899300,SUMOylation of transcription cofactors,1/43,45/10899,0.16326774364934915,0.3907893073309341,0.3696579460837675,NRIP1,1
R-HSA-445355,Smooth Muscle Contraction,1/43,45/10899,0.16326774364934915,0.3907893073309341,0.3696579460837675,TPM1,1
R-HSA-9634597,GPER1 signaling,1/43,45/10899,0.16326774364934915,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-6802949,Signaling by RAS mutants,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,NRIP1,1
R-HSA-9649948,Signaling downstream of RAS mutants,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-9707616,Heme signaling,1/43,47/10899,0.1698846348517823,0.3907893073309341,0.3696579460837675,NRIP1,1
R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),1/43,49/10899,0.1764504070684323,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-75893,TNF signaling,1/43,49/10899,0.1764504070684323,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,1/43,50/10899,0.17971424416484305,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-112043,PLC beta mediated events,1/43,51/10899,0.18296544588858787,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/43,51/10899,0.18296544588858787,0.3907893073309341,0.3696579460837675,WWTR1,1
R-HSA-350562,Regulation of ornithine decarboxylase (ODC),1/43,51/10899,0.18296544588858787,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/43,51/10899,0.18296544588858787,0.3907893073309341,0.3696579460837675,EFNB2,1
R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/43,51/10899,0.18296544588858787,0.3907893073309341,0.3696579460837675,PKD2,1
R-HSA-180534,Vpu mediated degradation of CD4,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-381070,IRE1alpha activates chaperones,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,HSPA5,1
R-HSA-445717,Aquaporin-mediated transport,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-69610,p53-Independent DNA Damage Response,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,1/43,52/10899,0.18620405999503997,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-9705683,SARS-CoV-2-host interactions,2/43,202/10899,0.18925558794764688,0.3907893073309341,0.3696579460837675,SEC24A/IFNAR1,2
R-HSA-983169,Class I MHC mediated antigen processing & presentation,3/43,381/10899,0.18940568788049691,0.3907893073309341,0.3696579460837675,SEC24A/PSMD5/HSPA5,3
R-HSA-169911,Regulation of Apoptosis,1/43,53/10899,0.18943013406346554,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-180585,Vif-mediated degradation of APOBEC3G,1/43,54/10899,0.19264371549766002,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,1/43,54/10899,0.19264371549766002,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-9604323,Negative regulation of NOTCH4 signaling,1/43,54/10899,0.19264371549766002,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-397014,Muscle contraction,2/43,205/10899,0.19354904128485254,0.3907893073309341,0.3696579460837675,TPM1/WWTR1,2
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,SEC24A,1
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-4641257,Degradation of AXIN,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,LDHA,1
R-HSA-8941858,Regulation of RUNX3 expression and activity,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-9013409,RHOJ GTPase cycle,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,SLC4A7,1
R-HSA-9639288,Amino acids regulate mTORC1,1/43,55/10899,0.19584485152657616,0.3907893073309341,0.3696579460837675,ATP6V1A,1
R-HSA-112040,G-protein mediated events,1/43,56/10899,0.19903358920495695,0.3907893073309341,0.3696579460837675,PRKAR1A,1
R-HSA-432722,Golgi Associated Vesicle Biogenesis,1/43,56/10899,0.19903358920495695,0.3907893073309341,0.3696579460837675,ACBD3,1
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,1/43,56/10899,0.19903358920495695,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5362768,Hh mutants are degraded by ERAD,1/43,56/10899,0.19903358920495695,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5357801,Programmed Cell Death,2/43,210/10899,0.2007344257007897,0.3907893073309341,0.3696579460837675,BIRC3/PSMD5,2
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/43,57/10899,0.2022099754139569,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-4641258,Degradation of DVL,1/43,57/10899,0.2022099754139569,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5218859,Regulated Necrosis,1/43,57/10899,0.2022099754139569,0.3907893073309341,0.3696579460837675,BIRC3,1
R-HSA-69541,Stabilization of p53,1/43,57/10899,0.2022099754139569,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-917937,Iron uptake and transport,1/43,58/10899,0.2053740568617709,0.3907893073309341,0.3696579460837675,ATP6V1A,1
R-HSA-3000171,Non-integrin membrane-ECM interactions,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,ITGB3,1
R-HSA-351202,Metabolism of polyamines,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5387390,Hh mutants abrogate ligand secretion,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-9013406,RHOQ GTPase cycle,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,SLC4A7,1
R-HSA-9664407,Parasite infection,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,ACTR3,1
R-HSA-9664417,Leishmania phagocytosis,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,ACTR3,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/43,59/10899,0.20852588008425454,0.3907893073309341,0.3696579460837675,ACTR3,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/43,60/10899,0.21166549144554359,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,1/43,60/10899,0.21166549144554359,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5610780,Degradation of GLI1 by the proteasome,1/43,60/10899,0.21166549144554359,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5610783,Degradation of GLI2 by the proteasome,1/43,60/10899,0.21166549144554359,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,1/43,60/10899,0.21166549144554359,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,1/43,61/10899,0.21479293713867453,0.3907893073309341,0.3696579460837675,LOXL1,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/43,61/10899,0.21479293713867453,0.3907893073309341,0.3696579460837675,ACTR3,1
R-HSA-5678895,Defective CFTR causes cystic fibrosis,1/43,61/10899,0.21479293713867453,0.3907893073309341,0.3696579460837675,PSMD5,1
R-HSA-5689880,Ub-specific processing proteases,2/43,220/10899,0.2152017829411445,0.3907893073309341,0.3696579460837675,BIRC3/PSMD5,2
R-HSA-8939211,ESR-mediated signaling,2/43,223/10899,0.21956346250056924,0.3967359594688504,0.37528304168935234,ESR2/NRIP1,2
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,1/43,64/10899,0.22410273958586213,0.4009681370041161,0.3792863704033167,PSMD5,1
R-HSA-4608870,Asymmetric localization of PCP proteins,1/43,64/10899,0.22410273958586213,0.4009681370041161,0.3792863704033167,PSMD5,1
R-HSA-373755,Semaphorin interactions,1/43,65/10899,0.22718198113619048,0.4021099961007174,0.38036648513636717,MET,1
R-HSA-5358346,Hedgehog ligand biogenesis,1/43,65/10899,0.22718198113619048,0.4021099961007174,0.38036648513636717,PSMD5,1
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,1/43,66/10899,0.230249285438493,0.4021099961007174,0.38036648513636717,PSMD5,1
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/43,66/10899,0.230249285438493,0.4021099961007174,0.38036648513636717,PSMD5,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/43,66/10899,0.230249285438493,0.4021099961007174,0.38036648513636717,PSMD5,1
R-HSA-1169091,Activation of NF-kappaB in B cells,1/43,67/10899,0.23330469767205175,0.4035839556886203,0.381760742511514,PSMD5,1
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,1/43,67/10899,0.23330469767205175,0.4035839556886203,0.381760742511514,ITGB3,1
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,1/43,68/10899,0.23634826284931376,0.4050099339906081,0.38310961311872954,PSMD5,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/43,68/10899,0.23634826284931376,0.4050099339906081,0.38310961311872954,PSMD5,1
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/43,69/10899,0.23938002581648954,0.40638934615357525,0.3844144355829061,HSPA5,1
R-HSA-8948751,Regulation of PTEN stability and activity,1/43,69/10899,0.23938002581648954,0.40638934615357525,0.3844144355829061,PSMD5,1
R-HSA-400253,Circadian Clock,1/43,70/10899,0.24240003125415233,0.4091928045343931,0.38706630104479006,NRIP1,1
R-HSA-8951664,Neddylation,2/43,240/10899,0.2444170733581483,0.4091928045343931,0.38706630104479006,FEM1B/PSMD5,2
R-HSA-68949,Orc1 removal from chromatin,1/43,71/10899,0.24540832367783627,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-199992,trans-Golgi Network Vesicle Budding,1/43,72/10899,0.24840494743862807,0.4091928045343931,0.38706630104479006,ACBD3,1
R-HSA-909733,Interferon alpha/beta signaling,1/43,72/10899,0.24840494743862807,0.4091928045343931,0.38706630104479006,IFNAR1,1
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,1/43,73/10899,0.2513899467237616,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,1/43,73/10899,0.2513899467237616,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,1/43,74/10899,0.2543633655572066,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,1/43,74/10899,0.2543633655572066,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-9013408,RHOG GTPase cycle,1/43,74/10899,0.2543633655572066,0.4091928045343931,0.38706630104479006,STBD1,1
R-HSA-1234174,Cellular response to hypoxia,1/43,75/10899,0.2573252478002588,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-5668914,Diseases of metabolism,2/43,249/10899,0.2576385513722594,0.4091928045343931,0.38706630104479006,GBE1/SLC35D1,2
R-HSA-9012999,RHO GTPase cycle,3/43,449/10899,0.2602590162764459,0.4091928045343931,0.38706630104479006,STBD1/AKAP12/SLC4A7,3
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,1/43,76/10899,0.260275637152124,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-3000178,ECM proteoglycans,1/43,76/10899,0.260275637152124,0.4091928045343931,0.38706630104479006,ITGB3,1
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,1/43,77/10899,0.26321457715050334,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/43,77/10899,0.26321457715050334,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-9009391,Extra-nuclear estrogen signaling,1/43,77/10899,0.26321457715050334,0.4091928045343931,0.38706630104479006,ESR2,1
R-HSA-422356,Regulation of insulin secretion,1/43,78/10899,0.2661421111721748,0.4091928045343931,0.38706630104479006,PRKAR1A,1
R-HSA-5619084,ABC transporter disorders,1/43,78/10899,0.2661421111721748,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-6806834,Signaling by MET,1/43,79/10899,0.26905828243357355,0.4091928045343931,0.38706630104479006,MET,1
R-HSA-74752,Signaling by Insulin receptor,1/43,79/10899,0.26905828243357355,0.4091928045343931,0.38706630104479006,ATP6V1A,1
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,1/43,79/10899,0.26905828243357355,0.4091928045343931,0.38706630104479006,PRKAR1A,1
R-HSA-9664433,Leishmania parasite growth and survival,1/43,79/10899,0.26905828243357355,0.4091928045343931,0.38706630104479006,PRKAR1A,1
R-HSA-9759194,Nuclear events mediated by NFE2L2,1/43,79/10899,0.26905828243357355,0.4091928045343931,0.38706630104479006,PSMD5,1
R-HSA-438064,Post NMDA receptor activation events,1/43,80/10899,0.2719631339913702,0.41189437305746934,0.38962178619423204,PRKAR1A,1
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,1/43,81/10899,0.2748567087430448,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/43,82/10899,0.2777390494274644,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-9013694,Signaling by NOTCH4,1/43,82/10899,0.2777390494274644,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-76002,"Platelet activation, signaling and aggregation",2/43,263/10899,0.27823865688914273,0.4129948487834252,0.3906627553019855,ITGB3/HSPA5,2
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),1/43,83/10899,0.28061019862545056,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/43,83/10899,0.28061019862545056,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/43,83/10899,0.28061019862545056,0.4129948487834252,0.3906627553019855,PSMD5,1
R-HSA-6802957,Oncogenic MAPK signaling,1/43,84/10899,0.2834701987603534,0.41306904591302207,0.3907329403301262,ITGB3,1
R-HSA-216083,Integrin cell surface interactions,1/43,85/10899,0.2863190920986153,0.41306904591302207,0.3907329403301262,ITGB3,1
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",1/43,85/10899,0.2863190920986153,0.41306904591302207,0.3907329403301262,SLC39A14,1
R-HSA-5632684,Hedgehog 'on' state,1/43,85/10899,0.2863190920986153,0.41306904591302207,0.3907329403301262,PSMD5,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/43,85/10899,0.2863190920986153,0.41306904591302207,0.3907329403301262,PSMD5,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/43,86/10899,0.28915692075034105,0.4138912787210764,0.39151071209953303,ACTR3,1
R-HSA-6794362,Protein-protein interactions at synapses,1/43,86/10899,0.28915692075034105,0.4138912787210764,0.39151071209953303,PPFIBP1,1
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,1/43,88/10899,0.2947995516562798,0.41460160165738363,0.39218262536012066,PSMD5,1
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/43,88/10899,0.2947995516562798,0.41460160165738363,0.39218262536012066,PSMD5,1
R-HSA-453276,Regulation of mitotic cell cycle,1/43,88/10899,0.2947995516562798,0.41460160165738363,0.39218262536012066,PSMD5,1
R-HSA-9013404,RAC2 GTPase cycle,1/43,88/10899,0.2947995516562798,0.41460160165738363,0.39218262536012066,STBD1,1
R-HSA-6798695,Neutrophil degranulation,3/43,482/10899,0.29598892777263647,0.41460160165738363,0.39218262536012066,STBD1/CLEC5A/SLC2A3,3
R-HSA-3371556,Cellular response to heat stress,1/43,89/10899,0.29760443735406716,0.41460160165738363,0.39218262536012066,HSPA5,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/43,89/10899,0.29760443735406716,0.41460160165738363,0.39218262536012066,PSMD5,1
R-HSA-1236974,ER-Phagosome pathway,1/43,90/10899,0.30039842525358385,0.41532358036953826,0.392865564127494,PSMD5,1
R-HSA-1474290,Collagen formation,1/43,90/10899,0.30039842525358385,0.41532358036953826,0.392865564127494,LOXL1,1
R-HSA-111885,Opioid Signalling,1/43,92/10899,0.3059538728521144,0.418251549030044,0.39563520715747497,PRKAR1A,1
R-HSA-4086400,PCP/CE pathway,1/43,92/10899,0.3059538728521144,0.418251549030044,0.39563520715747497,PSMD5,1
R-HSA-69052,Switching of origins to a post-replicative state,1/43,92/10899,0.3059538728521144,0.418251549030044,0.39563520715747497,PSMD5,1
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,1/43,93/10899,0.30871541476636966,0.42045196414076463,0.3977166380336577,PRKAR1A,1
R-HSA-381119,Unfolded Protein Response (UPR),1/43,94/10899,0.31146622331394047,0.42105619077625284,0.3982881919959941,HSPA5,1
R-HSA-9013423,RAC3 GTPase cycle,1/43,94/10899,0.31146622331394047,0.42105619077625284,0.3982881919959941,STBD1,1
R-HSA-202424,Downstream TCR signaling,1/43,98/10899,0.32236293614248734,0.4296051887514543,0.40637491538710024,PSMD5,1
R-HSA-5619102,SLC transporter disorders,1/43,98/10899,0.32236293614248734,0.4296051887514543,0.40637491538710024,SLC33A1,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/43,99/10899,0.3250606857717696,0.4296051887514543,0.40637491538710024,ITGB3,1
R-HSA-9679191,Potential therapeutics for SARS,1/43,99/10899,0.3250606857717696,0.4296051887514543,0.40637491538710024,IFNAR1,1
R-HSA-71387,Metabolism of carbohydrates,2/43,295/10899,0.32517842928965424,0.4296051887514543,0.40637491538710024,GBE1/PRPS2,2
R-HSA-5688426,Deubiquitination,2/43,298/10899,0.32955162351104206,0.4296051887514543,0.40637491538710024,BIRC3/PSMD5,2
R-HSA-9694516,SARS-CoV-2 Infection,2/43,298/10899,0.32955162351104206,0.4296051887514543,0.40637491538710024,SEC24A/IFNAR1,2
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/43,101/10899,0.33042475111623426,0.4296051887514543,0.40637491538710024,PSMD5,1
R-HSA-6807878,COPI-mediated anterograde transport,1/43,101/10899,0.33042475111623426,0.4296051887514543,0.40637491538710024,USO1,1
R-HSA-9006931,Signaling by Nuclear Receptors,2/43,299/10899,0.33100788062495246,0.4296051887514543,0.40637491538710024,ESR2/NRIP1,2
R-HSA-1474244,Extracellular matrix organization,2/43,300/10899,0.33246337291343764,0.4296051887514543,0.40637491538710024,LOXL1/ITGB3,2
R-HSA-5689603,UCH proteinases,1/43,102/10899,0.333091146347018,0.4296051887514543,0.40637491538710024,PSMD5,1
R-HSA-9755511,KEAP1-NFE2L2 pathway,1/43,102/10899,0.333091146347018,0.4296051887514543,0.40637491538710024,PSMD5,1
R-HSA-382556,ABC-family proteins mediated transport,1/43,103/10899,0.33574716938184945,0.4315060451562502,0.4081729857570297,PSMD5,1
R-HSA-1236975,Antigen processing-Cross presentation,1/43,105/10899,0.34102825627977174,0.43522836902838,0.4116940304003134,PSMD5,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/43,105/10899,0.34102825627977174,0.43522836902838,0.4116940304003134,BIRC3,1
R-HSA-163685,Integration of energy metabolism,1/43,108/10899,0.3488730751873833,0.44061824374877134,0.4167924555143389,PRKAR1A,1
R-HSA-194138,Signaling by VEGF,1/43,108/10899,0.3488730751873833,0.44061824374877134,0.4167924555143389,ITGB3,1
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,1/43,108/10899,0.3488730751873833,0.44061824374877134,0.4167924555143389,SLC4A7,1
R-HSA-156580,Phase II - Conjugation of compounds,1/43,109/10899,0.3514676871572602,0.4423645028013792,0.41844428815819,SLC35D1,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/43,110/10899,0.3540521996180793,0.4425652495225991,0.41863417979354733,BIRC3,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/43,110/10899,0.3540521996180793,0.4425652495225991,0.41863417979354733,BIRC3,1
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/43,112/10899,0.35919107938951544,0.44745646408591516,0.4232609090704547,PSMD5,1
R-HSA-9020702,Interleukin-1 signaling,1/43,115/10899,0.36682460761008073,0.4554115026451682,0.4307857905338578,PSMD5,1
R-HSA-373760,L1CAM interactions,1/43,119/10899,0.37686461980406105,0.46629012280841453,0.4410761651944052,ITGB3,1
R-HSA-202403,TCR signaling,1/43,120/10899,0.3793502247528947,0.4677798379554276,0.4424853261698061,PSMD5,1
R-HSA-69239,Synthesis of DNA,1/43,121/10899,0.3818261446281732,0.46924761881913546,0.4438737389262478,PSMD5,1
R-HSA-2132295,MHC class II antigen presentation,1/43,123/10899,0.38674907639115264,0.4737027277945326,0.4480879443881952,SEC24A,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/43,124/10899,0.38919616155403147,0.4751056821646204,0.44941503604901367,SLC2A3,1
R-HSA-1483206,Glycerophospholipid biosynthesis,1/43,129/10899,0.40128923348536116,0.48628074157008566,0.45998582043255404,PCYT1A,1
R-HSA-162909,Host Interactions of HIV factors,1/43,130/10899,0.4036796293033862,0.48628074157008566,0.45998582043255404,PSMD5,1
R-HSA-6809371,Formation of the cornified envelope,1/43,130/10899,0.4036796293033862,0.48628074157008566,0.45998582043255404,PERP,1
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,1/43,130/10899,0.4036796293033862,0.48628074157008566,0.45998582043255404,PSMD5,1
R-HSA-69206,G1/S Transition,1/43,131/10899,0.40606070237794767,0.48753998805247,0.46117697499988525,PSMD5,1
R-HSA-5576891,Cardiac conduction,1/43,132/10899,0.408432488206119,0.4887798629351916,0.462349805458523,WWTR1,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/43,134/10899,0.41314833945269236,0.49280765980468205,0.4661598050928211,PSMD5,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/43,137/10899,0.42015334184422815,0.4995308461665905,0.47251944496796444,ITGB3,1
R-HSA-6807070,PTEN Regulation,1/43,140/10899,0.4270766503118375,0.5061135628695477,0.47874621087588076,PSMD5,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/43,142/10899,0.4316472636147387,0.5082298426431601,0.480748055910473,PSMD5,1
R-HSA-68875,Mitotic Prophase,1/43,142/10899,0.4316472636147387,0.5082298426431601,0.480748055910473,USO1,1
R-HSA-68867,Assembly of the pre-replicative complex,1/43,143/10899,0.4339191951629925,0.5092620779244125,0.4817244745759402,PSMD5,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/43,146/10899,0.44068189636660204,0.5106314037263802,0.48301975608436254,BIRC3,1
R-HSA-3858494,Beta-catenin independent WNT signaling,1/43,146/10899,0.44068189636660204,0.5106314037263802,0.48301975608436254,PSMD5,1
R-HSA-73887,Death Receptor Signalling,1/43,146/10899,0.44068189636660204,0.5106314037263802,0.48301975608436254,BIRC3,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/43,146/10899,0.44068189636660204,0.5106314037263802,0.48301975608436254,ACTR3,1
R-HSA-8980692,RHOA GTPase cycle,1/43,147/10899,0.44291854460023317,0.5115989518325478,0.4839349854392954,STBD1,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/43,149/10899,0.4473656636650659,0.5151055748824891,0.4872519929674302,PSMD5,1
R-HSA-9018519,Estrogen-dependent gene expression,1/43,150/10899,0.44957620101040574,0.5160229980150883,0.48811980778355873,NRIP1,1
R-HSA-8957322,Metabolism of steroids,1/43,154/10899,0.4583323060490452,0.5244241119369953,0.4960666437356437,SEC24A,1
R-HSA-9711097,Cellular response to starvation,1/43,156/10899,0.46265919024523305,0.527720638873469,0.4991849157909094,ATP6V1A,1
R-HSA-418555,G alpha (s) signalling events,1/43,157/10899,0.46480995398156855,0.5285222218170483,0.4999431543071142,PRKAR1A,1
R-HSA-69002,DNA Replication Pre-Initiation,1/43,160/10899,0.4712119180167077,0.5341377331555849,0.5052550150685851,PSMD5,1
R-HSA-69242,S Phase,1/43,163/10899,0.47753906162026893,0.5396339241219757,0.5104540075328278,PSMD5,1
R-HSA-112316,Neuronal System,2/43,410/10899,0.4849036235593768,0.5439203147570665,0.5145086178523945,PPFIBP1/PRKAR1A,2
R-HSA-69481,G2/M Checkpoints,1/43,167/10899,0.4858603401760716,0.5439203147570665,0.5145086178523945,PSMD5,1
R-HSA-168898,Toll-like Receptor Cascades,1/43,168/10899,0.4879203481310128,0.5439203147570665,0.5145086178523945,BIRC3,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/43,168/10899,0.4879203481310128,0.5439203147570665,0.5145086178523945,PRKAR1A,1
R-HSA-9679506,SARS-CoV Infections,2/43,413/10899,0.48878318695977485,0.5439203147570665,0.5145086178523945,SEC24A/IFNAR1,2
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,1/43,171/10899,0.49405211919192293,0.5477328480323662,0.5181149939570762,PSMD5,1
R-HSA-68886,M Phase,2/43,418/10899,0.4952105201388517,0.5477328480323662,0.5181149939570762,PSMD5/USO1,2
R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,1/43,178/10899,0.508082027333822,0.5602717219844261,0.5299758466067535,LDHA,1
R-HSA-109581,Apoptosis,1/43,180/10899,0.5120202860928014,0.5629138687466039,0.5324751231402628,PSMD5,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/43,182/10899,0.5159277429488727,0.5655063849139296,0.5349274527808764,NRIP1,1
R-HSA-983712,Ion channel transport,1/43,186/10899,0.5236511900624412,0.5722535460263204,0.5413097710068728,ATP6V1A,1
R-HSA-2990846,SUMOylation,1/43,188/10899,0.5274676455059512,0.5729931268145004,0.5420093600437093,NRIP1,1
R-HSA-69306,DNA Replication,1/43,188/10899,0.5274676455059512,0.5729931268145004,0.5420093600437093,PSMD5,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/43,190/10899,0.5312542294439627,0.5753940467271407,0.5442804537173818,SLC2A3,1
R-HSA-2467813,Separation of Sister Chromatids,1/43,191/10899,0.5331363910028304,0.5757242092190329,0.5445927631545574,PSMD5,1
R-HSA-9711123,Cellular response to chemical stress,1/43,194/10899,0.5387386942247787,0.5800578861122249,0.5486921027968559,PSMD5,1
R-HSA-69275,G2/M Transition,1/43,196/10899,0.5424370265348251,0.5823221020153269,0.5508338845307201,PSMD5,1
R-HSA-453274,Mitotic G2-G2/M phases,1/43,198/10899,0.5461063902985288,0.5845420306714457,0.5529337737858232,PSMD5,1
R-HSA-913531,Interferon Signaling,1/43,200/10899,0.5497470070614674,0.5867182970100455,0.5549923616994809,IFNAR1,1
R-HSA-5617833,Cilium Assembly,1/43,201/10899,0.5515566040982329,0.5869334125243586,0.5551958451564228,PKD2,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/43,202/10899,0.5533590967158974,0.5871397392479727,0.5553910150636915,GOLGA5,1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/43,205/10899,0.5587242198472415,0.5911140296934584,0.5591504015557444,PRKAR1A,1
R-HSA-449147,Signaling by Interleukins,2/43,473/10899,0.5625805356699927,0.5934736864726801,0.5613824633396947,PTPN14/PSMD5,2
R-HSA-1483257,Phospholipid metabolism,1/43,212/10899,0.5709992203659985,0.6006187764656756,0.5681411930230472,PCYT1A,1
R-HSA-6805567,Keratinization,1/43,214/10899,0.5744446740262517,0.6025066264930513,0.5699269603164263,PERP,1
R-HSA-376176,Signaling by ROBO receptors,1/43,218/10899,0.5812546889716281,0.6079024684087228,0.5750310299583594,PSMD5,1
R-HSA-211859,Biological oxidations,1/43,222/10899,0.5879582202995883,0.6131564297409993,0.5800008910023007,SLC35D1,1
R-HSA-162906,HIV Infection,1/43,231/10899,0.6026602179125649,0.626697947401955,0.5928101708661607,PSMD5,1
R-HSA-201681,TCF dependent signaling in response to WNT,1/43,233/10899,0.6058570635040468,0.6282324664175485,0.5942617130063618,PSMD5,1
R-HSA-157118,Signaling by NOTCH,1/43,236/10899,0.6106052787819857,0.6294199481800593,0.5953849834262711,PSMD5,1
R-HSA-68882,Mitotic Anaphase,1/43,236/10899,0.6106052787819857,0.6294199481800593,0.5953849834262711,PSMD5,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/43,237/10899,0.6121755660381399,0.6294199481800593,0.5953849834262711,PSMD5,1
R-HSA-8878171,Transcriptional regulation by RUNX1,1/43,239/10899,0.615297607202458,0.6308528837890369,0.5967404351342585,PSMD5,1
R-HSA-112315,Transmission across Chemical Synapses,1/43,270/10899,0.6606631636827169,0.6754679404599206,0.6389429977530036,PRKAR1A,1
R-HSA-69620,Cell Cycle Checkpoints,1/43,293/10899,0.690901386760802,0.7044106317533316,0.6663206552706353,PSMD5,1
R-HSA-1852241,Organelle biogenesis and maintenance,1/43,296/10899,0.6946460604272109,0.7062557438883899,0.6680659956608274,PKD2,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/43,309/10899,0.7103673311140244,0.7202335440461636,0.6812879666824563,PSMD5,1
R-HSA-418594,G alpha (i) signalling events,1/43,318/10899,0.7207852242247437,0.7287717641053502,0.6893644949576204,PRKAR1A,1
R-HSA-195258,RHO GTPase Effectors,1/43,327/10899,0.7308367998724049,0.7368934584348834,0.6970470205238407,ACTR3,1
R-HSA-195721,Signaling by WNT,1/43,332/10899,0.7362673728140154,0.7403239423612001,0.7002920060402988,PSMD5,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/43,362/10899,0.7666731940033383,0.768779439041809,0.7272088132825189,PERP,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/43,374/10899,0.7778519838869201,0.7778519838869201,0.7357907735109152,PSMD5,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,7/28,200/4383,1.9361438965167813e-4,0.002807408649949333,0.002241850827545747,LDHA/STBD1/GBE1/AKAP12/PPP1R15A/SLC2A3/HSPA5,7
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,7/28,200/4383,1.9361438965167813e-4,0.002807408649949333,0.002241850827545747,LDHA/GBE1/ACTR3/PPP1R15A/SLC2A3/USO1/HSPA5,7
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,5/28,200/4383,0.007837690670231412,0.0757643431455703,0.06050147184038281,PTPN14/PPP1R15A/PERP/SLC35D1/DNTTIP2,5
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,4/28,200/4383,0.036490681091914105,0.17637162527758482,0.1408412252670369,LOXL1/PDLIM4/ITGB3/TPM1,4
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,4/28,200/4383,0.036490681091914105,0.17637162527758482,0.1408412252670369,MET/CLEC5A/ITGB3/IFNAR1,4
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,4/28,200/4383,0.036490681091914105,0.17637162527758482,0.1408412252670369,BIRC3/PPP1R15A/SLC2A3/DUSP5,4
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,2/28,54/4383,0.04591589307468126,0.19022298559510809,0.15190220265308085,PPP1R15A/WWTR1,2
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,3/28,144/4383,0.06250986116935466,0.22659824673891063,0.1809495981218161,RASA2/MET/ITGB3,3
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,2/28,87/4383,0.10564619864861918,0.34041552897888405,0.2718381719613593,ITGB3/IFNAR1,2
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,3/28,200/4383,0.13327670112340934,0.35136584841626095,0.2805825286808617,LDHA/MET/HSPA5,3
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,3/28,200/4383,0.13327670112340934,0.35136584841626095,0.2805825286808617,AKAP12/BIRC3/PPP1R15A,3
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,2/28,199/4383,0.3654514730220385,0.7110735672938266,0.567826442122112,RASA2/PKD2,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/28,200/4383,0.36779667273818617,0.7110735672938266,0.567826442122112,HSPA5/DUSP5,2
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,2/28,200/4383,0.36779667273818617,0.7110735672938266,0.567826442122112,PERP/NRIP1,2
HALLMARK_MYC_TARGETS_V1,HALLMARK_MYC_TARGETS_V1,2/28,200/4383,0.36779667273818617,0.7110735672938266,0.567826442122112,LDHA/PRPS2,2
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/28,96/4383,0.4631486308178452,0.7306850114698548,0.5834871234967987,USO1,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/28,100/4383,0.4770421420567632,0.7306850114698548,0.5834871234967987,AKAP12,1
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,1/28,104/4383,0.49058861441397195,0.7306850114698548,0.5834871234967987,ESR2,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/28,105/4383,0.4939219910899263,0.7306850114698548,0.5834871234967987,ACTR3,1
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,1/28,113/4383,0.5198422805900142,0.7306850114698548,0.5834871234967987,HSPA5,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/28,138/4383,0.5928527879106713,0.7306850114698548,0.5834871234967987,ITGB3,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/28,158/4383,0.6434338356553777,0.7306850114698548,0.5834871234967987,LDHA,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/28,161/4383,0.6504777407425946,0.7306850114698548,0.5834871234967987,BIRC3,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,1/28,199/4383,0.7288705697761964,0.7306850114698548,0.5834871234967987,SLC2A3,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.5834871234967987,GBE1,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.5834871234967987,NRIP1,1
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.5834871234967987,WWTR1,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.5834871234967987,LDHA,1
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,1/28,200/4383,0.7306850114698548,0.7306850114698548,0.5834871234967987,SLC35D1,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,11/56,481/21728,3.3858057440057e-8,5.413903384665115e-5,4.2162191527986776e-5,ACBD3/GBE1/ACTR3/BIRC3/SLC2A3/PSMD5/PRKAR1A/WWTR1/ATP6V1A/DUSP5/PKD2,11
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,5/56,48/21728,1.490551141904659e-7,8.259072737408577e-5,6.431969354764061e-5,AKAP12/SLC4A7/EFNB2/SLC2A3/DUSP5,5
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,7/56,157/21728,1.549544603641384e-7,8.259072737408577e-5,6.431969354764061e-5,ACBD3/GBE1/AKAP12/PPP1R15A/PDLIM4/SLC39A14/HSPA5,7
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,8/56,407/21728,9.157009784716637e-6,0.0036605146614404754,0.002850721730347311,LOXL1/MCFD2/PRPS2/SLC33A1/SEC24A/SLC39A14/FNDC3B/PKD2,8
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,8/56,437/21728,1.5316230173255568e-5,0.0041554879747753935,0.0032361951707707386,ACBD3/ACTR3/PTPN14/BIRC3/LOXL1/SLC2A3/PRKAR1A/HSPA5,8
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,5/56,123/21728,1.6243008014380318e-5,0.0041554879747753935,0.0032361951707707386,AKAP12/EHBP1/SH3GLB1/SLC39A14/WWTR1,5
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,6/56,215/21728,1.8814682347804497e-5,0.0041554879747753935,0.0032361951707707386,ACBD3/TMCO3/PPP1R15A/SH3GLB1/GOLGA5/HSPA5,6
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,8/56,456/21728,2.079043389506138e-5,0.0041554879747753935,0.0032361951707707386,BIRC3/MET/PERP/EHBP1/SH3GLB1/ZBTB38/WWTR1/FNDC3B,8
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,8/56,466/21728,2.427814232799761e-5,0.004313416620274242,0.003359186242575576,AKAP12/MET/LOXL1/MCFD2/EHBP1/SH3GLB1/TPM1/WWTR1,8
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,6/56,232/21728,2.887225939307141e-5,0.004616674276952119,0.0035953560907372078,BIRC3/RASA2/PPP1R15A/PPFIBP1/ZBTB38/DUSP5,6
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,5/56,146/21728,3.707497454218924e-5,0.004968783768773277,0.0038695705858653676,ACBD3/NRBF2/SH3GLB1/WWTR1/FNDC3B,5
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,8/56,495/21728,3.7289184005803204e-5,0.004968783768773277,0.0038695705858653676,BIRC3/MET/PDLIM4/SLC2A3/ITGB3/PPFIBP1/ZBTB38/ATP6V1A,8
DORSEY_GAB2_TARGETS,DORSEY_GAB2_TARGETS,3/56,30/21728,6.266437947812515e-5,0.007707718675809393,0.006002587928957251,AKAP12/ITGB3/DUSP5,3
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,7/56,401/21728,7.364872363230932e-5,0.008411736363433042,0.006550860154663302,LDHA/RECQL/GBE1/ACTR3/RASA2/NRIP1/SEC24A,7
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,5/56,172/21728,8.081533463039877e-5,0.008614914671600507,0.00670909058721135,STBD1/GBE1/AKAP12/MET/LOXL1,5
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,5/56,178/21728,9.500164436668366e-5,0.009494226833895449,0.007393877979328078,LDHA/PTPN14/PERP/SLC2A3/DUSP5,5
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,7/56,451/21728,1.5272855132983986e-4,0.013553890850839382,0.010555447731505211,BIRC3/MET/PDLIM4/SLC39A14/PPFIBP1/ZBTB38/DUSP5,7
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,4/56,105/21728,1.5588878228958315e-4,0.013553890850839382,0.010555447731505211,STBD1/GBE1/AKAP12/LOXL1,4
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,3/56,42/21728,1.7334815945898373e-4,0.013553890850839382,0.010555447731505211,PPP1R15A/SLC2A3/DUSP5,3
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,5/56,204/21728,1.7984908994381755e-4,0.013553890850839382,0.010555447731505211,BIRC3/PPP1R15A/EFNB2/HSPA5/DUSP5,5
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,5/56,205/21728,1.8398606737277017e-4,0.013553890850839382,0.010555447731505211,GBE1/SLC2A3/SEC24A/TPM1/FNDC3B,5
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,4/56,110/21728,1.864825507932873e-4,0.013553890850839382,0.010555447731505211,AKAP12/PERP/EHBP1/DUSP5,4
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,4/56,116/21728,2.286545639747812e-4,0.015234110324819796,0.01186396268342834,NRBF2/SLC4A7/NRIP1/FNDC3B,4
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,4/56,116/21728,2.286545639747812e-4,0.015234110324819796,0.01186396268342834,BIRC3/PDLIM4/DUSP5/PKD2,4
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,3/56,48/21728,2.583260010375498e-4,0.016522531026361684,0.012867354072733532,SH3GLB1/TPM1/HSPA5,3
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,5/56,235/21728,3.456933830627799e-4,0.019530753970036882,0.015210086532078363,SLC4A7/PDLIM4/NRIP1/SLC2A3/EHBP1,5
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,3/56,53/21728,3.467049969277903e-4,0.019530753970036882,0.015210086532078363,STBD1/AKAP12/SLC4A7,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,2/56,11/21728,3.5352194264898283e-4,0.019530753970036882,0.015210086532078363,SLC35D1/EFNB2,2
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,6/56,368/21728,3.6028690043052005e-4,0.019530753970036882,0.015210086532078363,LDHA/GBE1/AKAP12/PRPS2/EHBP1/PKD2,6
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,3/56,54/21728,3.66430656098253e-4,0.019530753970036882,0.015210086532078363,EFNB2/FNDC3B/ATP6V1A,3
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,4/56,133/21728,3.851278037982782e-4,0.019865140589466024,0.015470498875835757,STBD1/GBE1/AKAP12/MET,4
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,5/56,243/21728,4.029279815328532e-4,0.019918107381788227,0.01551174815355352,LDHA/GBE1/MET/SLC2A3/HSPA5,5
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,5/56,245/21728,4.1829380988937207e-4,0.019918107381788227,0.01551174815355352,ACBD3/PPP1R15A/FEM1B/SLC33A1/GOLGA5,5
BIOCARTA_CBL_PATHWAY,BIOCARTA_CBL_PATHWAY,2/56,12/21728,4.23524484665916e-4,0.019918107381788227,0.01551174815355352,MET/SH3GLB1,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,6/56,383/21728,4.452589084479217e-4,0.02000307264485763,0.015577917079007656,LDHA/NRBF2/PERP/PCYT1A/LRRC8E/GOLGA5,6
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,5/56,249/21728,4.5035060363656957e-4,0.02000307264485763,0.015577917079007656,SLC4A7/SLC35D1/SLC2A3/SLC33A1/SLC39A14,5
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,3/56,59/21728,4.758995869802689e-4,0.02033813561222551,0.015838856146448622,BIRC3/SLC4A7/NRIP1,3
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,6/56,389/21728,4.833328037927263e-4,0.02033813561222551,0.015838856146448622,AKAP12/BIRC3/MOXD1/TPM1/PRKAR1A/DUSP5,6
HASINA_NOL7_TARGETS_DN,HASINA_NOL7_TARGETS_DN,2/56,13/21728,4.997009979282351e-4,0.020487740915057638,0.015955365197006806,MET/EML1,2
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,3/56,62/21728,5.506289965596162e-4,0.02201139413747066,0.01714195007710595,BIRC3/PPP1R15A/DUSP5,3
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,3/56,68/21728,7.217180224563985e-4,0.02814700287579954,0.02192021618911218,MCFD2/SEC24A/USO1,3
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,2/56,16/21728,7.649634650622572e-4,0.029123251919870217,0.022680495718512536,ITGB3/IFNAR1,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,6/56,428/21728,7.968444303614112e-4,0.02939394532901312,0.022891305305435976,PPP1R15A/MET/MOXD1/NRIP1/MCFD2/SLC2A3,6
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,6/56,432/21728,8.362439439745927e-4,0.02939394532901312,0.022891305305435976,ESR2/MET/ITGB3/PSMD5/PPFIBP1/PRKAR1A,6
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,5/56,286/21728,8.421096946126932e-4,0.02939394532901312,0.022891305305435976,HIVEP3/BIRC3/PPP1R15A/EFNB2/ITGB3,5
KIM_HYPOXIA,KIM_HYPOXIA,2/56,17/21728,8.655255345922639e-4,0.02939394532901312,0.022891305305435976,LDHA/PDLIM4,2
KORKOLA_TERATOMA_UP,KORKOLA_TERATOMA_UP,2/56,17/21728,8.655255345922639e-4,0.02939394532901312,0.022891305305435976,RECQL/SLC2A3,2
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,5/56,289/21728,8.823698410210317e-4,0.02939394532901312,0.022891305305435976,AKAP12/SLC35D1/EFNB2/PPFIBP1/PKD2,5
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,5/56,293/21728,9.382646169006718e-4,0.030478412996993463,0.023735862924487854,PPP1R15A/SLC33A1/PPFIBP1/ZBTB38/HSPA5,5
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,3/56,75/21728,9.601111836201819e-4,0.030478412996993463,0.023735862924487854,MET/SLC4A7/WWTR1,3
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,2/56,18/21728,9.721069811423807e-4,0.030478412996993463,0.023735862924487854,MET/SLC2A3,2
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,3/56,78/21728,0.0010758057900983596,0.03260270620954835,0.025390211938972188,AKAP12/WWTR1/ATP6V1A,3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,6/56,454/21728,0.0010806400432183006,0.03260270620954835,0.025390211938972188,STBD1/AKAP12/PPP1R15A/SLC39A14/FNDC3B/DUSP5,6
SCHUHMACHER_MYC_TARGETS_UP,SCHUHMACHER_MYC_TARGETS_UP,3/56,80/21728,0.0011576213112556573,0.03427845327218141,0.026695243883341963,LDHA/PRPS2/SLC39A14,3
BIOCARTA_STATHMIN_PATHWAY,BIOCARTA_STATHMIN_PATHWAY,2/56,20/21728,0.00120320580588435,0.03435582292159064,0.026755497525586206,PRKAR1A/HSPA5,2
KORKOLA_YOLK_SAC_TUMOR_UP,KORKOLA_YOLK_SAC_TUMOR_UP,2/56,20/21728,0.00120320580588435,0.03435582292159064,0.026755497525586206,RECQL/SLC2A3,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,6/56,466/21728,0.0012352921597972013,0.03458486982952228,0.026933873808185946,GBE1/SLC4A7/NRIP1/EHBP1/SEC24A/PKD2,6
WU_CELL_MIGRATION,WU_CELL_MIGRATION,4/56,183/21728,0.0012708817021270388,0.03458486982952228,0.026933873808185946,AKAP12/PERP/EFNB2/WWTR1,4
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,5/56,314/21728,0.0012761146466177702,0.03458486982952228,0.026933873808185946,BIRC3/PCYT1A/SLC33A1/PSMD5/ATP6V1A,5
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,3/56,84/21728,0.0013328052067095178,0.035519258758808646,0.02766155367609403,BIRC3/SLC39A14/DUSP5,3
LANDIS_ERBB2_BREAST_TUMORS_65_UP,LANDIS_ERBB2_BREAST_TUMORS_65_UP,2/56,22/21728,0.0014580166658099028,0.0370058515655561,0.028819276786184043,PERP/ATP6V1A,2
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,2/56,22/21728,0.0014580166658099028,0.0370058515655561,0.028819276786184043,STBD1/PPP1R15A,2
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,2/56,22/21728,0.0014580166658099028,0.0370058515655561,0.028819276786184043,LDHA/SLC2A3,2
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,5/56,327/21728,0.0015259983054976903,0.038126113913918853,0.02969171045071986,RASA2/MET/ITGB3/PSMD5/DUSP5,5
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,4/56,195/21728,0.0016048033859550092,0.038686340890064154,0.03012800189127803,HIVEP3/PPP1R15A/ITGB3/DUSP5,4
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,6/56,491/21728,0.0016116894132054374,0.038686340890064154,0.03012800189127803,AKAP12/MET/PDLIM4/SH3GLB1/TPM1/PKD2,6
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,3/56,90/21728,0.0016254504651138438,0.038686340890064154,0.03012800189127803,RECQL/WWTR1/FNDC3B,3
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,6/56,493/21728,0.0016451977364129846,0.038686340890064154,0.03012800189127803,TMCO3/LOXL1/EML1/EFNB2/PCYT1A/PKD2,6
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,4/56,199/21728,0.0017284918079241275,0.0395459778824744,0.030797466729184174,PPP1R15A/PERP/SLC2A3/TPM1,4
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,3/56,92/21728,0.0017312185439482227,0.0395459778824744,0.030797466729184174,STBD1/GBE1/LOXL1,3
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,4/56,200/21728,0.0017604200563614651,0.03964664324115469,0.030875862515576183,STBD1/AKAP12/PPP1R15A/HSPA5,4
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,3/56,94/21728,0.0018411988834079421,0.04071324683359478,0.031706508017604836,BIRC3/NRIP1/PPFIBP1,3
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,2/56,25/21728,0.0018841652693471003,0.04071324683359478,0.031706508017604836,SEC24A/HSPA5,2
WP_UNFOLDED_PROTEIN_RESPONSE,WP_UNFOLDED_PROTEIN_RESPONSE,2/56,25/21728,0.0018841652693471003,0.04071324683359478,0.031706508017604836,PPP1R15A/HSPA5,2
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,5/56,353/21728,0.002131695309751463,0.04544774400390119,0.03539362177454008,LOXL1/EML1/SLC2A3/WWTR1/PKD2,5
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,3/56,100/21728,0.0021970038557571426,0.04622380480731146,0.03599799946482963,GBE1/PPP1R15A/SLC2A3,3
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,4/56,216/21728,0.0023285959126985363,0.04835616707019428,0.037658632463737095,AKAP12/PDLIM4/WWTR1/DUSP5,4
LEE_DOUBLE_POLAR_THYMOCYTE,LEE_DOUBLE_POLAR_THYMOCYTE,2/56,28/21728,0.0023623155406567956,0.04842746858346431,0.03771416038592428,TBC1D19/EFNB2,2
WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,2/56,29/21728,0.0025331166111434255,0.051271562800232116,0.03992907329757058,PPP1R15A/HSPA5,2
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,4/56,223/21728,0.0026128395098207495,0.05157874283630064,0.04016829780148359,NRBF2/BIRC3/SEC24A/DUSP5,4
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,3/56,107/21728,0.002662750966570062,0.05157874283630064,0.04016829780148359,AKAP12/NRIP1/EHBP1,3
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,3/56,107/21728,0.002662750966570062,0.05157874283630064,0.04016829780148359,RECQL/AKAP12/RASA2,3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,2/56,30/21728,0.0027095774848338045,0.05157874283630064,0.04016829780148359,SLC4A7/SEC24A,2
PID_EPHRINB_REV_PATHWAY,PID_EPHRINB_REV_PATHWAY,2/56,30/21728,0.0027095774848338045,0.05157874283630064,0.04016829780148359,EFNB2/ITGB3,2
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,2/56,32/21728,0.003079361755797143,0.05659654537378887,0.04407604303820956,BIRC3/PPP1R15A,2
NOJIMA_SFRP2_TARGETS_UP,NOJIMA_SFRP2_TARGETS_UP,2/56,32/21728,0.003079361755797143,0.05659654537378887,0.04407604303820956,PPP1R15A/HSPA5,2
WP_OVARIAN_INFERTILITY,WP_OVARIAN_INFERTILITY,2/56,32/21728,0.003079361755797143,0.05659654537378887,0.04407604303820956,ESR2/NRIP1,2
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,2/56,33/21728,0.0032726269809216432,0.058143672694374524,0.04528090898748893,EHBP1/WWTR1,2
REACTOME_CARGO_CONCENTRATION_IN_THE_ER,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,2/56,33/21728,0.0032726269809216432,0.058143672694374524,0.04528090898748893,MCFD2/SEC24A,2
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,2/56,33/21728,0.0032726269809216432,0.058143672694374524,0.04528090898748893,MCFD2/DUSP5,2
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,2/56,34/21728,0.0034714356642564217,0.060998083814791416,0.04750385645824577,AKAP12/PPP1R15A,2
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,2/56,35/21728,0.0036757589890276873,0.06259569051474213,0.04874803454721039,MET/ITGB3,2
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,2/56,35/21728,0.0036757589890276873,0.06259569051474213,0.04874803454721039,AKAP12/SLC4A7,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,3/56,120/21728,0.003679796690672771,0.06259569051474213,0.04874803454721039,HIVEP3/PSMD5/WWTR1,3
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,2/56,36/21728,0.0038855682455585148,0.06434658135927485,0.05011158668116398,PRKAR1A/ATP6V1A,2
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,2/56,36/21728,0.0038855682455585148,0.06434658135927485,0.05011158668116398,LDHA/SLC2A3,2
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,3/56,123/21728,0.00394369291632829,0.06434658135927485,0.05011158668116398,PPP1R15A/EFNB2/SLC2A3,3
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,3/56,123/21728,0.00394369291632829,0.06434658135927485,0.05011158668116398,MET/ITGB3/PRKAR1A,3
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,4/56,251/21728,0.003988886664330804,0.06442656339661572,0.050173874788977585,AKAP12/PPP1R15A/PERP/TPM1,4
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,3/56,124/21728,0.004034155277750922,0.06450614289123725,0.050235849406098335,SLC2A3/DNTTIP2/TPM1,3
WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,2/56,37/21728,0.004100834830924154,0.06467915908883583,0.05037059030452769,LDHA/SLC2A3,2
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,3/56,125/21728,0.0041258750638281765,0.06467915908883583,0.05037059030452769,BIRC3/PERP/DUSP5,3
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,3/56,126/21728,0.004218857547721974,0.06487250032311105,0.050521159857964106,STBD1/PTPN14/LOXL1,3
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,5/56,414/21728,0.004219349614511288,0.06487250032311105,0.050521159857964106,TMCO3/SLC4A7/SLC39A14/PPFIBP1/DUSP5,5
GENTILE_UV_RESPONSE_CLUSTER_D2,GENTILE_UV_RESPONSE_CLUSTER_D2,2/56,38/21728,0.004321530248608372,0.06518987610872441,0.050768324569053676,NRIP1/DUSP5,2
STONER_ESOPHAGEAL_CARCINOGENESIS_UP,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,2/56,38/21728,0.004321530248608372,0.06518987610872441,0.050768324569053676,PPP1R15A/USO1,2
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,5/56,423/21728,0.004619443694446649,0.06903262119084291,0.053760963015547315,AKAP12/LOXL1/EFNB2/WWTR1/PKD2,5
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,5/56,425/21728,0.0047119082143749205,0.06976241884060647,0.05432931206243208,SLC2A3/SLC33A1/IFNAR1/TPM1/FNDC3B,5
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,2/56,40/21728,0.004779094124855223,0.07010799546461928,0.05459843891553576,AKAP12/MOXD1,2
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,4/56,265/21728,0.004832594094881897,0.07024834507014686,0.05470773984923717,MET/SLC4A7/NRIP1/TPM1,4
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,5/56,432/21728,0.005045954519797554,0.07268902051492152,0.05660847981906598,PTPN14/MET/MOXD1/PRPS2/TASP1,5
KORKOLA_EMBRYONAL_CARCINOMA_UP,KORKOLA_EMBRYONAL_CARCINOMA_UP,2/56,42/21728,0.005258034017343547,0.07375084555905555,0.05743540390136119,RECQL/SLC2A3,2
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,2/56,42/21728,0.005258034017343547,0.07375084555905555,0.05743540390136119,ACTR3/EFNB2,2
REACTOME_RHOF_GTPASE_CYCLE,REACTOME_RHOF_GTPASE_CYCLE,2/56,42/21728,0.005258034017343547,0.07375084555905555,0.05743540390136119,AKAP12/SLC4A7,2
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,3/56,137/21728,0.005326448315050013,0.07406079005013018,0.05767678129706331,MET/PERP/DUSP5,3
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,2/56,43/21728,0.005505449849245343,0.07577921775497556,0.05901505191016498,SLC35D1/SLC33A1,2
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,3/56,139/21728,0.005544820811339676,0.07577921775497556,0.05901505191016498,SLC33A1/WWTR1/DUSP5,3
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,3/56,140/21728,0.005655999887832538,0.07609291796674471,0.059259354171790915,PERP/SEC24A/SLC39A14,3
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,5/56,445/21728,0.005710540506001819,0.07609291796674471,0.059259354171790915,STBD1/NRBF2/PPP1R15A/SLC2A3/DUSP5,5
KAAB_FAILED_HEART_VENTRICLE_DN,KAAB_FAILED_HEART_VENTRICLE_DN,2/56,44/21728,0.0057581257498287115,0.07609291796674471,0.059259354171790915,LDHA/SLC39A14,2
KORKOLA_SEMINOMA_UP,KORKOLA_SEMINOMA_UP,2/56,44/21728,0.0057581257498287115,0.07609291796674471,0.059259354171790915,RECQL/SLC2A3,2
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,3/56,142/21728,0.005882365489844575,0.07695710638944357,0.05993236355532191,PDLIM4/SLC2A3/TPM1,3
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,2/56,45/21728,0.0060160339578989655,0.07695710638944357,0.05993236355532191,LOXL1/ITGB3,2
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/56,45/21728,0.0060160339578989655,0.07695710638944357,0.05993236355532191,PPP1R15A/DUSP5,2
WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,2/56,45/21728,0.0060160339578989655,0.07695710638944357,0.05993236355532191,LDHA/SLC2A3,2
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,3/56,145/21728,0.00623199614849157,0.07723350583626898,0.060147616868639085,MCFD2/SLC33A1/HSPA5,3
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,4/56,285/21728,0.0062350480046205106,0.07723350583626898,0.060147616868639085,HIVEP3/MCFD2/SEC24A/FNDC3B,4
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,2/56,46/21728,0.0062791468159568275,0.07723350583626898,0.060147616868639085,LOXL1/HSPA5,2
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,2/56,46/21728,0.0062791468159568275,0.07723350583626898,0.060147616868639085,LDHA/SH3GLB1,2
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,2/56,46/21728,0.0062791468159568275,0.07723350583626898,0.060147616868639085,BIRC3/NRIP1,2
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,2/56,47/21728,0.006547436769863779,0.07888677436665713,0.061435143066887445,AKAP12/TPM1,2
WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,2/56,47/21728,0.006547436769863779,0.07888677436665713,0.061435143066887445,PPP1R15A/HSPA5,2
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,3/56,148/21728,0.00659382422606012,0.07888677436665713,0.061435143066887445,TMCO3/PPP1R15A/DUSP5,3
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,5/56,461/21728,0.006610899165185775,0.07888677436665713,0.061435143066887445,AKAP12/BIRC3/MET/EFNB2/TPM1,5
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,2/56,48/21728,0.006820876368508387,0.08078949120922156,0.06291693367598769,AKAP12/TPM1,2
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,3/56,151/21728,0.006967956567167557,0.08192472463897738,0.06380102646253266,AKAP12/PERP/ATP6V1A,3
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,2/56,50/21728,0.007383095208705472,0.08617203823883247,0.06710873324547502,LDHA/BIRC3,2
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,3/56,155/21728,0.0074861158750679155,0.08674129916111302,0.06755206010835503,MCFD2/SEC24A/USO1,3
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,2/56,51/21728,0.007671820060181503,0.08762314483021588,0.06823882053529863,GBE1/EFNB2,2
ROESSLER_LIVER_CANCER_METASTASIS_DN,ROESSLER_LIVER_CANCER_METASTASIS_DN,2/56,51/21728,0.007671820060181503,0.08762314483021588,0.06823882053529863,SH3GLB1/WWTR1,2
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,2/56,52/21728,0.007965585775581967,0.08989605644165263,0.0700089100230243,NRIP1/PRKAR1A,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,3/56,159/21728,0.008026561138739039,0.08989605644165263,0.0700089100230243,CLEC5A/NRIP1/FNDC3B,3
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,4/56,307/21728,0.008065288152923056,0.08989605644165263,0.0700089100230243,ESR2/MET/PSMD5/PRKAR1A,4
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,4/56,309/21728,0.008247369886700117,0.08989605644165263,0.0700089100230243,BIRC3/SLC2A3/FNDC3B/DUSP5,4
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,4/56,309/21728,0.008247369886700117,0.08989605644165263,0.0700089100230243,MET/SLC2A3/ITGB3/IFNAR1,4
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,2/56,53/21728,0.008264365413960561,0.08989605644165263,0.0700089100230243,BIRC3/PPP1R15A,2
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,2/56,53/21728,0.008264365413960561,0.08989605644165263,0.0700089100230243,NRBF2/ESR2,2
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,2/56,54/21728,0.008568132135416804,0.09257056273332075,0.0720917518933007,PERP/TPM1,2
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,3/56,164/21728,0.008733786014174719,0.09372700561520386,0.07299236209656441,EFNB2/SLC39A14/FNDC3B,3
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,2/56,55/21728,0.008876859200769206,0.09430841316670152,0.07344514846529601,PPFIBP1/PRKAR1A,2
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,4/56,316/21728,0.008905922694291388,0.09430841316670152,0.07344514846529601,PERP/SH3GLB1/TPM1/WWTR1,4
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,5/56,500/21728,0.009216390398339816,0.09586723158028936,0.07465911915966052,BIRC3/MOXD1/LOXL1/IFNAR1/TPM1,5
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,3/56,168/21728,0.00932514615940671,0.09586723158028936,0.07465911915966052,RECQL/WWTR1/ATP6V1A,3
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,3/56,168/21728,0.00932514615940671,0.09586723158028936,0.07465911915966052,ACBD3/EFNB2/TPM1,3
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,4/56,321/21728,0.009396846248899846,0.09586723158028936,0.07465911915966052,BIRC3/NRIP1/SLC2A3/SLC39A14,4
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,2/56,57/21728,0.009509087908077356,0.09586723158028936,0.07465911915966052,TPM1/PPFIBP1,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,4/56,323/21728,0.009598068562097673,0.09586723158028936,0.07465911915966052,BIRC3/MET/GOLGA5/PRKAR1A,4
LEI_MYB_TARGETS,LEI_MYB_TARGETS,4/56,323/21728,0.009598068562097673,0.09586723158028936,0.07465911915966052,ACBD3/SLC2A3/PSMD5/TPM1,4
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,3/56,170/21728,0.009629418035169887,0.09586723158028936,0.07465911915966052,MOXD1/LOXL1/DUSP5,3
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,3/56,170/21728,0.009629418035169887,0.09586723158028936,0.07465911915966052,RECQL/WWTR1/FNDC3B,3
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,4/56,324/21728,0.009699727179920247,0.09586723158028936,0.07465911915966052,PERP/SLC2A3/WWTR1/ATP6V1A,4
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,4/56,325/21728,0.00980208659533075,0.09586723158028936,0.07465911915966052,RECQL/BIRC3/ZBTB38/DUSP5,4
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,2/56,58/21728,0.00983253657233737,0.09586723158028936,0.07465911915966052,SLC35D1/DUSP5,2
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,2/56,58/21728,0.00983253657233737,0.09586723158028936,0.07465911915966052,LOXL1/PDLIM4,2
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,3/56,173/21728,0.010096628191617605,0.09784550592967607,0.07619975215747131,ACTR3/MET/PERP,3
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/56,59/21728,0.010160839624455168,0.09787459373195068,0.07622240504584948,PERP/SH3GLB1,2
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,3/56,176/21728,0.010576864385062905,0.10127189312404541,0.07886814098663358,MET/FEM1B/SLC33A1,3
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,3/56,177/21728,0.010739849577101572,0.10222035401062746,0.07960677976009499,MOXD1/SLC2A3/WWTR1,3
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,2/56,63/21728,0.011522072382163202,0.10531913864194294,0.08202003950720418,SLC33A1/HSPA5,2
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,2/56,63/21728,0.011522072382163202,0.10531913864194294,0.08202003950720418,PPP1R15A/PRKAR1A,2
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,2/56,63/21728,0.011522072382163202,0.10531913864194294,0.08202003950720418,BIRC3/DUSP5,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,2/56,63/21728,0.011522072382163202,0.10531913864194294,0.08202003950720418,MET/SLC2A3,2
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,3/56,182/21728,0.011576681221133667,0.10531913864194294,0.08202003950720418,SLC2A3/ITGB3/TPM1,3
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,4/56,342/21728,0.011651179434101218,0.10531913864194294,0.08202003950720418,HIVEP3/GBE1/RASA2/EHBP1,4
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,AKAP12/SLC39A14,2
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,GBE1/EHBP1,2
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,NRIP1/PPFIBP1,2
KIM_GERMINAL_CENTER_T_HELPER_UP,KIM_GERMINAL_CENTER_T_HELPER_UP,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,ACTR3/PTPN14,2
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,PPP1R15A/HSPA5,2
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,2/56,64/21728,0.011874255737519067,0.10531913864194294,0.08202003950720418,ESR2/NRIP1,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,3/56,184/21728,0.011921678607999796,0.10531913864194294,0.08202003950720418,SLC2A3/PPFIBP1/PRKAR1A,3
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/56,185/21728,0.012096385487425513,0.1062753867823813,0.08276474280870087,EML1/ITGB3/TPM1,3
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,3/56,186/21728,0.012272567221096015,0.10723407096465862,0.08351134324162547,MCFD2/SEC24A/USO1,3
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,2/56,67/21728,0.012958893812691726,0.11200687138645442,0.0872282866595409,NRIP1/SLC2A3,2
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,2/56,67/21728,0.012958893812691726,0.11200687138645442,0.0872282866595409,BIRC3/MOXD1,2
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,2/56,68/21728,0.01332971732148674,0.11244115789879296,0.08756649866315926,ZBTB38/ATP6V1A,2
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,2/56,68/21728,0.01332971732148674,0.11244115789879296,0.08756649866315926,MET/ATP6V1A,2
REACTOME_REGULATION_OF_RAS_BY_GAPS,REACTOME_REGULATION_OF_RAS_BY_GAPS,2/56,68/21728,0.01332971732148674,0.11244115789879296,0.08756649866315926,RASA2/PSMD5,2
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,3/56,192/21728,0.013360737961707732,0.11244115789879296,0.08756649866315926,EML1/ITGB3/TPM1,3
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,3/56,192/21728,0.013360737961707732,0.11244115789879296,0.08756649866315926,AKAP12/PCYT1A/ITGB3,3
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,4/56,357/21728,0.01345826363257521,0.11266891910203018,0.08774387366953142,AKAP12/EFNB2/TPM1/PKD2,4
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,4/56,359/21728,0.0137119591887168,0.1141949101185321,0.0889322791680481,LDHA/AKAP12/BIRC3/DUSP5,4
WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,2/56,70/21728,0.01408512824248796,0.11609340236978478,0.09041077976594279,PSMD5/HSPA5,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,2/56,70/21728,0.01408512824248796,0.11609340236978478,0.09041077976594279,LDHA/USO1,2
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,2/56,71/21728,0.014469665216390572,0.11865125477440268,0.09240277436431875,ITGB3/TPM1,2
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,3/56,199/21728,0.01469798729108451,0.11968399358922698,0.0932070467832234,BIRC3/MET/ITGB3,3
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,4/56,367/21728,0.014757258166142798,0.11968399358922698,0.0932070467832234,LOXL1/PDLIM4/SLC35D1/WWTR1,4
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,2/56,72/21728,0.014858723066081206,0.11968399358922698,0.0932070467832234,BIRC3/MET,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,3/56,200/21728,0.014895006081461019,0.11968399358922698,0.0932070467832234,HIVEP3/TPM1/WWTR1,3
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2/56,73/21728,0.015252276810526494,0.12166357798640227,0.09474870001508436,HIVEP3/PSMD5,2
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,3/56,202/21728,0.015293545450448316,0.12166357798640227,0.09474870001508436,BIRC3/MET/ITGB3,3
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,3/56,204/21728,0.015698095984703713,0.12365150482532629,0.09629685014210264,MET/LOXL1/PKD2,3
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,3/56,204/21728,0.015698095984703713,0.12365150482532629,0.09629685014210264,MET/SLC35D1/EFNB2,3
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2/56,75/21728,0.01605277253269218,0.12582540823419017,0.09798983439718705,PPP1R15A/WWTR1,2
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,4/56,378/21728,0.01627533180438406,0.12694758807419568,0.09886376135859481,STBD1/BIRC3/RASA2/SEC24A,4
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,2/56,76/21728,0.016459665020567407,0.12714494863713663,0.09901746106957153,BIRC3/DUSP5,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,2/56,76/21728,0.016459665020567407,0.12714494863713663,0.09901746106957153,PERP/EFNB2,2
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,2/56,77/21728,0.016870954422893807,0.12966368326424238,0.1009789916734793,LDHA/SLC2A3,2
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,3/56,210/21728,0.01694791107081092,0.12966368326424238,0.1009789916734793,LOXL1/TPM1/WWTR1,3
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2/56,78/21728,0.017286616229019995,0.1310014187213411,0.10202078822115568,ESR2/MET,2
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,2/56,78/21728,0.017286616229019995,0.1310014187213411,0.10202078822115568,BIRC3/SLC4A7,2
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,4/56,387/21728,0.017588126108753058,0.1326576115466799,0.10331059179073916,HIVEP3/CLEC5A/GOLGA5/FNDC3B,4
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,2/56,80/21728,0.01813095947556213,0.13610987887992415,0.10599913545633803,HSPA5/FNDC3B,2
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,2/56,81/21728,0.01855959235926179,0.13675939254589678,0.10650496124669755,RECQL/USO1,2
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,2/56,81/21728,0.01855959235926179,0.13675939254589678,0.10650496124669755,TPM1/HSPA5,2
HARRIS_HYPOXIA,HARRIS_HYPOXIA,2/56,81/21728,0.01855959235926179,0.13675939254589678,0.10650496124669755,LDHA/SLC2A3,2
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,2/56,81/21728,0.01855959235926179,0.13675939254589678,0.10650496124669755,PRKAR1A/HSPA5,2
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,4/56,395/21728,0.018809313434196798,0.13796372560220493,0.10744286717843946,GBE1/MET/DUSP5/PKD2,4
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,2/56,82/21728,0.01899250053272454,0.13867127101290658,0.10799388671094994,PTPN14/EFNB2,2
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,2/56,83/21728,0.019429659948073087,0.14064876023225448,0.10953390826816567,ITGB3/TPM1,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,4/56,399/21728,0.019439259544295335,0.14064876023225448,0.10953390826816567,MET/SLC4A7/WWTR1/FNDC3B,4
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,3/56,223/21728,0.01984278292563496,0.1418473374637592,0.11046733170048854,MOXD1/LOXL1/TPM1,3
LEIN_MIDBRAIN_MARKERS,LEIN_MIDBRAIN_MARKERS,2/56,84/21728,0.01987104664908196,0.1418473374637592,0.11046733170048854,SLC39A14/KCTD9,2
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,2/56,84/21728,0.01987104664908196,0.1418473374637592,0.11046733170048854,BIRC3/TPM1,2
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,3/56,225/21728,0.020310933037280196,0.1437446999851094,0.11194495249161276,PPP1R15A/SEC24A/DUSP5,3
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,2/56,85/21728,0.0203166367708785,0.1437446999851094,0.11194495249161276,AKAP12/TPM1,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,4/56,408/21728,0.020904271451628435,0.14725079317688927,0.11467541445525825,AKAP12/MET/MCFD2/PPFIBP1,4
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,2/56,87/21728,0.021220332272321105,0.14817166508053034,0.11539256758517982,PERP/HSPA5,2
KEGG_APOPTOSIS,KEGG_APOPTOSIS,2/56,87/21728,0.021220332272321105,0.14817166508053034,0.11539256758517982,BIRC3/PRKAR1A,2
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,2/56,89/21728,0.022140557349174146,0.15392500522317157,0.11987313200948749,ACBD3/DNTTIP2,2
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,2/56,90/21728,0.022606809778357335,0.15581158980859217,0.12134235920052962,ITGB3/TPM1,2
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,2/56,90/21728,0.022606809778357335,0.15581158980859217,0.12134235920052962,PSMD5/HSPA5,2
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,4/56,419/21728,0.022785328518244413,0.1563679841230593,0.12177566585535642,ACBD3/PCYT1A/SLC39A14/HSPA5,4
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,3/56,238/21728,0.02350242552983015,0.15982988907159498,0.12447171506645395,PPP1R15A/PCYT1A/WWTR1,3
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,2/56,92/21728,0.023551477803028766,0.15982988907159498,0.12447171506645395,ACTR3/EFNB2,2
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,3/56,239/21728,0.02375859523591579,0.15982988907159498,0.12447171506645395,AKAP12/PPP1R15A/PDLIM4,3
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,3/56,239/21728,0.02375859523591579,0.15982988907159498,0.12447171506645395,GBE1/PTPN14/PERP,3
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,2/56,93/21728,0.02402984702011453,0.15982988907159498,0.12447171506645395,MET/DNTTIP2,2
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,4/56,428/21728,0.024399247152942033,0.15982988907159498,0.12447171506645395,GBE1/ACTR3/FEM1B/PRKAR1A,4
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,3/56,243/21728,0.024798519462573915,0.15982988907159498,0.12447171506645395,PTPN14/SLC35D1/EFNB2,3
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,3/56,243/21728,0.024798519462573915,0.15982988907159498,0.12447171506645395,BIRC3/PDLIM4/ZBTB38,3
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,3/56,244/21728,0.02506231127951293,0.15982988907159498,0.12447171506645395,SLC2A3/TPM1/DUSP5,3
BIOCARTA_SODD_PATHWAY,BIOCARTA_SODD_PATHWAY,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,BIRC3,1
MATZUK_PREOVULATORY_FOLLICLE,MATZUK_PREOVULATORY_FOLLICLE,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,ESR2,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,PERP,1
RADAEVA_RESPONSE_TO_IFNA1_DN,RADAEVA_RESPONSE_TO_IFNA1_DN,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,MET,1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,SH3GLB1,1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,HSPA5,1
REACTOME_BICARBONATE_TRANSPORTERS,REACTOME_BICARBONATE_TRANSPORTERS,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,SLC4A7,1
REACTOME_MET_RECEPTOR_RECYCLING,REACTOME_MET_RECEPTOR_RECYCLING,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,MET,1
REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,SLC39A14,1
TAKAYAMA_BOUND_BY_AR,TAKAYAMA_BOUND_BY_AR,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,MET,1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1/56,10/21728,0.025481541859702306,0.15982988907159498,0.12447171506645395,MET,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2/56,96/21728,0.025488819082712146,0.15982988907159498,0.12447171506645395,PSMD5/WWTR1,2
WP_G_PROTEIN_SIGNALING_PATHWAYS,WP_G_PROTEIN_SIGNALING_PATHWAYS,2/56,96/21728,0.025488819082712146,0.15982988907159498,0.12447171506645395,AKAP12/PRKAR1A,2
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,4/56,438/21728,0.02627234235977153,0.16399191543213065,0.12771300217649886,LDHA/PTPN14/ITGB3/DUSP5,4
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,3/56,250/21728,0.026677056243960207,0.16399191543213065,0.12771300217649886,PPP1R15A/SLC2A3/DUSP5,3
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,2/56,99/21728,0.02698310821275114,0.16399191543213065,0.12771300217649886,RECQL/SH3GLB1,2
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,2/56,99/21728,0.02698310821275114,0.16399191543213065,0.12771300217649886,MET/PRKAR1A,2
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,3/56,253/21728,0.02750498196426799,0.16399191543213065,0.12771300217649886,MET/WWTR1/DUSP5,3
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,4/56,445/21728,0.027633919537152534,0.16399191543213065,0.12771300217649886,MET/PDLIM4/NRIP1/DUSP5,4
BIOCARTA_AGPCR_PATHWAY,BIOCARTA_AGPCR_PATHWAY,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,PRKAR1A,1
BIOCARTA_CFTR_PATHWAY,BIOCARTA_CFTR_PATHWAY,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,PRKAR1A,1
BIOCARTA_PLCE_PATHWAY,BIOCARTA_PLCE_PATHWAY,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,PRKAR1A,1
BIOCARTA_VITCB_PATHWAY,BIOCARTA_VITCB_PATHWAY,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,SLC2A3,1
REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,MET,1
REACTOME_MET_ACTIVATES_RAS_SIGNALING,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,MET,1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,EHBP1,1
WP_GLYCOLYSIS_IN_SENESCENCE,WP_GLYCOLYSIS_IN_SENESCENCE,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,LDHA,1
WP_SEROTONIN_TRANSPORTER_ACTIVITY,WP_SEROTONIN_TRANSPORTER_ACTIVITY,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,ITGB3,1
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,1/56,11/21728,0.027994343851407977,0.16399191543213065,0.12771300217649886,SLC2A3,1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2/56,101/21728,0.02799861970792475,0.16399191543213065,0.12771300217649886,BIRC3/PSMD5,2
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,2/56,101/21728,0.02799861970792475,0.16399191543213065,0.12771300217649886,LDHA/DUSP5,2
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,3/56,257/21728,0.028630171654304985,0.16701478530848488,0.13006714131854621,MOXD1/EML1/TPM1,3
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,2/56,104/21728,0.029550417060828928,0.16701478530848488,0.13006714131854621,PPP1R15A/WWTR1,2
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,3/56,262/21728,0.030070822785142854,0.16701478530848488,0.13006714131854621,GBE1/PTPN14/PPFIBP1,3
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,2/56,105/21728,0.030075202049090765,0.16701478530848488,0.13006714131854621,RECQL/PRKAR1A,2
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,2/56,105/21728,0.030075202049090765,0.16701478530848488,0.13006714131854621,ESR2/MET,2
XU_GH1_EXOGENOUS_TARGETS_DN,XU_GH1_EXOGENOUS_TARGETS_DN,2/56,105/21728,0.030075202049090765,0.16701478530848488,0.13006714131854621,SLC4A7/ITGB3,2
AMIT_EGF_RESPONSE_20_HELA,AMIT_EGF_RESPONSE_20_HELA,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,PPP1R15A,1
BIOCARTA_CARM1_PATHWAY,BIOCARTA_CARM1_PATHWAY,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,PRKAR1A,1
BIOCARTA_PRION_PATHWAY,BIOCARTA_PRION_PATHWAY,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,HSPA5,1
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,SLC2A3,1
ITO_PTTG1_TARGETS_UP,ITO_PTTG1_TARGETS_UP,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,SLC2A3,1
NEBEN_AML_WITH_FLT3_OR_NRAS_DN,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,HSPA5,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,ITGB3,1
REACTOME_ALK_MUTANTS_BIND_TKIS,REACTOME_ALK_MUTANTS_BIND_TKIS,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,PRKAR1A,1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,HSPA5,1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,PRKAR1A,1
REACTOME_PECAM1_INTERACTIONS,REACTOME_PECAM1_INTERACTIONS,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,ITGB3,1
REACTOME_PHYSIOLOGICAL_FACTORS,REACTOME_PHYSIOLOGICAL_FACTORS,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,WWTR1,1
WP_AEROBIC_GLYCOLYSIS,WP_AEROBIC_GLYCOLYSIS,1/56,12/21728,0.030500781975656865,0.16701478530848488,0.13006714131854621,LDHA,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,2/56,106/21728,0.03060370987829022,0.16701478530848488,0.13006714131854621,EFNB2/SEC24A,2
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,2/56,107/21728,0.031135918619465828,0.16876723346618933,0.13143190625094764,PPP1R15A/PPFIBP1,2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,2/56,107/21728,0.031135918619465828,0.16876723346618933,0.13143190625094764,PERP/TPM1,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,4/56,467/21728,0.03218613709518827,0.17283876215032276,0.13460271592365744,HIVEP3/SLC35D1/FEM1B/SLC39A14,4
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,2/56,109/21728,0.032211351545213374,0.17283876215032276,0.13460271592365744,MCFD2/DNTTIP2,2
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,2/56,109/21728,0.032211351545213374,0.17283876215032276,0.13460271592365744,GBE1/SLC2A3,2
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,2/56,110/21728,0.03275453229434206,0.17358024480051898,0.13518016497087912,GBE1/PDLIM4,2
BIOCARTA_DREAM_PATHWAY,BIOCARTA_DREAM_PATHWAY,1/56,13/21728,0.03300087205713431,0.17358024480051898,0.13518016497087912,PRKAR1A,1
WP_GANGLIO_SPHINGOLIPID_METABOLISM,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1/56,13/21728,0.03300087205713431,0.17358024480051898,0.13518016497087912,SLC33A1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/56,13/21728,0.03300087205713431,0.17358024480051898,0.13518016497087912,NRIP1,1
WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,1/56,13/21728,0.03300087205713431,0.17358024480051898,0.13518016497087912,ITGB3,1
WP_OSTEOPONTIN_SIGNALING,WP_OSTEOPONTIN_SIGNALING,1/56,13/21728,0.03300087205713431,0.17358024480051898,0.13518016497087912,ITGB3,1
REACTOME_HEDGEHOG_OFF_STATE,REACTOME_HEDGEHOG_OFF_STATE,2/56,113/21728,0.03440567283570293,0.17718539979445277,0.13798777390924435,PSMD5/PRKAR1A,2
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,2/56,113/21728,0.03440567283570293,0.17718539979445277,0.13798777390924435,ESR2/MET,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,2/56,113/21728,0.03440567283570293,0.17718539979445277,0.13798777390924435,NRBF2/PERP,2
BIOCARTA_GATA3_PATHWAY,BIOCARTA_GATA3_PATHWAY,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,PRKAR1A,1
BIOCARTA_RANKL_PATHWAY,BIOCARTA_RANKL_PATHWAY,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,IFNAR1,1
BIOCARTA_UCALPAIN_PATHWAY,BIOCARTA_UCALPAIN_PATHWAY,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,ITGB3,1
CASTELLANO_NRAS_TARGETS_DN,CASTELLANO_NRAS_TARGETS_DN,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,AKAP12,1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,MOXD1,1
DAZARD_UV_RESPONSE_CLUSTER_G3,DAZARD_UV_RESPONSE_CLUSTER_G3,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,PPP1R15A,1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,HSPA5,1
REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,USO1,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,PERP,1
ROETH_TERT_TARGETS_UP,ROETH_TERT_TARGETS_UP,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,NRIP1,1
WP_OSTEOBLAST_SIGNALING,WP_OSTEOBLAST_SIGNALING,1/56,14/21728,0.03549462988190066,0.17718539979445277,0.13798777390924435,ITGB3,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,2/56,115/21728,0.0355242177335347,0.17718539979445277,0.13798777390924435,SEC24A/PRKAR1A,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,4/56,482/21728,0.03552950563773977,0.17718539979445277,0.13798777390924435,LDHA/PCYT1A/PSMD5/HSPA5,4
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,3/56,280/21728,0.0355700521163348,0.17718539979445277,0.13798777390924435,PTPN14/LOXL1/DNTTIP2,3
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,2/56,116/21728,0.036088761766324425,0.17810361244803438,0.13870285607848634,PDLIM4/SLC39A14,2
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,2/56,118/21728,0.037228287528384536,0.17810361244803438,0.13870285607848634,ITGB3/TPM1,2
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,3/56,286/21728,0.03751127446767742,0.17810361244803438,0.13870285607848634,AKAP12/PPP1R15A/DUSP5,3
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,2/56,119/21728,0.03780322731490612,0.17810361244803438,0.13870285607848634,ACTR3/EFNB2,2
BIOCARTA_HIF_PATHWAY,BIOCARTA_HIF_PATHWAY,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,LDHA,1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,MET,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,SLC33A1,1
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,ESR2,1
MATZUK_OVULATION,MATZUK_OVULATION,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,NRIP1,1
NGO_MALIGNANT_GLIOMA_1P_LOH,NGO_MALIGNANT_GLIOMA_1P_LOH,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,HSPA5,1
PID_ERB_GENOMIC_PATHWAY,PID_ERB_GENOMIC_PATHWAY,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,ESR2,1
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,ITGB3,1
REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,MET,1
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,ITGB3,1
REACTOME_PENTOSE_PHOSPHATE_PATHWAY,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,PRPS2,1
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,PPP1R15A,1
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,WWTR1,1
TERAMOTO_OPN_TARGETS_CLUSTER_4,TERAMOTO_OPN_TARGETS_CLUSTER_4,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,LDHA,1
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,PRKAR1A,1
WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,1/56,15/21728,0.037982071197485756,0.17810361244803438,0.13870285607848634,PCYT1A,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,3/56,289/21728,0.03850201921046225,0.17948900500737358,0.13978176684356866,TPM1/ZBTB38/PKD2,3
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,3/56,289/21728,0.03850201921046225,0.17948900500737358,0.13978176684356866,MET/NRIP1/DUSP5,3
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,2/56,122/21728,0.03954850435006087,0.18304299355423695,0.14254952857026584,WWTR1/HSPA5,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,2/56,123/21728,0.04013701362995726,0.18304299355423695,0.14254952857026584,LOXL1/EFNB2,2
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,2/56,123/21728,0.04013701362995726,0.18304299355423695,0.14254952857026584,ACTR3/TPM1,2
BIOCARTA_CK1_PATHWAY,BIOCARTA_CK1_PATHWAY,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,PRKAR1A,1
BIOCARTA_SHH_PATHWAY,BIOCARTA_SHH_PATHWAY,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,PRKAR1A,1
DASU_IL6_SIGNALING_SCAR_DN,DASU_IL6_SIGNALING_SCAR_DN,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,TPM1,1
MAINA_VHL_TARGETS_DN,MAINA_VHL_TARGETS_DN,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,GBE1,1
REACTOME_GLYCOGEN_STORAGE_DISEASES,REACTOME_GLYCOGEN_STORAGE_DISEASES,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,GBE1,1
REACTOME_GLYCOGEN_SYNTHESIS,REACTOME_GLYCOGEN_SYNTHESIS,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,GBE1,1
WU_HBX_TARGETS_2_DN,WU_HBX_TARGETS_2_DN,1/56,16/21728,0.04046321171298051,0.18304299355423695,0.14254952857026584,PTPN14,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,3/56,295/21728,0.04052358956735452,0.18304299355423695,0.14254952857026584,PERP/NRIP1/ITGB3,3
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/56,125/21728,0.041324034314895744,0.18506191183695045,0.14412181409638417,BIRC3/WWTR1,2
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,2/56,126/21728,0.04192250490791468,0.18506191183695045,0.14412181409638417,FNDC3B/DUSP5,2
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,3/56,300/21728,0.04224886314517656,0.18506191183695045,0.14412181409638417,NRIP1/EFNB2/FEM1B,3
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,3/56,300/21728,0.04224886314517656,0.18506191183695045,0.14412181409638417,PPP1R15A/NRIP1/SLC2A3,3
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,2/56,127/21728,0.0425242552594136,0.18506191183695045,0.14412181409638417,ACTR3/PPP1R15A,2
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,2/56,127/21728,0.0425242552594136,0.18506191183695045,0.14412181409638417,NRIP1/PKD2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,SLC2A3,1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,LOXL1,1
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,HSPA5,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,HSPA5,1
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,PRKAR1A,1
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,BIRC3,1
REACTOME_ZINC_TRANSPORTERS,REACTOME_ZINC_TRANSPORTERS,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,SLC39A14,1
RUAN_RESPONSE_TO_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,NRIP1,1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,SLC2A3,1
WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,LOXL1,1
WP_CORI_CYCLE,WP_CORI_CYCLE,1/56,17/21728,0.04293806709912984,0.18506191183695045,0.14412181409638417,LDHA,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,2/56,128/21728,0.04312926516217963,0.18521744420532907,0.14424293900457807,EML1/PRKAR1A,2
KEGG_AXON_GUIDANCE,KEGG_AXON_GUIDANCE,2/56,129/21728,0.0437375144880471,0.18521744420532907,0.14424293900457807,MET/EFNB2,2
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,2/56,129/21728,0.0437375144880471,0.18521744420532907,0.14424293900457807,ACTR3/ITGB3,2
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,3/56,305/21728,0.04401086187655473,0.18521744420532907,0.14424293900457807,MCFD2/SEC24A/USO1,3
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,2/56,130/21728,0.04434898318763606,0.18521744420532907,0.14424293900457807,LDHA/PRPS2,2
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,2/56,130/21728,0.04434898318763606,0.18521744420532907,0.14424293900457807,BIRC3/PERP,2
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,NRIP1/TASP1,2
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,NRIP1/PCYT1A,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,SLC39A14/DUSP5,2
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,RECQL/SLC39A14,2
WP_ADIPOGENESIS,WP_ADIPOGENESIS,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,NRIP1/WWTR1,2
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,RASA2/ITGB3,2
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,2/56,131/21728,0.04496365129009201,0.18521744420532907,0.14424293900457807,EFNB2/TPM1,2
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,DUSP5,1
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,NRIP1,1
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,DUSP5,1
REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,LOXL1,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,PKD2,1
TERAMOTO_OPN_TARGETS_CLUSTER_7,TERAMOTO_OPN_TARGETS_CLUSTER_7,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,PPP1R15A,1
WEBER_METHYLATED_IN_COLON_CANCER,WEBER_METHYLATED_IN_COLON_CANCER,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,WWTR1,1
WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,1/56,18/21728,0.04540665298842339,0.18521744420532907,0.14424293900457807,ITGB3,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2/56,132/21728,0.045581498902826104,0.18545754897104053,0.14442992688373718,ITGB3/HSPA5,2
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,3/56,310/21728,0.04580937266852627,0.18578278392069061,0.1446832121247997,LDHA/FEM1B/PPFIBP1,3
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,2/56,133/21728,0.04620250621125629,0.18578278392069061,0.1446832121247997,LOXL1/TPM1,2
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,2/56,133/21728,0.04620250621125629,0.18578278392069061,0.1446832121247997,MET/ITGB3,2
ABE_VEGFA_TARGETS,ABE_VEGFA_TARGETS,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,SLC4A7,1
BIOCARTA_CHREBP_PATHWAY,BIOCARTA_CHREBP_PATHWAY,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,PRKAR1A,1
BIOCARTA_MCALPAIN_PATHWAY,BIOCARTA_MCALPAIN_PATHWAY,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,PRKAR1A,1
BIOCARTA_MITOCHONDRIA_PATHWAY,BIOCARTA_MITOCHONDRIA_PATHWAY,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,BIRC3,1
CHOI_ATL_CHRONIC_VS_ACUTE_DN,CHOI_ATL_CHRONIC_VS_ACUTE_DN,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,ATP6V1A,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,SLC2A3,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,DUSP5,1
KAMIKUBO_MYELOID_MN1_NETWORK,KAMIKUBO_MYELOID_MN1_NETWORK,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,RECQL,1
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,EFNB2,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,BIRC3,1
PID_ARF_3PATHWAY,PID_ARF_3PATHWAY,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,USO1,1
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,BIRC3,1
REACTOME_EPHRIN_SIGNALING,REACTOME_EPHRIN_SIGNALING,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,EFNB2,1
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,BIRC3,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,BIRC3,1
WP_NUCLEOTIDE_METABOLISM,WP_NUCLEOTIDE_METABOLISM,1/56,19/21728,0.04786898497518732,0.18578278392069061,0.1446832121247997,PRPS2,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,2/56,137/21728,0.04871773882610093,0.18669722153902388,0.14539535438640286,BIRC3/SEC24A,2
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,3/56,318/21728,0.04876236730570258,0.18669722153902388,0.14539535438640286,LDHA/IFNAR1/WWTR1,3
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,2/56,138/21728,0.04935425010649318,0.18669722153902388,0.14539535438640286,PPP1R15A/SLC2A3,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,3/56,321/21728,0.04989348912905426,0.18669722153902388,0.14539535438640286,CLEC5A/SLC2A3/DNTTIP2,3
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,3/56,322/21728,0.050273392391615955,0.18669722153902388,0.14539535438640286,PTPN14/SLC4A7/ITGB3,3
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,MOXD1,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,IFNAR1,1
MARCHINI_TRABECTEDIN_RESISTANCE_UP,MARCHINI_TRABECTEDIN_RESISTANCE_UP,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,AKAP12,1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,PRKAR1A,1
REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,MET,1
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,PRKAR1A,1
REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,PPFIBP1,1
REACTOME_SIGNALING_BY_HIPPO,REACTOME_SIGNALING_BY_HIPPO,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,WWTR1,1
SEIDEN_MET_SIGNALING,SEIDEN_MET_SIGNALING,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,PRPS2,1
WANG_RECURRENT_LIVER_CANCER_UP,WANG_RECURRENT_LIVER_CANCER_UP,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,ZBTB38,1
WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,LDHA,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,PPP1R15A,1
ZIRN_TRETINOIN_RESPONSE_UP,ZIRN_TRETINOIN_RESPONSE_UP,1/56,20/21728,0.0503250786156767,0.18669722153902388,0.14539535438640286,AKAP12,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,2/56,140/21728,0.05063638068739639,0.18669722153902388,0.14539535438640286,MET/NRIP1,2
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,2/56,140/21728,0.05063638068739639,0.18669722153902388,0.14539535438640286,LOXL1/SH3GLB1,2
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,2/56,140/21728,0.05063638068739639,0.18669722153902388,0.14539535438640286,PTPN14/PSMD5,2
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,3/56,327/21728,0.05219428524377658,0.18669722153902388,0.14539535438640286,STBD1/AKAP12/PRPS2,3
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,2/56,143/21728,0.05258205861120964,0.18669722153902388,0.14539535438640286,MET/TPM1,2
AMIT_EGF_RESPONSE_240_MCF10A,AMIT_EGF_RESPONSE_240_MCF10A,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,AKAP12,1
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,GBE1,1
BIOCARTA_MPR_PATHWAY,BIOCARTA_MPR_PATHWAY,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,PRKAR1A,1
BIOCARTA_NOS1_PATHWAY,BIOCARTA_NOS1_PATHWAY,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,PRKAR1A,1
CHIBA_RESPONSE_TO_TSA_DN,CHIBA_RESPONSE_TO_TSA_DN,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,BIRC3,1
LEE_INTRATHYMIC_T_PROGENITOR,LEE_INTRATHYMIC_T_PROGENITOR,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,HIVEP3,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,MET,1
MOOTHA_GLYCOGEN_METABOLISM,MOOTHA_GLYCOGEN_METABOLISM,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,GBE1,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,MET,1
PID_S1P_S1P1_PATHWAY,PID_S1P_S1P1_PATHWAY,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,ITGB3,1
REACTOME_CELLULAR_HEXOSE_TRANSPORT,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,SLC2A3,1
REACTOME_INTERLEUKIN_37_SIGNALING,REACTOME_INTERLEUKIN_37_SIGNALING,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,PTPN14,1
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,MET,1
REACTOME_SIGNAL_TRANSDUCTION_BY_L1,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,ITGB3,1
REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,PKD2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,PPFIBP1,1
VERRECCHIA_RESPONSE_TO_TGFB1_C5,VERRECCHIA_RESPONSE_TO_TGFB1_C5,1/56,21/21728,0.05277494942816685,0.18669722153902388,0.14539535438640286,ITGB3,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,2/56,144/21728,0.053236536862991235,0.18750048996458807,0.1460209207255243,BIRC3/ITGB3,2
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,2/56,144/21728,0.053236536862991235,0.18750048996458807,0.1460209207255243,SLC2A3/LRRC8E,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/56,145/21728,0.05389394302683034,0.18786077024675005,0.1463014984377771,SLC2A3/SLC39A14,2
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,3/56,333/21728,0.054546102645296954,0.18786077024675005,0.1463014984377771,TBC1D19/AKAP12/SLC2A3,3
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,2/56,146/21728,0.054554258279024596,0.18786077024675005,0.1463014984377771,SLC2A3/DUSP5,2
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,2/56,147/21728,0.05521746387033423,0.18786077024675005,0.1463014984377771,LDHA/SLC39A14,2
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,2/56,147/21728,0.05521746387033423,0.18786077024675005,0.1463014984377771,MOXD1/NRIP1,2
BIOCARTA_CASPASE_PATHWAY,BIOCARTA_CASPASE_PATHWAY,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,BIRC3,1
BIOCARTA_CREB_PATHWAY,BIOCARTA_CREB_PATHWAY,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,PRKAR1A,1
BIOCARTA_CSK_PATHWAY,BIOCARTA_CSK_PATHWAY,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,PRKAR1A,1
BIOCARTA_EDG1_PATHWAY,BIOCARTA_EDG1_PATHWAY,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,ITGB3,1
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,LDHA,1
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,HSPA5,1
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,NRIP1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,STBD1,1
KANNAN_TP53_TARGETS_DN,KANNAN_TP53_TARGETS_DN,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,BIRC3,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,PPP1R15A,1
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1/56,22/21728,0.055218612893040975,0.18786077024675005,0.1463014984377771,NRIP1,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,3/56,339/21728,0.056948463956515025,0.19043067143201992,0.14830287633987002,AKAP12/BIRC3/PPP1R15A,3
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,2/56,150/21728,0.05722423629831253,0.19043067143201992,0.14830287633987002,PSMD5/PRKAR1A,2
BIOCARTA_IGF1R_PATHWAY,BIOCARTA_IGF1R_PATHWAY,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,PRKAR1A,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,ATP6V1A,1
HASLINGER_B_CLL_WITH_11Q23_DELETION,HASLINGER_B_CLL_WITH_11Q23_DELETION,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,SLC4A7,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,IFNAR1,1
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,BIRC3,1
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,DUSP5,1
VERNELL_RETINOBLASTOMA_PATHWAY_DN,VERNELL_RETINOBLASTOMA_PATHWAY_DN,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,PPFIBP1,1
WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,IFNAR1,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,RECQL,1
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,PTPN14,1
ZIRN_TRETINOIN_RESPONSE_WT1_UP,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1/56,23/21728,0.05765608445288517,0.19043067143201992,0.14830287633987002,AKAP12,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,3/56,341/21728,0.057760397526284965,0.19043067143201992,0.14830287633987002,LDHA/NRIP1/WWTR1,3
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,3/56,341/21728,0.057760397526284965,0.19043067143201992,0.14830287633987002,BIRC3/PDLIM4/HSPA5,3
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,3/56,345/21728,0.05940087108232372,0.192544528738703,0.149949098119144,MET/ITGB3/IFNAR1,3
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,2/56,154/21728,0.059939273091839475,0.192544528738703,0.149949098119144,PPP1R15A/PRKAR1A,2
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,2/56,154/21728,0.059939273091839475,0.192544528738703,0.149949098119144,LDHA/HSPA5,2
DAZARD_UV_RESPONSE_CLUSTER_G24,DAZARD_UV_RESPONSE_CLUSTER_G24,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,PDLIM4,1
KEGG_PROTEIN_EXPORT,KEGG_PROTEIN_EXPORT,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,HSPA5,1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,MET,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,BIRC3,1
REACTOME_DARPP_32_EVENTS,REACTOME_DARPP_32_EVENTS,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,PRKAR1A,1
REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,WWTR1,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,MET,1
SHI_SPARC_TARGETS_UP,SHI_SPARC_TARGETS_UP,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,PPP1R15A,1
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,NRIP1,1
WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,PCYT1A,1
WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1/56,24/21728,0.060087379512578365,0.192544528738703,0.149949098119144,SH3GLB1,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,2/56,156/21728,0.06131332236972463,0.19608000493837935,0.15270244287028262,GBE1/SLC2A3,2
BIOCARTA_BAD_PATHWAY,BIOCARTA_BAD_PATHWAY,1/56,25/21728,0.06251251343937969,0.19851906500816577,0.15460192482450225,PRKAR1A,1
REACTOME_GLUCURONIDATION,REACTOME_GLUCURONIDATION,1/56,25/21728,0.06251251343937969,0.19851906500816577,0.15460192482450225,SLC35D1,1
WANG_BARRETTS_ESOPHAGUS_DN,WANG_BARRETTS_ESOPHAGUS_DN,1/56,25/21728,0.06251251343937969,0.19851906500816577,0.15460192482450225,ACTR3,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,2/56,159/21728,0.0633946532607737,0.19851906500816577,0.15460192482450225,PERP/SLC2A3,2
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,2/56,160/21728,0.06409376051327424,0.19851906500816577,0.15460192482450225,LOXL1/PCYT1A,2
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,3/56,357/21728,0.06445373303866524,0.19851906500816577,0.15460192482450225,MET/PDLIM4/USO1,3
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,2/56,161/21728,0.06479550329691351,0.19851906500816577,0.15460192482450225,LDHA/DUSP5,2
BIOCARTA_CARM_ER_PATHWAY,BIOCARTA_CARM_ER_PATHWAY,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,NRIP1,1
BIOCARTA_VIP_PATHWAY,BIOCARTA_VIP_PATHWAY,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,PRKAR1A,1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,MOXD1,1
DALESSIO_TSA_RESPONSE,DALESSIO_TSA_RESPONSE,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,PPP1R15A,1
DEN_INTERACT_WITH_LCA5,DEN_INTERACT_WITH_LCA5,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,HSPA5,1
GROSS_HIF1A_TARGETS_DN,GROSS_HIF1A_TARGETS_DN,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,GBE1,1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,MET,1
HAHTOLA_CTCL_CUTANEOUS,HAHTOLA_CTCL_CUTANEOUS,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,RECQL,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,MET,1
PID_INTEGRIN_CS_PATHWAY,PID_INTEGRIN_CS_PATHWAY,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,ITGB3,1
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,PPP1R15A,1
REACTOME_INSULIN_RECEPTOR_RECYCLING,REACTOME_INSULIN_RECEPTOR_RECYCLING,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,ATP6V1A,1
REACTOME_METAL_ION_SLC_TRANSPORTERS,REACTOME_METAL_ION_SLC_TRANSPORTERS,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,SLC39A14,1
REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,LRRC8E,1
REACTOME_REGULATION_OF_IFNA_SIGNALING,REACTOME_REGULATION_OF_IFNA_SIGNALING,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,IFNAR1,1
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,1/56,26/21728,0.06493150156302108,0.19851906500816577,0.15460192482450225,TPM1,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,2/56,162/21728,0.06549986395011442,0.19949387134520566,0.1553610808079907,PDLIM4/TPM1,2
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,2/56,162/21728,0.06549986395011442,0.19949387134520566,0.1553610808079907,ESR2/PRKAR1A,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,3/56,361/21728,0.06618129552423348,0.2005281756463691,0.15616657239041154,ACBD3/SH3GLB1/PSMD5,3
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/56,164/21728,0.06691636857161679,0.2005281756463691,0.15616657239041154,EFNB2/ITGB3,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,SLC4A7,1
KEGG_PENTOSE_PHOSPHATE_PATHWAY,KEGG_PENTOSE_PHOSPHATE_PATHWAY,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,PRPS2,1
NICK_RESPONSE_TO_PROC_TREATMENT_DN,NICK_RESPONSE_TO_PROC_TREATMENT_DN,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,ATP6V1A,1
REACTOME_GLYCOGEN_METABOLISM,REACTOME_GLYCOGEN_METABOLISM,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,GBE1,1
REACTOME_INTEGRIN_SIGNALING,REACTOME_INTEGRIN_SIGNALING,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,ITGB3,1
REACTOME_SYNDECAN_INTERACTIONS,REACTOME_SYNDECAN_INTERACTIONS,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,ITGB3,1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,ITGB3,1
VALK_AML_CLUSTER_7,VALK_AML_CLUSTER_7,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,TPM1,1
WP_MTHFR_DEFICIENCY,WP_MTHFR_DEFICIENCY,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,PCYT1A,1
XU_AKT1_TARGETS_6HR,XU_AKT1_TARGETS_6HR,1/56,27/21728,0.06734435917579751,0.2005281756463691,0.15616657239041154,PRKAR1A,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,2/56,165/21728,0.06762847756878121,0.20099988035777164,0.15653392479723768,SLC35D1/SLC2A3,2
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,2/56,166/21728,0.06834313449276387,0.2020792134761934,0.15737448375125035,EFNB2/EHBP1,2
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,2/56,166/21728,0.06834313449276387,0.2020792134761934,0.15737448375125035,MOXD1/TPM1,2
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,3/56,366/21728,0.06837076578525368,0.2020792134761934,0.15737448375125035,PERP/SLC4A7/SLC2A3,3
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,2/56,167/21728,0.06906032203259663,0.20213452299243417,0.1574175574866197,PDLIM4/WWTR1,2
BIOCARTA_NO1_PATHWAY,BIOCARTA_NO1_PATHWAY,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,PRKAR1A,1
CHEN_LUNG_CANCER_SURVIVAL,CHEN_LUNG_CANCER_SURVIVAL,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,HSPA5,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,EFNB2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,PPP1R15A,1
LOPES_METHYLATED_IN_COLON_CANCER_UP,LOPES_METHYLATED_IN_COLON_CANCER_UP,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,ESR2,1
PLASARI_NFIC_TARGETS_BASAL_UP,PLASARI_NFIC_TARGETS_BASAL_UP,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,PERP,1
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,WWTR1,1
REACTOME_SYNTHESIS_OF_PC,REACTOME_SYNTHESIS_OF_PC,1/56,28/21728,0.06975110153265496,0.20213452299243417,0.1574175574866197,PCYT1A,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,2/56,168/21728,0.0697800229467315,0.20213452299243417,0.1574175574866197,PTPN14/NRIP1,2
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,2/56,168/21728,0.0697800229467315,0.20213452299243417,0.1574175574866197,MET/IFNAR1,2
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,DUSP5,1
BIOCARTA_DEATH_PATHWAY,BIOCARTA_DEATH_PATHWAY,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,BIRC3,1
GENTLES_LEUKEMIC_STEM_CELL_UP,GENTLES_LEUKEMIC_STEM_CELL_UP,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,BIRC3,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,ATP6V1A,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,PPP1R15A,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,LOXL1,1
PID_S1P_S1P3_PATHWAY,PID_S1P_S1P3_PATHWAY,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,ITGB3,1
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,WWTR1,1
REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,BIRC3,1
VALK_AML_CLUSTER_1,VALK_AML_CLUSTER_1,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,SLC2A3,1
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,SH3GLB1,1
WP_CANNABINOID_RECEPTOR_SIGNALING,WP_CANNABINOID_RECEPTOR_SIGNALING,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,PRKAR1A,1
WP_LIPID_METABOLISM_PATHWAY,WP_LIPID_METABOLISM_PATHWAY,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,PRKAR1A,1
XIE_LT_HSC_S1PR3_OE_UP,XIE_LT_HSC_S1PR3_OE_UP,1/56,29/21728,0.0721517438512802,0.20383505020882872,0.15874188762518965,AKAP12,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,3/56,377/21728,0.07330341278271606,0.2044588950226326,0.15922772312417258,SEC24A/PSMD5/HSPA5,3
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,2/56,173/21728,0.07341562950796035,0.2044588950226326,0.15922772312417258,MET/SEC24A,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,2/56,173/21728,0.07341562950796035,0.2044588950226326,0.15922772312417258,IFNAR1/ZBTB38,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,2/56,173/21728,0.07341562950796035,0.2044588950226326,0.15922772312417258,PPP1R15A/DUSP5,2
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,3/56,378/21728,0.07375963743054267,0.2044588950226326,0.15922772312417258,AKAP12/BIRC3/SEC24A,3
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,AKAP12,1
BIOCARTA_GPCR_PATHWAY,BIOCARTA_GPCR_PATHWAY,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,PRKAR1A,1
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,MCFD2,1
PID_NECTIN_PATHWAY,PID_NECTIN_PATHWAY,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,ITGB3,1
PID_RAS_PATHWAY,PID_RAS_PATHWAY,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,RASA2,1
PID_RETINOIC_ACID_PATHWAY,PID_RETINOIC_ACID_PATHWAY,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,NRIP1,1
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,MET,1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,BIRC3,1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,SLC39A14,1
VALK_AML_CLUSTER_12,VALK_AML_CLUSTER_12,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,NRIP1,1
WANG_RESPONSE_TO_BEXAROTENE_DN,WANG_RESPONSE_TO_BEXAROTENE_DN,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,PCYT1A,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/56,30/21728,0.07454630131219186,0.2044588950226326,0.15922772312417258,MET,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2/56,177/21728,0.07636762222738734,0.20449435073062605,0.15925533518602458,SLC33A1/PSMD5,2
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,3/56,384/21728,0.07652393625680767,0.20449435073062605,0.15925533518602458,TPM1/PRKAR1A/HSPA5,3
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,PPP1R15A,1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,NRIP1,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,MOXD1,1
HUNSBERGER_EXERCISE_REGULATED_GENES,HUNSBERGER_EXERCISE_REGULATED_GENES,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,LDHA,1
MOOTHA_GLUCONEOGENESIS,MOOTHA_GLUCONEOGENESIS,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,LDHA,1
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,ITGB3,1
PID_CD40_PATHWAY,PID_CD40_PATHWAY,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,BIRC3,1
REACTOME_PYRUVATE_METABOLISM,REACTOME_PYRUVATE_METABOLISM,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,LDHA,1
REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,WWTR1,1
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,ATP6V1A,1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,PRKAR1A,1
TSENG_ADIPOGENIC_POTENTIAL_UP,TSENG_ADIPOGENIC_POTENTIAL_UP,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,EFNB2,1
URS_ADIPOCYTE_DIFFERENTIATION_DN,URS_ADIPOCYTE_DIFFERENTIATION_DN,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,LOXL1,1
WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,WP_CELL_MIGRATION_AND_INVASION_THROUGH_P75NTR,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,EFNB2,1
WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,IFNAR1,1
WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,1/56,31/21728,0.07693478905882878,0.20449435073062605,0.15925533518602458,IFNAR1,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,3/56,385/21728,0.07698911766093613,0.20449435073062605,0.15925533518602458,LOXL1/SLC4A7/TPM1,3
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,2/56,179/21728,0.07785775341905805,0.205713530175204,0.16020480313173782,SLC39A14/FNDC3B,2
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,2/56,180/21728,0.07860629493809669,0.205713530175204,0.16020480313173782,PRPS2/SLC39A14,2
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,LOXL1,1
FARDIN_HYPOXIA_11,FARDIN_HYPOXIA_11,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,SLC2A3,1
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,ESR2,1
LIU_BREAST_CANCER,LIU_BREAST_CANCER,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,PCYT1A,1
POS_HISTAMINE_RESPONSE_NETWORK,POS_HISTAMINE_RESPONSE_NETWORK,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,LOXL1,1
REACTOME_PERK_REGULATES_GENE_EXPRESSION,REACTOME_PERK_REGULATES_GENE_EXPRESSION,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,HSPA5,1
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,WWTR1,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,PPP1R15A,1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,IFNAR1,1
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,1/56,32/21728,0.0793172221976357,0.205713530175204,0.16020480313173782,ITGB3,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,2/56,181/21728,0.07935713190383122,0.205713530175204,0.16020480313173782,MET/SH3GLB1,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,2/56,182/21728,0.08011024802252781,0.205713530175204,0.16020480313173782,PTPN14/PERP,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,2/56,182/21728,0.08011024802252781,0.205713530175204,0.16020480313173782,AKAP12/TPM1,2
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,2/56,182/21728,0.08011024802252781,0.205713530175204,0.16020480313173782,BIRC3/SLC4A7,2
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,2/56,183/21728,0.0808656270664624,0.205713530175204,0.16020480313173782,LDHA/HSPA5,2
BIOCARTA_MET_PATHWAY,BIOCARTA_MET_PATHWAY,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,MET,1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,SEC24A,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,TPM1,1
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,BIRC3,1
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,GBE1,1
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,PDLIM4,1
KEGG_PROPANOATE_METABOLISM,KEGG_PROPANOATE_METABOLISM,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,LDHA,1
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,ZBTB38,1
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,PKD2,1
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,PRKAR1A,1
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,PRKAR1A,1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,NRIP1,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,IFNAR1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,ESR2,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,NRIP1,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1/56,33/21728,0.08169361579815793,0.205713530175204,0.16020480313173782,BIRC3,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,2/56,185/21728,0.08238310934786508,0.20712357208684948,0.16130291022595894,RASA2/MET,2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,2/56,186/21728,0.08314518045793876,0.20724749224480757,0.16139941629676924,MCFD2/USO1,2
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,2/56,186/21728,0.08314518045793876,0.20724749224480757,0.16139941629676924,NRIP1/TPM1,2
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,LDHA,1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,ESR2,1
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,LOXL1,1
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,GBE1,1
REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,SLC35D1,1
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,BIRC3,1
VANTVEER_BREAST_CANCER_BRCA1_UP,VANTVEER_BREAST_CANCER_BRCA1_UP,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,DNTTIP2,1
WANG_RESPONSE_TO_BEXAROTENE_UP,WANG_RESPONSE_TO_BEXAROTENE_UP,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,RASA2,1
WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,MET,1
WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,1/56,34/21728,0.08406398489312505,0.20724749224480757,0.16139941629676924,PERP,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,3/56,400/21728,0.08411733737766111,0.20724749224480757,0.16139941629676924,AKAP12/ATP6V1A/PKD2,3
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,2/56,188/21728,0.08467590278711878,0.2083027208563122,0.16222120323426967,MOXD1/PDLIM4,2
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,2/56,190/21728,0.08621529291162099,0.20844483080118356,0.16233187507837146,DUSP5/PKD2,2
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,LOXL1,1
FRASOR_RESPONSE_TO_ESTRADIOL_UP,FRASOR_RESPONSE_TO_ESTRADIOL_UP,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,NRIP1,1
GYORFFY_MITOXANTRONE_RESISTANCE,GYORFFY_MITOXANTRONE_RESISTANCE,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,SLC33A1,1
HONMA_DOCETAXEL_RESISTANCE,HONMA_DOCETAXEL_RESISTANCE,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,HSPA5,1
KEGG_PRION_DISEASES,KEGG_PRION_DISEASES,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,HSPA5,1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,EFNB2,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,TPM1,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,TPM1,1
PID_HIV_NEF_PATHWAY,PID_HIV_NEF_PATHWAY,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,BIRC3,1
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,BIRC3,1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,ACTR3,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/56,35/21728,0.08642834447853953,0.20844483080118356,0.16233187507837146,BIRC3,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,3/56,409/21728,0.08852701097205568,0.21095088932022954,0.16428353383090194,LOXL1/FEM1B/PKD2,3
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,3/56,409/21728,0.08852701097205568,0.21095088932022954,0.16428353383090194,STBD1/PPP1R15A/DUSP5,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,2/56,193/21728,0.088540355049137,0.21095088932022954,0.16428353383090194,BIRC3/TPM1,2
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,EFNB2,1
HEIDENBLAD_AMPLICON_12P11_12_UP,HEIDENBLAD_AMPLICON_12P11_12_UP,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,ACTR3,1
REACTOME_NOD1_2_SIGNALING_PATHWAY,REACTOME_NOD1_2_SIGNALING_PATHWAY,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,BIRC3,1
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,ACTR3,1
REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,ATP6V1A,1
REACTOME_STRIATED_MUSCLE_CONTRACTION,REACTOME_STRIATED_MUSCLE_CONTRACTION,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,TPM1,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/56,36/21728,0.08878670951376766,0.21095088932022954,0.16428353383090194,DUSP5,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,2/56,194/21728,0.08931957389883123,0.21181891392394928,0.16495953074094466,ITGB3/TPM1,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,3/56,412/21728,0.09001852897677712,0.21181891392394928,0.16495953074094466,CLEC5A/SLC2A3/DNTTIP2,3
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,2/56,195/21728,0.09010086600971354,0.21181891392394928,0.16495953074094466,MET/WWTR1,2
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,2/56,195/21728,0.09010086600971354,0.21181891392394928,0.16495953074094466,NRIP1/PCYT1A,2
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,2/56,195/21728,0.09010086600971354,0.21181891392394928,0.16495953074094466,TPM1/WWTR1,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,CLEC5A,1
GENTILE_UV_RESPONSE_CLUSTER_D7,GENTILE_UV_RESPONSE_CLUSTER_D7,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,MET,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,GBE1,1
REACTOME_CA_DEPENDENT_EVENTS,REACTOME_CA_DEPENDENT_EVENTS,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,PRKAR1A,1
REACTOME_RHOH_GTPASE_CYCLE,REACTOME_RHOH_GTPASE_CYCLE,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,SLC4A7,1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,BIRC3,1
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,ITGB3,1
WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,IFNAR1,1
WP_PRION_DISEASE_PATHWAY,WP_PRION_DISEASE_PATHWAY,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,HSPA5,1
WP_ZINC_HOMEOSTASIS,WP_ZINC_HOMEOSTASIS,1/56,37/21728,0.0911390949216242,0.21181891392394928,0.16495953074094466,SLC39A14,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,2/56,197/21728,0.09166960851980527,0.21274267637615185,0.1656789349613164,SLC4A7/PKD2,2
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,2/56,198/21728,0.0924570283285923,0.21324299490150062,0.16606857112568726,ATP6V1A/TASP1,2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,2/56,199/21728,0.09324646021729799,0.21324299490150062,0.16606857112568726,PRKAR1A/PKD2,2
BERNARD_PPAPDC1B_TARGETS_UP,BERNARD_PPAPDC1B_TARGETS_UP,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,ZBTB38,1
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,MOXD1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,PERP,1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,LOXL1,1
PID_FAS_PATHWAY,PID_FAS_PATHWAY,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,BIRC3,1
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,ITGB3,1
REACTOME_SMOOTH_MUSCLE_CONTRACTION,REACTOME_SMOOTH_MUSCLE_CONTRACTION,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,TPM1,1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,TBC1D19,1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,TPM1,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/56,38/21728,0.09348551558846274,0.21324299490150062,0.16606857112568726,TPM1,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,2/56,200/21728,0.09403788904695293,0.21419741394028166,0.16681184996632975,LOXL1/SLC33A1,2
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,2/56,201/21728,0.09483129974070456,0.21460189383256617,0.16712684928338487,PRKAR1A/HSPA5,2
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,2/56,201/21728,0.09483129974070456,0.21460189383256617,0.16712684928338487,FNDC3B/DUSP5,2
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,3/56,422/21728,0.09506685668574406,0.21460189383256617,0.16712684928338487,BIRC3/CLEC5A/DUSP5,3
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,TPM1,1
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,TPM1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,SLC2A3,1
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,HIVEP3,1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,EFNB2,1
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,ITGB3,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,NRIP1,1
WP_NUCLEAR_RECEPTORS,WP_NUCLEAR_RECEPTORS,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,ESR2,1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1/56,39/21728,0.09582598636426032,0.21460189383256617,0.16712684928338487,NRIP1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,2/56,203/21728,0.09642400672241216,0.21501188325790077,0.1674461392937011,PPFIBP1/HSPA5,2
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,2/56,205/21728,0.09802446178197047,0.21501188325790077,0.1674461392937011,MET/DUSP5,2
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,2/56,205/21728,0.09802446178197047,0.21501188325790077,0.1674461392937011,DNTTIP2/DUSP5,2
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,3/56,428/21728,0.0981514515877012,0.21501188325790077,0.1674461392937011,SLC4A7/SLC39A14/HSPA5,3
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,SLC4A7,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,GBE1,1
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,EFNB2,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,PPP1R15A,1
HOFMANN_CELL_LYMPHOMA_DN,HOFMANN_CELL_LYMPHOMA_DN,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,IFNAR1,1
KEGG_PYRUVATE_METABOLISM,KEGG_PYRUVATE_METABOLISM,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,LDHA,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,SLC35D1,1
PID_EPHB_FWD_PATHWAY,PID_EPHB_FWD_PATHWAY,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,EFNB2,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,ESR2,1
REACTOME_MAP2K_AND_MAPK_ACTIVATION,REACTOME_MAP2K_AND_MAPK_ACTIVATION,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,ITGB3,1
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,AKAP12,1
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1/56,40/21728,0.09816052206270642,0.21501188325790077,0.1674461392937011,GBE1,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,2/56,208/21728,0.10043941328383808,0.2162612796777975,0.1684191395008949,BIRC3/PSMD5,2
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,HSPA5,1
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,NRIP1,1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,SH3GLB1,1
LEONARD_HYPOXIA,LEONARD_HYPOXIA,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,SLC2A3,1
LIAO_HAVE_SOX4_BINDING_SITES,LIAO_HAVE_SOX4_BINDING_SITES,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,PTPN14,1
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,NRIP1,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,NRIP1,1
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,MET,1
REACTOME_DAG_AND_IP3_SIGNALING,REACTOME_DAG_AND_IP3_SIGNALING,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,PRKAR1A,1
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,MET,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,WWTR1,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/56,41/21728,0.10048913746129051,0.2162612796777975,0.1684191395008949,SLC39A14,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,3/56,433/21728,0.10075317985980904,0.21653808413418638,0.16863470822602447,GOLGA5/PPFIBP1/DUSP5,3
CHEN_HOXA5_TARGETS_9HR_DN,CHEN_HOXA5_TARGETS_9HR_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,LOXL1,1
ELLWOOD_MYC_TARGETS_DN,ELLWOOD_MYC_TARGETS_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,MCFD2,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,SLC2A3,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,MET,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,PKD2,1
PID_BMP_PATHWAY,PID_BMP_PATHWAY,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,PPP1R15A,1
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,MET,1
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,ITGB3,1
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,PRKAR1A,1
WIERENGA_PML_INTERACTOME,WIERENGA_PML_INTERACTOME,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,HSPA5,1
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,BIRC3,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,ZHAN_MULTIPLE_MYELOMA_MF_DN,1/56,42/21728,0.10281184730138637,0.21745521671285292,0.16934894925861887,MOXD1,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,2/56,212/21728,0.10368536997383342,0.2190130866422188,0.1705621812960369,PTPN14/PERP,2
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,3/56,440/21728,0.10444247731054045,0.22031551427923846,0.1715764809534506,MET/DNTTIP2/HSPA5,3
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,1/56,43/21728,0.10512866628834205,0.22031551427923846,0.1715764809534506,HIVEP3,1
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,1/56,43/21728,0.10512866628834205,0.22031551427923846,0.1715764809534506,ITGB3,1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1/56,43/21728,0.10512866628834205,0.22031551427923846,0.1715764809534506,DUSP5,1
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1/56,43/21728,0.10512866628834205,0.22031551427923846,0.1715764809534506,NRIP1,1
REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,1/56,43/21728,0.10512866628834205,0.22031551427923846,0.1715764809534506,PRKAR1A,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,2/56,215/21728,0.10613884819598009,0.22138651409460094,0.17241055012929987,MET/EFNB2,2
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,2/56,216/21728,0.10696021923096663,0.22138651409460094,0.17241055012929987,MET/PCYT1A,2
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,2/56,216/21728,0.10696021923096663,0.22138651409460094,0.17241055012929987,WWTR1/FNDC3B,2
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,ACTR3,1
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,CLEC5A,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,BIRC3,1
PID_HNF3A_PATHWAY,PID_HNF3A_PATHWAY,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,NRIP1,1
REACTOME_DAP12_INTERACTIONS,REACTOME_DAP12_INTERACTIONS,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,CLEC5A,1
REACTOME_INTRA_GOLGI_TRAFFIC,REACTOME_INTRA_GOLGI_TRAFFIC,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,GOLGA5,1
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,BIRC3,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,PERP,1
VANHARANTA_UTERINE_FIBROID_UP,VANHARANTA_UTERINE_FIBROID_UP,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,EFNB2,1
WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1/56,44/21728,0.10743960909156369,0.22138651409460094,0.17241055012929987,LDHA,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,3/56,446/21728,0.10764749044101761,0.2215293915253374,0.17252181967313396,MET/ITGB3/WWTR1,3
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,2/56,218/21728,0.10860819398707007,0.22253401880879506,0.17330419950021694,MET/EFNB2,2
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/56,219/21728,0.10943476966163927,0.22253401880879506,0.17330419950021694,ESR2/NRIP1,2
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,2/56,219/21728,0.10943476966163927,0.22253401880879506,0.17330419950021694,BIRC3/PSMD5,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,LDHA,1
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,PSMD5,1
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,DUSP5,1
REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,ITGB3,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,PPFIBP1,1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,LDHA,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,ACTR3,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/56,45/21728,0.10974469034460166,0.22253401880879506,0.17330419950021694,SLC39A14,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,3/56,450/21728,0.10980571659796078,0.22253401880879506,0.17330419950021694,STBD1/AKAP12/SLC4A7,3
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,2/56,220/21728,0.11026305226670963,0.22317800072717559,0.17380571729715855,TMCO3/ATP6V1A,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,2/56,222/21728,0.11192468281503365,0.22338932108196444,0.1739702885619064,BIRC3/PPP1R15A,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,PDLIM4,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,PPP1R15A,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,PPFIBP1,1
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,MET,1
LANDIS_BREAST_CANCER_PROGRESSION_UP,LANDIS_BREAST_CANCER_PROGRESSION_UP,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,ATP6V1A,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,DUSP5,1
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,MET,1
PID_SYNDECAN_1_PATHWAY,PID_SYNDECAN_1_PATHWAY,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,MET,1
PID_TNF_PATHWAY,PID_TNF_PATHWAY,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,BIRC3,1
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,WWTR1,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/56,46/21728,0.11204392464523794,0.22338932108196444,0.1739702885619064,ESR2,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,2/56,223/21728,0.11275800317602372,0.2245330598735516,0.17486100512189298,STBD1/LRRC8E,2
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,3/56,456/21728,0.11307484636780743,0.22488392953000508,0.17513425406273395,HIVEP3/GBE1/DUSP5,3
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/56,47/21728,0.11433732655557216,0.22598935125137193,0.17599513020004148,SLC2A3,1
PID_DELTA_NP63_PATHWAY,PID_DELTA_NP63_PATHWAY,1/56,47/21728,0.11433732655557216,0.22598935125137193,0.17599513020004148,PERP,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/56,47/21728,0.11433732655557216,0.22598935125137193,0.17599513020004148,NRIP1,1
YANG_BREAST_CANCER_ESR1_LASER_DN,YANG_BREAST_CANCER_ESR1_LASER_DN,1/56,47/21728,0.11433732655557216,0.22598935125137193,0.17599513020004148,FNDC3B,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1/56,47/21728,0.11433732655557216,0.22598935125137193,0.17599513020004148,LDHA,1
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,TPM1,1
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,FEM1B,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,TPM1,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,LDHA,1
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,MET,1
REACTOME_HEME_SIGNALING,REACTOME_HEME_SIGNALING,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,NRIP1,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,LDHA,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,SLC39A14,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,NRIP1,1
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1/56,48/21728,0.11662491060210556,0.22769625403268226,0.17732442547688565,ITGB3,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,2/56,228/21728,0.11694910936692592,0.22805076326550552,0.17760050883321354,NRIP1/TPM1,2
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,2/56,229/21728,0.11779213674525583,0.22852379729572933,0.1779688964819116,AKAP12/SLC39A14,2
FAELT_B_CLL_WITH_VH3_21_DN,FAELT_B_CLL_WITH_VH3_21_DN,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,ACBD3,1
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,MOXD1,1
JIANG_AGING_CEREBRAL_CORTEX_DN,JIANG_AGING_CEREBRAL_CORTEX_DN,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,ACTR3,1
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,BIRC3,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,BIRC3,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,GBE1,1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,PSMD5,1
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,SLC2A3,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,STBD1,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,ZHAN_MULTIPLE_MYELOMA_PR_DN,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,SH3GLB1,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/56,49/21728,0.11890669127582665,0.22852379729572933,0.1779688964819116,ITGB3,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,2/56,233/21728,0.12117982077354898,0.23040560067615481,0.17943440018425408,AKAP12/EML1,2
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,EFNB2,1
BUFFA_HYPOXIA_METAGENE,BUFFA_HYPOXIA_METAGENE,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,LDHA,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,GBE1,1
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,PSMD5,1
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,HSPA5,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,BIRC3,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,SLC2A3,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,ZHAN_MULTIPLE_MYELOMA_MS_UP,1/56,50/21728,0.12118268303229907,0.23040560067615481,0.17943440018425408,NRIP1,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,3/56,472/21728,0.12197387851169875,0.2306088639795494,0.17959269680906287,PERP/SLC33A1/HSPA5,3
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,2/56,234/21728,0.12203056928667343,0.2306088639795494,0.17959269680906287,FEM1B/PSMD5,2
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,3/56,473/21728,0.12253860499033449,0.2306088639795494,0.17959269680906287,BIRC3/PERP/SLC2A3,3
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,2/56,235/21728,0.1228828225475704,0.2306088639795494,0.17959269680906287,DUSP5/PKD2,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,3/56,474/21728,0.12310431531585989,0.2306088639795494,0.17959269680906287,GBE1/SLC2A3/DUSP5,3
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,LDHA,1
BIOCARTA_NFAT_PATHWAY,BIOCARTA_NFAT_PATHWAY,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,PRKAR1A,1
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,PKD2,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,PPP1R15A,1
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,BIRC3,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,BIRC3,1
REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,PKD2,1
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,EFNB2,1
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,AKAP12,1
VILIMAS_NOTCH1_TARGETS_UP,VILIMAS_NOTCH1_TARGETS_UP,1/56,51/21728,0.12345290029174127,0.2306088639795494,0.17959269680906287,BIRC3,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,2/56,236/21728,0.12373656752559892,0.23086904489315363,0.1797953195145655,BIRC3/KCTD9,2
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,2/56,237/21728,0.12459179124506257,0.23192348568201984,0.18061649291453835,RASA2/SLC2A3,2
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,2/56,237/21728,0.12459179124506257,0.23192348568201984,0.18061649291453835,PERP/WWTR1,2
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/56,238/21728,0.12544848078502227,0.23212708377037874,0.18077505026191243,PTPN14/LOXL1,2
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,2/56,238/21728,0.12544848078502227,0.23212708377037874,0.18077505026191243,LOXL1/TPM1,2
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1/56,52/21728,0.12571735743911694,0.23212708377037874,0.18077505026191243,PKD2,1
KEGG_STARCH_AND_SUCROSE_METABOLISM,KEGG_STARCH_AND_SUCROSE_METABOLISM,1/56,52/21728,0.12571735743911694,0.23212708377037874,0.18077505026191243,GBE1,1
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,1/56,52/21728,0.12571735743911694,0.23212708377037874,0.18077505026191243,ITGB3,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/56,52/21728,0.12571735743911694,0.23212708377037874,0.18077505026191243,SLC2A3,1
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,1/56,52/21728,0.12571735743911694,0.23212708377037874,0.18077505026191243,PRKAR1A,1
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,3/56,479/21728,0.12594750454297968,0.23228380595642964,0.1808971017718023,STBD1/CLEC5A/SLC2A3,3
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,2/56,240/21728,0.12716620591533054,0.23426124799379439,0.18243708658481209,SLC2A3/DNTTIP2,2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1/56,53/21728,0.12797606882421608,0.23450028037164772,0.18262323931382066,AKAP12,1
MARTIN_VIRAL_GPCR_SIGNALING_DN,MARTIN_VIRAL_GPCR_SIGNALING_DN,1/56,53/21728,0.12797606882421608,0.23450028037164772,0.18262323931382066,STBD1,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/56,53/21728,0.12797606882421608,0.23450028037164772,0.18262323931382066,PPP1R15A,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,3/56,483/21728,0.12823941479483703,0.23450028037164772,0.18262323931382066,BIRC3/PPP1R15A/NRIP1,3
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,2/56,242/21728,0.12888964063703134,0.23450028037164772,0.18262323931382066,SLC2A3/SLC33A1,2
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,3/56,485/21728,0.1293910804541891,0.23450028037164772,0.18262323931382066,PDLIM4/WWTR1/TASP1,3
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,NRIP1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,LOXL1,1
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,SLC39A14,1
KEGG_VIBRIO_CHOLERAE_INFECTION,KEGG_VIBRIO_CHOLERAE_INFECTION,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,ATP6V1A,1
PID_RAC1_PATHWAY,PID_RAC1_PATHWAY,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,ACTR3,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,PERP,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,PPP1R15A,1
REACTOME_G_PROTEIN_MEDIATED_EVENTS,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,PRKAR1A,1
REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,PSMD5,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,NRIP1,1
SUNG_METASTASIS_STROMA_DN,SUNG_METASTASIS_STROMA_DN,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,EML1,1
WAKASUGI_HAVE_ZNF143_BINDING_SITES,WAKASUGI_HAVE_ZNF143_BINDING_SITES,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,RECQL,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,HSPA5,1
WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1/56,54/21728,0.13022904876174057,0.23450028037164772,0.18262323931382066,PCYT1A,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,2/56,246/21728,0.13235323405154256,0.23510501902185316,0.18309419538715135,GBE1/SLC35D1,2
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,MET,1
PID_FGF_PATHWAY,PID_FGF_PATHWAY,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,MET,1
REACTOME_AMINO_ACIDS_REGULATE_MTORC1,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,ATP6V1A,1
REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,PSMD5,1
REACTOME_DEGRADATION_OF_AXIN,REACTOME_DEGRADATION_OF_AXIN,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,PSMD5,1
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,LDHA,1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,SEC24A,1
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,PSMD5,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,SLC4A7,1
RICKMAN_HEAD_AND_NECK_CANCER_F,RICKMAN_HEAD_AND_NECK_CANCER_F,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,TPM1,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,IFNAR1,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/56,55/21728,0.13247631153138817,0.23510501902185316,0.18309419538715135,MET,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,3/56,493/21728,0.1340351689785558,0.23645870069519231,0.18414841046865643,PERP/ITGB3/TPM1,3
BIOCARTA_HIVNEF_PATHWAY,BIOCARTA_HIVNEF_PATHWAY,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,BIRC3,1
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,PPP1R15A,1
MAYBURD_RESPONSE_TO_L663536_DN,MAYBURD_RESPONSE_TO_L663536_DN,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,IFNAR1,1
OUILLETTE_CLL_13Q14_DELETION_DN,OUILLETTE_CLL_13Q14_DELETION_DN,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,PKD2,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,PDLIM4,1
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,ACBD3,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,BIRC3,1
REACTOME_REGULATED_NECROSIS,REACTOME_REGULATED_NECROSIS,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,BIRC3,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/56,56/21728,0.13471787137793634,0.23645870069519231,0.18414841046865643,LDHA,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,3/56,496/21728,0.13579189309893186,0.23751522155706234,0.18497120377999718,ACTR3/NRIP1/TASP1,3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/56,250/21728,0.13583845996960556,0.23751522155706234,0.18497120377999718,BIRC3/DUSP5,2
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,AKAP12,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,PPFIBP1,1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,GBE1,1
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,DUSP5,1
REACTOME_DEGRADATION_OF_DVL,REACTOME_DEGRADATION_OF_DVL,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,PSMD5,1
REACTOME_STABILIZATION_OF_P53,REACTOME_STABILIZATION_OF_P53,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,PSMD5,1
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SMIRNOV_RESPONSE_TO_IR_2HR_DN,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,SLC2A3,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,TPM1,1
ZAMORA_NOS2_TARGETS_UP,ZAMORA_NOS2_TARGETS_UP,1/56,57/21728,0.13695374251132675,0.23751522155706234,0.18497120377999718,PTPN14,1
CROMER_TUMORIGENESIS_UP,CROMER_TUMORIGENESIS_UP,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,SLC2A3,1
HUPER_BREAST_BASAL_VS_LUMINAL_DN,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,LOXL1,1
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,ATP6V1A,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,BIRC3,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,SLC4A7,1
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,SLC2A3,1
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,HIVEP3,1
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,SLC35D1,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,PERP,1
REACTOME_IRON_UPTAKE_AND_TRANSPORT,REACTOME_IRON_UPTAKE_AND_TRANSPORT,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,ATP6V1A,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/56,58/21728,0.13918393910674765,0.238537104642754,0.18576702201532405,ATP6V1A,1
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,AKAP12,1
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,RECQL,1
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,PPP1R15A,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,NRIP1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,WWTR1,1
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,GOLGA5,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,BIRC3,1
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,DUSP5,1
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,PSMD5,1
REACTOME_METABOLISM_OF_POLYAMINES,REACTOME_METABOLISM_OF_POLYAMINES,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,PSMD5,1
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,ITGB3,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,SLC4A7,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/56,59/21728,0.141408475304718,0.23901918817361953,0.18614245719982353,MET,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/56,258/21728,0.1428706726177992,0.24120110408813758,0.1878416814036844,AKAP12/MET,2
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/56,60/21728,0.14362736521117137,0.24120110408813758,0.1878416814036844,MET,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1/56,60/21728,0.14362736521117137,0.24120110408813758,0.1878416814036844,DUSP5,1
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1/56,60/21728,0.14362736521117137,0.24120110408813758,0.1878416814036844,PSMD5,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/56,60/21728,0.14362736521117137,0.24120110408813758,0.1878416814036844,PSMD5,1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,1/56,60/21728,0.14362736521117137,0.24120110408813758,0.1878416814036844,PDLIM4,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,2/56,259/21728,0.14375525465665737,0.24120110408813758,0.1878416814036844,LOXL1/SLC2A3,2
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2/56,261/21728,0.1455279921413801,0.24266301354127193,0.18898018170522676,ITGB3/HSPA5,2
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,SLC33A1,1
ISSAEVA_MLL2_TARGETS,ISSAEVA_MLL2_TARGETS,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,LOXL1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,MET,1
PID_AR_PATHWAY,PID_AR_PATHWAY,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,NRIP1,1
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,LOXL1,1
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,PSMD5,1
WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1/56,61/21728,0.1458406228975374,0.24266301354127193,0.18898018170522676,RASA2,1
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,2/56,262/21728,0.14641612421335115,0.24336734159786744,0.18952869563890407,ACTR3/PERP,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,2/56,263/21728,0.1473054163396436,0.24430255064903944,0.190257014198225,SH3GLB1/WWTR1,2
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,LDHA,1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,BIRC3,1
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,NRIP1,1
REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,PSMD5,1
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,ITGB3,1
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1/56,62/21728,0.14804826240082503,0.24430255064903944,0.190257014198225,ITGB3,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,2/56,265/21728,0.14908743455931714,0.24551061571611546,0.19119782653116396,MET/IFNAR1,2
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,2/56,265/21728,0.14908743455931714,0.24551061571611546,0.19119782653116396,BIRC3/SLC2A3,2
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,1/56,63/21728,0.15025029772370702,0.24615801850431096,0.19170200842013094,PTPN14,1
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/56,63/21728,0.15025029772370702,0.24615801850431096,0.19170200842013094,TPM1,1
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,1/56,63/21728,0.15025029772370702,0.24615801850431096,0.19170200842013094,HSPA5,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1/56,63/21728,0.15025029772370702,0.24615801850431096,0.19170200842013094,ATP6V1A,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,1/56,63/21728,0.15025029772370702,0.24615801850431096,0.19170200842013094,LDHA,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,2/56,267/21728,0.1508739549065141,0.2469267695962293,0.19230069348101728,RASA2/DUSP5,2
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,2/56,268/21728,0.15176887487800642,0.24797796723552745,0.19311934119326485,MET/NRIP1,2
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1/56,64/21728,0.1524467428345988,0.24797796723552745,0.19311934119326485,MET,1
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,1/56,64/21728,0.1524467428345988,0.24797796723552745,0.19311934119326485,ITGB3,1
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1/56,64/21728,0.1524467428345988,0.24797796723552745,0.19311934119326485,PSMD5,1
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,1/56,64/21728,0.1524467428345988,0.24797796723552745,0.19311934119326485,MET,1
WP_PROTEASOME_DEGRADATION,WP_PROTEASOME_DEGRADATION,1/56,64/21728,0.1524467428345988,0.24797796723552745,0.19311934119326485,PSMD5,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,2/56,269/21728,0.1526648862800779,0.2480804402051266,0.1931991447040353,PERP/PDLIM4,2
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,FEM1B,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,DUSP5,1
KORKOLA_YOLK_SAC_TUMOR,KORKOLA_YOLK_SAC_TUMOR,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,SLC2A3,1
PID_CD8_TCR_DOWNSTREAM_PATHWAY,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,IFNAR1,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,MET,1
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,PSMD5,1
REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,PSMD5,1
REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,ITGB3,1
RHODES_CANCER_META_SIGNATURE,RHODES_CANCER_META_SIGNATURE,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,LDHA,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,DUSP5,1
WP_FERROPTOSIS,WP_FERROPTOSIS,1/56,65/21728,0.1546376116677438,0.24850808146404257,0.1935321815423866,SLC39A14,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1/56,66/21728,0.15682291812329574,0.251010856936086,0.19548128353601904,MOXD1,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/56,66/21728,0.15682291812329574,0.251010856936086,0.19548128353601904,DUSP5,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/56,66/21728,0.15682291812329574,0.251010856936086,0.19548128353601904,SLC2A3,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/56,66/21728,0.15682291812329574,0.251010856936086,0.19548128353601904,LDHA,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,2/56,274/21728,0.15716092219197234,0.2510492653196441,0.19551119507135314,PPP1R15A/DUSP5,2
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,2/56,274/21728,0.15716092219197234,0.2510492653196441,0.19551119507135314,MOXD1/PDLIM4,2
CADWELL_ATG16L1_TARGETS_DN,CADWELL_ATG16L1_TARGETS_DN,1/56,67/21728,0.1590026760673955,0.2527289055981763,0.19681925895964097,PPFIBP1,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1/56,67/21728,0.1590026760673955,0.2527289055981763,0.19681925895964097,PERP,1
RIGGINS_TAMOXIFEN_RESISTANCE_UP,RIGGINS_TAMOXIFEN_RESISTANCE_UP,1/56,67/21728,0.1590026760673955,0.2527289055981763,0.19681925895964097,TPM1,1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1/56,67/21728,0.1590026760673955,0.2527289055981763,0.19681925895964097,DUSP5,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/56,67/21728,0.1590026760673955,0.2527289055981763,0.19681925895964097,MET,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,PERP,1
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,PTPN14,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,BIRC3,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,PSMD5,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,ACTR3,1
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,IFNAR1,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1/56,68/21728,0.16117689933225987,0.2544144738719482,0.1981319394295874,LDHA,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/56,279/21728,0.1616825748063975,0.254709790261507,0.19836192480784884,STBD1/LRRC8E,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/56,279/21728,0.1616825748063975,0.254709790261507,0.19836192480784884,BIRC3/SLC4A7,2
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,1/56,69/21728,0.16334560171625745,0.25606825210225065,0.19941986257000266,BIRC3,1
LEE_AGING_NEOCORTEX_DN,LEE_AGING_NEOCORTEX_DN,1/56,69/21728,0.16334560171625745,0.25606825210225065,0.19941986257000266,FEM1B,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/56,69/21728,0.16334560171625745,0.25606825210225065,0.19941986257000266,BIRC3,1
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,1/56,69/21728,0.16334560171625745,0.25606825210225065,0.19941986257000266,ITGB3,1
REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1/56,69/21728,0.16334560171625745,0.25606825210225065,0.19941986257000266,PSMD5,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,2/56,282/21728,0.16440729545171615,0.25669114100621276,0.19990495362914304,PPP1R15A/ZBTB38,2
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,2/56,283/21728,0.1653174260933076,0.25669114100621276,0.19990495362914304,AKAP12/BIRC3,2
DITTMER_PTHLH_TARGETS_DN,DITTMER_PTHLH_TARGETS_DN,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,SEC24A,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,SLC35D1,1
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,MET,1
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,SLC2A3,1
PID_CDC42_PATHWAY,PID_CDC42_PATHWAY,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,ACTR3,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,NRIP1,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,TPM1,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,HSPA5,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/56,70/21728,0.16550879698399334,0.25669114100621276,0.19990495362914304,PCYT1A,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,2/56,285/21728,0.16714045937093572,0.2582839418953317,0.20114538906696783,AKAP12/TPM1,2
KEGG_MELANOMA,KEGG_MELANOMA,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,MET,1
LIN_NPAS4_TARGETS_DN,LIN_NPAS4_TARGETS_DN,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,SLC4A7,1
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,IFNAR1,1
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,PSMD5,1
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,SLC35D1,1
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1/56,71/21728,0.16766649886638796,0.2582839418953317,0.20114538906696783,BIRC3,1
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/56,72/21728,0.16981872106075835,0.2605951391325841,0.20294529448921825,SLC2A3,1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1/56,72/21728,0.16981872106075835,0.2605951391325841,0.20294529448921825,ACBD3,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/56,72/21728,0.16981872106075835,0.2605951391325841,0.20294529448921825,PERP,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/56,72/21728,0.16981872106075835,0.2605951391325841,0.20294529448921825,MET,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,2/56,290/21728,0.17171372346951083,0.2618788553259142,0.2039450221194539,LDHA/PERP,2
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,PERP,1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,DUSP5,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,SLC2A3,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,MET,1
LINDVALL_IMMORTALIZED_BY_TERT_DN,LINDVALL_IMMORTALIZED_BY_TERT_DN,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,AKAP12,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,SLC35D1,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/56,73/21728,0.1719654772309005,0.2618788553259142,0.2039450221194539,SEC24A,1
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,2/56,291/21728,0.17263098143327743,0.26263843663251035,0.20453656596969141,RASA2/MET,2
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,HSPA5,1
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,BIRC3,1
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,ITGB3,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,MET,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,ITGB3,1
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,PSMD5,1
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,STBD1,1
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,DUSP5,1
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1/56,74/21728,0.1741067810071676,0.26263843663251035,0.20453656596969141,ITGB3,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,2/56,293/21728,0.17446802040722637,0.26293531067969367,0.20476776441465233,GBE1/PRPS2,2
MCCLUNG_COCAINE_REWARD_5D,MCCLUNG_COCAINE_REWARD_5D,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,HSPA5,1
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,PSMD5,1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,ESR2,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,EFNB2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,TPM1,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/56,75/21728,0.1762426459865526,0.2639672854843073,0.20557144184058165,MET,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,2/56,295/21728,0.1763083557831396,0.2639672854843073,0.20557144184058165,ESR2/NRIP1,2
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,2/56,296/21728,0.17722973441788112,0.26509854568212526,0.20645244036862131,HIVEP3/PPP1R15A,2
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,2/56,297/21728,0.1781519069978088,0.2655666332278325,0.2068169758128606,BIRC3/PSMD5,2
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/56,76/21728,0.17837308573276556,0.2655666332278325,0.2068169758128606,ACTR3,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/56,76/21728,0.17837308573276556,0.2655666332278325,0.2068169758128606,LDHA,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/56,76/21728,0.17837308573276556,0.2655666332278325,0.2068169758128606,ITGB3,1
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1/56,76/21728,0.17837308573276556,0.2655666332278325,0.2068169758128606,ITGB3,1
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,PCYT1A,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,TPM1,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,MET,1
MALONEY_RESPONSE_TO_17AAG_DN,MALONEY_RESPONSE_TO_17AAG_DN,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,LDHA,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,HSPA5,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1/56,77/21728,0.18049811377631664,0.2672374851188244,0.2081181955140181,LDHA,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,2/56,300/21728,0.1809230890413275,0.26761888934050204,0.2084152240478022,LOXL1/PDLIM4,2
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,2/56,301/21728,0.18184833825555985,0.26863456489395965,0.20920620800470965,LOXL1/ITGB3,2
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/56,78/21728,0.18261774361459293,0.26863456489395965,0.20920620800470965,BIRC3,1
REACTOME_ABC_TRANSPORTER_DISORDERS,REACTOME_ABC_TRANSPORTER_DISORDERS,1/56,78/21728,0.18261774361459293,0.26863456489395965,0.20920620800470965,PSMD5,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/56,78/21728,0.18261774361459293,0.26863456489395965,0.20920620800470965,PRKAR1A,1
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1/56,78/21728,0.18261774361459293,0.26863456489395965,0.20920620800470965,ATP6V1A,1
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,1/56,78/21728,0.18261774361459293,0.26863456489395965,0.20920620800470965,CLEC5A,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/56,304/21728,0.1846285145405311,0.2690222677143843,0.2095081417373468,EFNB2/SLC39A14,2
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,WWTR1,1
BILD_CTNNB1_ONCOGENIC_SIGNATURE,BILD_CTNNB1_ONCOGENIC_SIGNATURE,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,DUSP5,1
KEGG_CARDIAC_MUSCLE_CONTRACTION,KEGG_CARDIAC_MUSCLE_CONTRACTION,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,TPM1,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,PDLIM4,1
PID_MET_PATHWAY,PID_MET_PATHWAY,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,MET,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,LDHA,1
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,MET,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,PSMD5,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,NRIP1,1
WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,1/56,79/21728,0.1847319887119412,0.2690222677143843,0.2095081417373468,IFNAR1,1
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,1/56,80/21728,0.1868408624997434,0.27159867194280884,0.21151458405473347,MET,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/56,80/21728,0.1868408624997434,0.27159867194280884,0.21151458405473347,RECQL,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,2/56,307/21728,0.18741513064107412,0.2719156266822953,0.2117614208651166,RECQL/PRPS2,2
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,2/56,308/21728,0.18834538900428488,0.2719156266822953,0.2117614208651166,ACTR3/PRKAR1A,2
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,AKAP12,1
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,MET,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,SEC24A,1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,PSMD5,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,LDHA,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,NRIP1,1
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,HSPA5,1
WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,RECQL,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/56,81/21728,0.18894437837649913,0.2719156266822953,0.2117614208651166,PCYT1A,1
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,BIRC3,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,TPM1,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,SLC2A3,1
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,ITGB3,1
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,HSPA5,1
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,PSMD5,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,CLEC5A,1
SATOH_COLORECTAL_CANCER_MYC_UP,SATOH_COLORECTAL_CANCER_MYC_UP,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,PRPS2,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,LDHA,1
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,PPFIBP1,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/56,82/21728,0.19104254970790402,0.2719156266822953,0.2117614208651166,SLC39A14,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,2/56,311/21728,0.19114019036328952,0.2719156266822953,0.2117614208651166,ACBD3/PRPS2,2
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,2/56,311/21728,0.19114019036328952,0.2719156266822953,0.2117614208651166,GBE1/PPFIBP1,2
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,NRIP1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,SLC4A7,1
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,AKAP12,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,PTPN14,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,BIRC3,1
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,RECQL,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,TPM1,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/56,83/21728,0.19313538982692624,0.2728122688456317,0.21245970444974313,MET,1
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,TPM1,1
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,ITGB3,1
HILLION_HMGA1_TARGETS,HILLION_HMGA1_TARGETS,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,ESR2,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,ITGB3,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,BIRC3,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,BIRC3,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,SLC4A7,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/56,84/21728,0.1952229120338883,0.273825821352796,0.2132490350287072,MET,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,2/56,317/21728,0.19674707050351453,0.2743399149781499,0.21364939891323617,AKAP12/BIRC3,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,DUSP5,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,GBE1,1
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,AKAP12,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,PSMD5,1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,PSMD5,1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,ITGB3,1
SANA_TNF_SIGNALING_DN,SANA_TNF_SIGNALING_DN,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,PDLIM4,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,AKAP12,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1/56,85/21728,0.19730512959654312,0.2743399149781499,0.21364939891323617,PERP,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/56,319/21728,0.19862087944498624,0.27507498459404306,0.2142218536419163,TMCO3/SEC24A,2
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,SLC39A14,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,SLC39A14,1
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,ACBD3,1
REACTOME_HEDGEHOG_ON_STATE,REACTOME_HEDGEHOG_ON_STATE,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,PSMD5,1
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,SLC39A14,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,AKAP12,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,PRKAR1A,1
WP_APOPTOSIS,WP_APOPTOSIS,1/56,86/21728,0.19938205575015377,0.27507498459404306,0.2142218536419163,BIRC3,1
KEGG_HEMATOPOIETIC_CELL_LINEAGE,KEGG_HEMATOPOIETIC_CELL_LINEAGE,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,ITGB3,1
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,LRRC8E,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,IFNAR1,1
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,PPFIBP1,1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,PSMD5,1
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,LDHA,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/56,87/21728,0.20145370369757054,0.276264555928315,0.21514826349573526,IFNAR1,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,2/56,323/21728,0.20237533576356787,0.27729062715162384,0.21594734335299762,NRIP1/PKD2,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/56,88/21728,0.2035200866093091,0.2776694696999021,0.21624237691648346,EFNB2,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/56,88/21728,0.2035200866093091,0.2776694696999021,0.21624237691648346,HSPA5,1
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1/56,88/21728,0.2035200866093091,0.2776694696999021,0.21624237691648346,PSMD5,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/56,88/21728,0.2035200866093091,0.2776694696999021,0.21624237691648346,STBD1,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/56,88/21728,0.2035200866093091,0.2776694696999021,0.21624237691648346,PRKAR1A,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,2/56,325/21728,0.20425584046821257,0.2784357109195839,0.21683910734858483,BIRC3/MET,2
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,EML1,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,NRIP1,1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,MOXD1,1
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,PKD2,1
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,ACTR3,1
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,1/56,89/21728,0.20558121762362858,0.2788162569806464,0.21713546756729843,PERP,1
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,1/56,90/21728,0.20763710984660955,0.28112763644769573,0.2189355149057793,LOXL1,1
REACTOME_OPIOID_SIGNALLING,REACTOME_OPIOID_SIGNALLING,1/56,90/21728,0.20763710984660955,0.28112763644769573,0.2189355149057793,PRKAR1A,1
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1/56,91/21728,0.2096877763522289,0.28294578429300765,0.22035144519181593,PSMD5,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/56,91/21728,0.2096877763522289,0.28294578429300765,0.22035144519181593,PERP,1
WP_AMINO_ACID_METABOLISM,WP_AMINO_ACID_METABOLISM,1/56,91/21728,0.2096877763522289,0.28294578429300765,0.22035144519181593,LDHA,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/56,91/21728,0.2096877763522289,0.28294578429300765,0.22035144519181593,BIRC3,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,EFNB2,1
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,PDLIM4,1
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,PDLIM4,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,AKAP12,1
REACTOME_PCP_CE_PATHWAY,REACTOME_PCP_CE_PATHWAY,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,PSMD5,1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1/56,92/21728,0.21173323018243995,0.2842665281794471,0.2213800091085125,HSPA5,1
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,1/56,93/21728,0.21377348434724752,0.286284590846942,0.22295162830185472,SLC4A7,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/56,93/21728,0.21377348434724752,0.286284590846942,0.22295162830185472,PSMD5,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/56,93/21728,0.21377348434724752,0.286284590846942,0.22295162830185472,PDLIM4,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,TPM1,1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,RASA2,1
REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,PRKAR1A,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,STBD1,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,BIRC3,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1/56,94/21728,0.21580855182478664,0.2875648953065282,0.22394869895501981,ACTR3,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,2/56,339/21728,0.2174740426268351,0.2885863085771935,0.22474415130958159,MET/SH3GLB1,2
CHEN_LIVER_METABOLISM_QTL_CIS,CHEN_LIVER_METABOLISM_QTL_CIS,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,ACTR3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,SLC2A3,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,MOXD1,1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,PRKAR1A,1
WINTER_HYPOXIA_UP,WINTER_HYPOXIA_UP,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,LDHA,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/56,95/21728,0.2178384455613962,0.2885863085771935,0.22474415130958159,ITGB3,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/56,341/21728,0.2193693531699322,0.290373837515498,0.22613623631930097,BIRC3/DUSP5,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1/56,96/21728,0.2198631784716979,0.2907867844303101,0.22645782955206012,PERP,1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/56,97/21728,0.2218827634386722,0.29249013910835686,0.22778436165049615,PPP1R15A,1
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/56,97/21728,0.2218827634386722,0.29249013910835686,0.22778436165049615,NRIP1,1
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,1/56,97/21728,0.2218827634386722,0.29249013910835686,0.22778436165049615,SLC33A1,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/56,97/21728,0.2218827634386722,0.29249013910835686,0.22778436165049615,BIRC3,1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1/56,98/21728,0.2238972133137329,0.29465978937338183,0.22947403365834615,SLC39A14,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/56,98/21728,0.2238972133137329,0.29465978937338183,0.22947403365834615,BIRC3,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/56,99/21728,0.22590654091680407,0.2965718874597452,0.2309631301569261,SLC33A1,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1/56,99/21728,0.22590654091680407,0.2965718874597452,0.2309631301569261,TBC1D19,1
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,1/56,99/21728,0.22590654091680407,0.2965718874597452,0.2309631301569261,ITGB3,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/56,100/21728,0.22791075903639624,0.2979798067859343,0.2320595842320926,WWTR1,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/56,100/21728,0.22791075903639624,0.2979798067859343,0.2320595842320926,PSMD5,1
REACTOME_UCH_PROTEINASES,REACTOME_UCH_PROTEINASES,1/56,100/21728,0.22791075903639624,0.2979798067859343,0.2320595842320926,PSMD5,1
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,1/56,100/21728,0.22791075903639624,0.2979798067859343,0.2320595842320926,DUSP5,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1/56,100/21728,0.22791075903639624,0.2979798067859343,0.2320595842320926,HSPA5,1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1/56,101/21728,0.22990988042968086,0.3001027745363753,0.23371290100821693,HSPA5,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/56,101/21728,0.22990988042968086,0.3001027745363753,0.23371290100821693,DUSP5,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,2/56,354/21728,0.23172379382741484,0.30098568555055477,0.23440049110056038,PPP1R15A/HSPA5,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,GBE1,1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,FNDC3B,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,PDLIM4,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,IFNAR1,1
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,USO1,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/56,102/21728,0.23190391782256625,0.30098568555055477,0.23440049110056038,PSMD5,1
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1/56,103/21728,0.23389288390977336,0.3033209419073217,0.23621913319269383,PSMD5,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/56,104/21728,0.2358767913549087,0.30539837196477654,0.23783698629691621,ITGB3,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/56,104/21728,0.2358767913549087,0.30539837196477654,0.23783698629691621,IFNAR1,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,2/56,359/21728,0.23648926155631672,0.3056963049543657,0.23806900942102938,AKAP12/PERP,2
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/56,359/21728,0.23648926155631672,0.3056963049543657,0.23806900942102938,STBD1/MOXD1,2
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/56,105/21728,0.23785565279054122,0.3062247897037644,0.23848058077058248,BIRC3,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/56,105/21728,0.23785565279054122,0.3062247897037644,0.23848058077058248,PERP,1
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/56,105/21728,0.23785565279054122,0.3062247897037644,0.23848058077058248,ACTR3,1
RICKMAN_HEAD_AND_NECK_CANCER_A,RICKMAN_HEAD_AND_NECK_CANCER_A,1/56,105/21728,0.23785565279054122,0.3062247897037644,0.23848058077058248,MOXD1,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/56,105/21728,0.23785565279054122,0.3062247897037644,0.23848058077058248,PRPS2,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/56,106/21728,0.23982948081827715,0.3077747510661518,0.23968765380419185,PSMD5,1
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/56,106/21728,0.23982948081827715,0.3077747510661518,0.23968765380419185,ITGB3,1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1/56,106/21728,0.23982948081827715,0.3077747510661518,0.23968765380419185,SLC4A7,1
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,1/56,106/21728,0.23982948081827715,0.3077747510661518,0.23968765380419185,PPP1R15A,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/56,107/21728,0.2417982880088323,0.3098040565113164,0.24126802860530416,DUSP5,1
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,1/56,107/21728,0.2417982880088323,0.3098040565113164,0.24126802860530416,SLC39A14,1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/56,108/21728,0.24376208690210766,0.31157120460149496,0.2426442414953876,KCTD9,1
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,1/56,108/21728,0.24376208690210766,0.31157120460149496,0.2426442414953876,BIRC3,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/56,108/21728,0.24376208690210766,0.31157120460149496,0.2426442414953876,PRKAR1A,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/56,109/21728,0.24572089000726383,0.3133235272102192,0.24400890865323022,SLC4A7,1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1/56,109/21728,0.24572089000726383,0.3133235272102192,0.24400890865323022,SLC35D1,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/56,109/21728,0.24572089000726383,0.3133235272102192,0.24400890865323022,ITGB3,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,2/56,369/21728,0.2460378188340536,0.3134776671837862,0.24412894919747152,NRIP1/PRKAR1A,2
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,1/56,110/21728,0.24767470980279527,0.31506114636011906,0.24536212510715308,RECQL,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/56,110/21728,0.24767470980279527,0.31506114636011906,0.24536212510715308,SLC4A7,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,2/56,371/21728,0.24794985198455788,0.3151604239453959,0.24543944012863525,SLC2A3/SLC39A14,2
LIM_MAMMARY_LUMINAL_MATURE_UP,LIM_MAMMARY_LUMINAL_MATURE_UP,1/56,111/21728,0.24962355873660236,0.31653296623301125,0.2465083434078222,TMCO3,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,1/56,111/21728,0.24962355873660236,0.31653296623301125,0.2465083434078222,AKAP12,1
ZWANG_EGF_INTERVAL_UP,ZWANG_EGF_INTERVAL_UP,1/56,111/21728,0.24962355873660236,0.31653296623301125,0.2465083434078222,SLC33A1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/56,112/21728,0.251567449226067,0.3187451278228852,0.2482311222240698,FNDC3B,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,2/56,375/21728,0.2517757831301032,0.3187565140340736,0.24823998953445187,BIRC3/PPP1R15A,2
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,1/56,113/21728,0.25350639365812366,0.32069361033175614,0.24974855404527005,DUSP5,1
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,1/56,114/21728,0.25544040438933535,0.3221208254089489,0.2508600351922495,MOXD1,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/56,114/21728,0.25544040438933535,0.3221208254089489,0.2508600351922495,PRKAR1A,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/56,114/21728,0.25544040438933535,0.3221208254089489,0.2508600351922495,SLC2A3,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/56,114/21728,0.25544040438933535,0.3221208254089489,0.2508600351922495,BIRC3,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/56,115/21728,0.2573694937459652,0.324297730890306,0.25255535738996876,BIRC3,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/56,116/21728,0.25929367402404924,0.32587136595687227,0.25378086694116714,SLC2A3,1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1/56,116/21728,0.25929367402404924,0.32587136595687227,0.25378086694116714,PSMD5,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/56,116/21728,0.25929367402404924,0.32587136595687227,0.25378086694116714,ACTR3,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/56,383/21728,0.2594335515091297,0.32587136595687227,0.25378086694116714,PTPN14/WWTR1,2
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/56,117/21728,0.26121295748946916,0.32759177962796954,0.25512068417753725,CLEC5A,1
GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,1/56,117/21728,0.26121295748946916,0.32759177962796954,0.25512068417753725,SLC39A14,1
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,NRIP1,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,TPM1,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,SLC39A14,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,PERP,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,LDHA,1
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,1/56,118/21728,0.2631273563780254,0.3284470279847484,0.2557867312504245,RECQL,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/56,119/21728,0.26503688289550953,0.3303148680825563,0.2572413606804675,TPM1,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/56,119/21728,0.26503688289550953,0.3303148680825563,0.2572413606804675,EFNB2,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,2/56,390/21728,0.2661383109786083,0.3314292517560706,0.258109216172892,MET/WWTR1,2
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,1/56,120/21728,0.26694154921777546,0.3316546520584483,0.2582847525658434,PDLIM4,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1/56,120/21728,0.26694154921777546,0.3316546520584483,0.2582847525658434,PSMD5,1
REACTOME_SYNTHESIS_OF_DNA,REACTOME_SYNTHESIS_OF_DNA,1/56,120/21728,0.26694154921777546,0.3316546520584483,0.2582847525658434,PSMD5,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,2/56,392/21728,0.2680543426220634,0.3327786442955585,0.2591600909789972,USO1/ATP6V1A,2
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,1/56,121/21728,0.26884136749081344,0.333496777826075,0.2597193562873156,ITGB3,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,1/56,122/21728,0.27073634983081996,0.33532720633577157,0.26114485046260344,SLC39A14,1
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,1/56,122/21728,0.27073634983081996,0.33532720633577157,0.26114485046260344,PRKAR1A,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/56,123/21728,0.27262650832426927,0.3374069557356862,0.26276450981555366,SLC2A3,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,2/56,398/21728,0.27380269862660866,0.3386005530579638,0.26369405501304843,BIRC3/TPM1,2
REACTOME_CYTOPROTECTION_BY_HMOX1,REACTOME_CYTOPROTECTION_BY_HMOX1,1/56,124/21728,0.27451185502798814,0.33895324802297533,0.2639687254607681,PSMD5,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/56,124/21728,0.27451185502798814,0.33895324802297533,0.2639687254607681,PSMD5,1
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,2/56,400/21728,0.27571873711381,0.3399626544221436,0.2647548271494657,NRBF2/SEC24A,2
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/56,125/21728,0.27639240196922243,0.3399626544221436,0.2647548271494657,SEC24A,1
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1/56,125/21728,0.27639240196922243,0.3399626544221436,0.2647548271494657,MOXD1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,1/56,125/21728,0.27639240196922243,0.3399626544221436,0.2647548271494657,DUSP5,1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1/56,125/21728,0.27639240196922243,0.3399626544221436,0.2647548271494657,SH3GLB1,1
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1/56,126/21728,0.2782681611457134,0.3409584595187707,0.2655303364673353,AKAP12,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/56,126/21728,0.2782681611457134,0.3409584595187707,0.2655303364673353,SLC4A7,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/56,126/21728,0.2782681611457134,0.3409584595187707,0.2655303364673353,AKAP12,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1/56,126/21728,0.2782681611457134,0.3409584595187707,0.2655303364673353,ESR2,1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1/56,126/21728,0.2782681611457134,0.3409584595187707,0.2655303364673353,SEC24A,1
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,1/56,127/21728,0.2801391445257634,0.3424636789730089,0.2667025655673412,ACBD3,1
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,1/56,127/21728,0.2801391445257634,0.3424636789730089,0.2667025655673412,WWTR1,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/56,127/21728,0.2801391445257634,0.3424636789730089,0.2667025655673412,PCYT1A,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,2/56,405/21728,0.28050819125043547,0.3426528631088207,0.26684989767139655,USO1/FNDC3B,2
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1/56,128/21728,0.282005364048311,0.3439561991710521,0.2678649047887526,PCYT1A,1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1/56,128/21728,0.282005364048311,0.3439561991710521,0.2678649047887526,PSMD5,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/56,407/21728,0.2824235892448471,0.3442037493921574,0.2680576910114363,PERP/SH3GLB1,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/56,408/21728,0.2833811821737281,0.34510777631057976,0.2687617256676317,PCYT1A/TPM1,2
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1/56,129/21728,0.2838668316230003,0.345436121586893,0.2690174331571012,PERP,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/56,130/21728,0.2857235591302515,0.3474311566914617,0.27057111903228936,AKAP12,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,2/56,411/21728,0.2862534661087136,0.3475469189884837,0.2706612719550879,PPFIBP1/PRKAR1A,2
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,2/56,411/21728,0.2862534661087136,0.3475469189884837,0.2706612719550879,SLC4A7/PKD2,2
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,2/56,412/21728,0.28721070970447904,0.34835857417856525,0.2712933697068844,AKAP12/BIRC3,2
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/56,131/21728,0.28757555842132965,0.34835857417856525,0.2712933697068844,PPP1R15A,1
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1/56,131/21728,0.28757555842132965,0.34835857417856525,0.2712933697068844,PSMD5,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/56,132/21728,0.2894228413184178,0.34980130254584285,0.2724169322351022,EFNB2,1
KEGG_OXIDATIVE_PHOSPHORYLATION,KEGG_OXIDATIVE_PHOSPHORYLATION,1/56,132/21728,0.2894228413184178,0.34980130254584285,0.2724169322351022,ATP6V1A,1
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1/56,132/21728,0.2894228413184178,0.34980130254584285,0.2724169322351022,EFNB2,1
REACTOME_M_PHASE,REACTOME_M_PHASE,2/56,415/21728,0.2900818065543721,0.35033293706981944,0.27283095655415984,PSMD5/USO1,2
QI_HYPOXIA,QI_HYPOXIA,1/56,133/21728,0.2912654196146839,0.35096714842794235,0.27332486527122596,GBE1,1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/56,133/21728,0.2912654196146839,0.35096714842794235,0.27332486527122596,PRKAR1A,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1/56,133/21728,0.2912654196146839,0.35096714842794235,0.27332486527122596,LDHA,1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,1/56,135/21728,0.29493650943277916,0.3548558905816508,0.276353325142749,BIRC3,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/56,135/21728,0.29493650943277916,0.3548558905816508,0.276353325142749,AKAP12,1
MOOTHA_PGC,MOOTHA_PGC,2/56,421/21728,0.2958206367003664,0.35538482200141686,0.2767652443485575,LDHA/HSPA5,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,2/56,421/21728,0.2958206367003664,0.35538482200141686,0.2767652443485575,BIRC3/DUSP5,2
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/56,136/21728,0.29676504439650664,0.35598447561141344,0.27723224031355265,PSMD5,1
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,1/56,136/21728,0.29676504439650664,0.35598447561141344,0.27723224031355265,FEM1B,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/56,137/21728,0.29858892164334805,0.35736802822433644,0.27830971817214056,PRKAR1A,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/56,137/21728,0.29858892164334805,0.35736802822433644,0.27830971817214056,IFNAR1,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/56,137/21728,0.29858892164334805,0.35736802822433644,0.27830971817214056,PDLIM4,1
EPPERT_PROGENITOR,EPPERT_PROGENITOR,1/56,138/21728,0.3004081528224488,0.35847211668887735,0.2791695560007517,TPM1,1
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1/56,138/21728,0.3004081528224488,0.35847211668887735,0.2791695560007517,RECQL,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/56,138/21728,0.3004081528224488,0.35847211668887735,0.2791695560007517,PPFIBP1,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/56,138/21728,0.3004081528224488,0.35847211668887735,0.2791695560007517,IFNAR1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/56,139/21728,0.30222274955435935,0.3598318514798366,0.2802284851062485,PCYT1A,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/56,139/21728,0.30222274955435935,0.3598318514798366,0.2802284851062485,PERP,1
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,1/56,139/21728,0.30222274955435935,0.3598318514798366,0.2802284851062485,PSMD5,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/56,140/21728,0.3040327234310999,0.36118003325878806,0.2812784170008534,PTPN14,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/56,140/21728,0.3040327234310999,0.36118003325878806,0.2812784170008534,PPFIBP1,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/56,140/21728,0.3040327234310999,0.36118003325878806,0.2812784170008534,PSMD5,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/56,430/21728,0.304418229453271,0.36136952405031947,0.28142598792108753,LOXL1/PPFIBP1,2
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,AKAP12,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,AKAP12,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,PSMD5,1
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,BIRC3,1
REACTOME_MITOTIC_PROPHASE,REACTOME_MITOTIC_PROPHASE,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,USO1,1
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,1/56,141/21728,0.3058380860162334,0.3614450107464577,0.28148477516412196,DNTTIP2,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/56,434/21728,0.30823439194894475,0.3637393304253599,0.2832715367454664,PPP1R15A/SLC2A3,2
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,2/56,434/21728,0.30823439194894475,0.3637393304253599,0.2832715367454664,HIVEP3/DUSP5,2
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1/56,143/21728,0.3094350234240414,0.3643494863439191,0.28374671165850784,LDHA,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/56,143/21728,0.3094350234240414,0.3643494863439191,0.28374671165850784,GBE1,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/56,143/21728,0.3094350234240414,0.3643494863439191,0.28374671165850784,ACTR3,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,1/56,144/21728,0.31122662123216105,0.36618937994865747,0.2851795770246285,GOLGA5,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,2/56,438/21728,0.3120470099888485,0.366673137214503,0.28555631567411016,MET/PRKAR1A,2
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,1/56,145/21728,0.3130136537196977,0.366673137214503,0.28555631567411016,TPM1,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/56,145/21728,0.3130136537196977,0.366673137214503,0.28555631567411016,PKD2,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/56,145/21728,0.3130136537196977,0.366673137214503,0.28555631567411016,ACTR3,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/56,145/21728,0.3130136537196977,0.366673137214503,0.28555631567411016,BIRC3,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/56,145/21728,0.3130136537196977,0.366673137214503,0.28555631567411016,DUSP5,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/56,146/21728,0.31479613230894354,0.3672730988036769,0.2860235514859615,SLC39A14,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/56,146/21728,0.31479613230894354,0.3672730988036769,0.2860235514859615,PSMD5,1
REACTOME_DNA_REPLICATION_PRE_INITIATION,REACTOME_DNA_REPLICATION_PRE_INITIATION,1/56,146/21728,0.31479613230894354,0.3672730988036769,0.2860235514859615,PSMD5,1
WEI_MIR34A_TARGETS,WEI_MIR34A_TARGETS,1/56,146/21728,0.31479613230894354,0.3672730988036769,0.2860235514859615,ACBD3,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/56,146/21728,0.31479613230894354,0.3672730988036769,0.2860235514859615,DUSP5,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,2/56,441/21728,0.3149039515070926,0.3672730988036769,0.2860235514859615,MCFD2/DNTTIP2,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1/56,147/21728,0.3165740683941397,0.3689518479316541,0.2873309213673986,SLC39A14,1
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1/56,148/21728,0.3183474733415437,0.37047860980577024,0.28851992719148567,NRIP1,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/56,148/21728,0.3183474733415437,0.37047860980577024,0.28851992719148567,TASP1,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/56,149/21728,0.32011635848949915,0.3719956811226084,0.2897013862401144,PSMD5,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/56,149/21728,0.32011635848949915,0.3719956811226084,0.2897013862401144,STBD1,1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,DUSP5,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,LDHA,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,LDHA,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,PRPS2,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,BIRC3,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1/56,150/21728,0.32188073514850013,0.37242206621016766,0.29003344480209886,ATP6V1A,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,2/56,449/21728,0.32251080176817437,0.3728812523697113,0.2903910480585686,NRBF2/PPFIBP1,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,1/56,151/21728,0.3236406146012618,0.3739171551643191,0.2911977845096538,CLEC5A,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/56,152/21728,0.32539600810278335,0.3748618277783506,0.2919334730665803,AKAP12,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/56,152/21728,0.32539600810278335,0.3748618277783506,0.2919334730665803,LDHA,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/56,152/21728,0.32539600810278335,0.3748618277783506,0.2919334730665803,GBE1,1
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1/56,152/21728,0.32539600810278335,0.3748618277783506,0.2919334730665803,PRKAR1A,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,2/56,453/21728,0.32630728588571545,0.37564100081444135,0.29254027448963765,NRIP1/HSPA5,2
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/56,153/21728,0.3271469268804177,0.3759208020770734,0.29275817705617185,ATP6V1A,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/56,153/21728,0.3271469268804177,0.3759208020770734,0.29275817705617185,SEC24A,1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,2/56,454/21728,0.32725563257741475,0.3759208020770734,0.29275817705617185,LDHA/MET,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,1/56,154/21728,0.3288933821339376,0.3775308815737015,0.2940120686624462,IFNAR1,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/56,155/21728,0.33063538503560175,0.37817309060939,0.2945122057805262,PPFIBP1,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/56,155/21728,0.33063538503560175,0.37817309060939,0.2945122057805262,IFNAR1,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/56,155/21728,0.33063538503560175,0.37817309060939,0.2945122057805262,BIRC3,1
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,1/56,155/21728,0.33063538503560175,0.37817309060939,0.2945122057805262,ESR2,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,1/56,155/21728,0.33063538503560175,0.37817309060939,0.2945122057805262,PRKAR1A,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,2/56,459/21728,0.3319924888661685,0.3793464252830997,0.2954259709093887,RECQL/ACTR3,2
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/56,156/21728,0.33237294673022055,0.3793464252830997,0.2954259709093887,IFNAR1,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/56,156/21728,0.33237294673022055,0.3793464252830997,0.2954259709093887,ESR2,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/56,157/21728,0.33410607833522277,0.3807809118018683,0.2965431148820712,SLC39A14,1
REACTOME_CELLULAR_RESPONSE_TO_STARVATION,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,1/56,157/21728,0.33410607833522277,0.3807809118018683,0.2965431148820712,ATP6V1A,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/56,463/21728,0.3357758491509346,0.3822062852058467,0.29765316177776685,PTPN14/PSMD5,2
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/56,158/21728,0.3358347909407221,0.3822062852058467,0.29765316177776685,PRKAR1A,1
KEGG_PURINE_METABOLISM,KEGG_PURINE_METABOLISM,1/56,159/21728,0.33755909560958264,0.38362259692944045,0.2987561516523669,PRPS2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/56,159/21728,0.33755909560958264,0.38362259692944045,0.2987561516523669,GBE1,1
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1/56,160/21728,0.3392790033774836,0.38502989808417054,0.29985212431030833,PSMD5,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,1/56,160/21728,0.3392790033774836,0.38502989808417054,0.29985212431030833,MET,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,2/56,467/21728,0.33955345670274883,0.3850680689841811,0.2998818508991056,RECQL/FEM1B,2
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,1/56,161/21728,0.34099452525298735,0.38615456507048634,0.3007279882020904,SLC4A7,1
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,1/56,161/21728,0.34099452525298735,0.38615456507048634,0.3007279882020904,PTPN14,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,2/56,470/21728,0.3423827195563791,0.38726951934695747,0.3015962880665223,EML1/PRPS2,2
REACTOME_S_PHASE,REACTOME_S_PHASE,1/56,162/21728,0.3427056722176015,0.38726951934695747,0.3015962880665223,PSMD5,1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1/56,162/21728,0.3427056722176015,0.38726951934695747,0.3015962880665223,HSPA5,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/56,164/21728,0.3461148852053205,0.3902945708344905,0.30395212619545264,ITGB3,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/56,164/21728,0.3461148852053205,0.3902945708344905,0.30395212619545264,LDHA,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1/56,164/21728,0.3461148852053205,0.3902945708344905,0.30395212619545264,DNTTIP2,1
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1/56,165/21728,0.3478129730567625,0.39193301192231383,0.30522810513419385,CLEC5A,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1/56,166/21728,0.34950672965412033,0.3932873052195204,0.3062827965338156,HSPA5,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/56,166/21728,0.34950672965412033,0.3932873052195204,0.3062827965338156,PSMD5,1
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,1/56,167/21728,0.35119616584461155,0.3946329368837202,0.3073307424597222,SLC2A3,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/56,167/21728,0.35119616584461155,0.3946329368837202,0.3073307424597222,MET,1
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,2/56,480/21728,0.3517876306008011,0.3950199587996355,0.3076321459201269,PDLIM4/SLC2A3,2
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,1/56,168/21728,0.3528812924487903,0.3954149871237671,0.3079397845807686,RECQL,1
REACTOME_G2_M_CHECKPOINTS,REACTOME_G2_M_CHECKPOINTS,1/56,168/21728,0.3528812924487903,0.3954149871237671,0.3079397845807686,PSMD5,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/56,168/21728,0.3528812924487903,0.3954149871237671,0.3079397845807686,SLC35D1,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/56,169/21728,0.3545621202606115,0.3967423585001524,0.3089735098289591,PERP,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/56,169/21728,0.3545621202606115,0.3967423585001524,0.3089735098289591,AKAP12,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,2/56,484/21728,0.3555377586536361,0.3972284640278548,0.309352077248907,BIRC3/MET,2
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/56,484/21728,0.3555377586536361,0.3972284640278548,0.309352077248907,SLC4A7/PKD2,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/56,170/21728,0.3562386600474945,0.3972284640278548,0.309352077248907,SLC39A14,1
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,1/56,170/21728,0.3562386600474945,0.3972284640278548,0.309352077248907,CLEC5A,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/56,170/21728,0.3562386600474945,0.3972284640278548,0.309352077248907,PRKAR1A,1
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1/56,171/21728,0.35791092255038626,0.3985373016421084,0.31037136884408956,LDHA,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/56,171/21728,0.35791092255038626,0.3985373016421084,0.31037136884408956,STBD1,1
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1/56,172/21728,0.35957891848382706,0.40011599906446726,0.31160082083753976,PSMD5,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/56,173/21728,0.3612426585360121,0.4014086247387654,0.31260748695958623,FNDC3B,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/56,173/21728,0.3612426585360121,0.4014086247387654,0.31260748695958623,EML1,1
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1/56,174/21728,0.36290215336885756,0.40297259947000225,0.31382547327146093,PPP1R15A,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/56,176/21728,0.3662084498931688,0.40636177056153844,0.3164648790851519,LDHA,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/56,177/21728,0.3678552727776335,0.40790608957797225,0.31766755799397073,RECQL,1
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,1/56,178/21728,0.36949789282888157,0.4091600627654997,0.31864412247890866,LDHA,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/56,178/21728,0.36949789282888157,0.4091600627654997,0.31864412247890866,PRKAR1A,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/56,179/21728,0.3711363205783752,0.41068994920748925,0.3198355616421183,PSMD5,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/56,180/21728,0.37277056653167273,0.41221309535556344,0.32102175162478624,ACTR3,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/56,181/21728,0.3744006411684945,0.4137295267646321,0.3222027123284683,MET,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,1/56,182/21728,0.37602655494278137,0.414952699346796,0.32315529003473203,LOXL1,1
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,1/56,182/21728,0.37602655494278137,0.414952699346796,0.32315529003473203,ACBD3,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/56,183/21728,0.37764831828276146,0.4161679262123609,0.32410167980594645,PRPS2,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/56,183/21728,0.37764831828276146,0.4161679262123609,0.32410167980594645,ATP6V1A,1
WP_CILIOPATHIES,WP_CILIOPATHIES,1/56,184/21728,0.37926594159100735,0.41766270014051016,0.32526577417874564,PKD2,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/56,185/21728,0.3808794352445024,0.41886259763133377,0.3262002257976156,TPM1,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1/56,185/21728,0.3808794352445024,0.41886259763133377,0.3262002257976156,HSPA5,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/56,186/21728,0.38248880959470044,0.42005467482275144,0.32712858715336224,PSMD5,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/56,186/21728,0.38248880959470044,0.42005467482275144,0.32712858715336224,AKAP12,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/56,187/21728,0.38409407496758585,0.4206619355295683,0.3276015073443793,SLC4A7,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/56,187/21728,0.38409407496758585,0.4206619355295683,0.3276015073443793,SLC35D1,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/56,187/21728,0.38409407496758585,0.4206619355295683,0.3276015073443793,NRIP1,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1/56,187/21728,0.38409407496758585,0.4206619355295683,0.3276015073443793,ITGB3,1
REACTOME_DNA_REPLICATION,REACTOME_DNA_REPLICATION,1/56,189/21728,0.3872923199583913,0.4235844183402652,0.32987746742801993,PSMD5,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/56,189/21728,0.3872923199583913,0.4235844183402652,0.32987746742801993,SLC2A3,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1/56,190/21728,0.3888853201014959,0.4250359718675953,0.33100790278092573,PRKAR1A,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/56,191/21728,0.39047425231777944,0.4261899859768801,0.3319066215138733,RECQL,1
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1/56,191/21728,0.39047425231777944,0.4261899859768801,0.3319066215138733,PSMD5,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/56,193/21728,0.3936399537430456,0.4290594996831152,0.3341413305191569,GBE1,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/56,193/21728,0.3936399537430456,0.4290594996831152,0.3341413305191569,EFNB2,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/56,194/21728,0.39521674327591705,0.42960677940053793,0.3345675389426526,PRKAR1A,1
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1/56,194/21728,0.39521674327591705,0.42960677940053793,0.3345675389426526,PRPS2,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/56,194/21728,0.39521674327591705,0.42960677940053793,0.3345675389426526,ITGB3,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/56,194/21728,0.39521674327591705,0.42960677940053793,0.3345675389426526,MOXD1,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1/56,197/21728,0.399922988574238,0.43442721381128163,0.3383215785778916,STBD1,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/56,199/21728,0.4030404833744021,0.43751645140235507,0.34072740331719564,PTPN14,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,1/56,200/21728,0.40459326023031916,0.438606524141207,0.34157632603209104,MOXD1,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/56,200/21728,0.40459326023031916,0.438606524141207,0.34157632603209104,PSMD5,1
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,1/56,202/21728,0.40768692273301177,0.4416608329607627,0.343954949075134,PKD2,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/56,203/21728,0.4092278282578168,0.4427302418026042,0.3447877792386563,IFNAR1,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/56,203/21728,0.4092278282578168,0.4427302418026042,0.3447877792386563,GOLGA5,1
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1/56,205/21728,0.4122978373660112,0.4457499945559513,0.34713949083946577,PRKAR1A,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/56,206/21728,0.4138269606809535,0.44710088522219227,0.3481915323510441,MET,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,1/56,207/21728,0.4153521762836794,0.447237797897376,0.3482981566851623,BIRC3,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/56,207/21728,0.4153521762836794,0.447237797897376,0.3482981566851623,ATP6V1A,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/56,207/21728,0.4153521762836794,0.447237797897376,0.3482981566851623,MOXD1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,1/56,207/21728,0.4153521762836794,0.447237797897376,0.3482981566851623,CLEC5A,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/56,207/21728,0.4153521762836794,0.447237797897376,0.3482981566851623,NRIP1,1
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,1/56,209/21728,0.4183909235489012,0.4502066532669536,0.35061023061440116,AKAP12,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,1/56,210/21728,0.4199044747492945,0.4515314425851526,0.3516419450171064,ESR2,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/56,211/21728,0.42141415731338216,0.4525461635621881,0.35243218557260697,PCYT1A,1
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,1/56,211/21728,0.42141415731338216,0.4525461635621881,0.35243218557260697,ATP6V1A,1
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,1/56,212/21728,0.42291998095006245,0.4538584225094965,0.353454141620575,DNTTIP2,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,1/56,213/21728,0.4244219553443178,0.45485972291927895,0.35423393055758995,ZBTB38,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/56,213/21728,0.4244219553443178,0.45485972291927895,0.35423393055758995,ITGB3,1
REACTOME_KERATINIZATION,REACTOME_KERATINIZATION,1/56,217/21728,0.43039155336291657,0.4609484888327552,0.3589757165920473,PERP,1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,1/56,218/21728,0.4318744259867685,0.4622270462870434,0.35997142671904964,PSMD5,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,1/56,219/21728,0.4333535069790855,0.4631900118045172,0.36072136135396715,DNTTIP2,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/56,219/21728,0.4333535069790855,0.4631900118045172,0.36072136135396715,EHBP1,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,1/56,222/21728,0.43776809524142735,0.4672838346402151,0.36390953318151126,RECQL,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,1/56,222/21728,0.43776809524142735,0.4672838346402151,0.36390953318151126,SLC35D1,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/56,223/21728,0.4392321046651454,0.468221423573045,0.36463970513604704,PRKAR1A,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/56,223/21728,0.4392321046651454,0.468221423573045,0.36463970513604704,BIRC3,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/56,224/21728,0.4406923698192373,0.46852865647670244,0.3648789708119805,STBD1,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/56,224/21728,0.4406923698192373,0.46852865647670244,0.3648789708119805,PPP1R15A,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/56,224/21728,0.4406923698192373,0.46852865647670244,0.3648789708119805,PPFIBP1,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/56,224/21728,0.4406923698192373,0.46852865647670244,0.3648789708119805,FNDC3B,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/56,227/21728,0.44505079357256827,0.472847985995041,0.3682427618788937,PRKAR1A,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/56,229/21728,0.4479378598215613,0.4755993611252832,0.3703854673718509,WWTR1,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/56,230/21728,0.44937585600045293,0.47649336455220437,0.3710816959713359,MET,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/56,230/21728,0.44937585600045293,0.47649336455220437,0.3710816959713359,PCYT1A,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1/56,232/21728,0.4522408207883378,0.4792134343542427,0.3732000216194787,PSMD5,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/56,234/21728,0.4550911436452244,0.481914396482592,0.37530346666594666,PSMD5,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/56,235/21728,0.4565108373251291,0.4830978351309606,0.376225100529888,SLC2A3,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/56,236/21728,0.45792689804767994,0.48331690427606616,0.37639570636818165,EFNB2,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/56,236/21728,0.45792689804767994,0.48331690427606616,0.37639570636818165,CLEC5A,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/56,236/21728,0.45792689804767994,0.48331690427606616,0.37639570636818165,GBE1,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/56,236/21728,0.45792689804767994,0.48331690427606616,0.37639570636818165,PSMD5,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1/56,237/21728,0.4593393349409113,0.4844878605346419,0.37730761924392314,PSMD5,1
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,1/56,238/21728,0.46074815711034567,0.4853335330826368,0.3779662089047493,LOXL1,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/56,238/21728,0.46074815711034567,0.4853335330826368,0.3779662089047493,PDLIM4,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/56,241/21728,0.46495302599456545,0.4894403479692628,0.3811644986324597,FEM1B,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/56,242/21728,0.466347479875717,0.4902627352539589,0.3818049542842128,SLC4A7,1
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,1/56,242/21728,0.466347479875717,0.4902627352539589,0.3818049542842128,ITGB3,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/56,245/21728,0.4705094601917249,0.49431315824347444,0.38495932734408367,PSMD5,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,1/56,249/21728,0.476009211012256,0.4994348611604969,0.38894798772447775,SLC39A14,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/56,249/21728,0.476009211012256,0.4994348611604969,0.38894798772447775,RASA2,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/56,250/21728,0.477375358606805,0.5005398022375614,0.3898084895474377,CLEC5A,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,1/56,254/21728,0.48280505307774246,0.5059012318946987,0.39398384340964987,ITGB3,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/56,256/21728,0.4854990853824114,0.508390987247201,0.39592280564394766,PDLIM4,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/56,257/21728,0.48684092830429015,0.509462463585445,0.3967572459244801,NRIP1,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/56,259/21728,0.48951431102003606,0.5119250381432554,0.3986750404025353,PERP,1
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,1/56,262/21728,0.4934987566314346,0.5154177085915507,0.40139504905289775,SLC39A14,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/56,262/21728,0.4934987566314346,0.5154177085915507,0.40139504905289775,CLEC5A,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/56,265/21728,0.49745265391320515,0.5188694022225799,0.4040831459328607,PDLIM4,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/56,265/21728,0.49745265391320515,0.5188694022225799,0.4040831459328607,FEM1B,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1/56,266/21728,0.49876387095559716,0.5188831682875731,0.4040938666167664,SLC35D1,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/56,266/21728,0.49876387095559716,0.5188831682875731,0.4040938666167664,LOXL1,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/56,266/21728,0.49876387095559716,0.5188831682875731,0.4040938666167664,PKD2,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/56,266/21728,0.49876387095559716,0.5188831682875731,0.4040938666167664,NRBF2,1
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,1/56,267/21728,0.5000717277828493,0.5199055219276827,0.4048900513086789,TPM1,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/56,268/21728,0.5013762328499087,0.5209230645399636,0.40568248928657846,FNDC3B,1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1/56,270/21728,0.5039752214188811,0.5229437891296501,0.40725618152159315,PRKAR1A,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1/56,270/21728,0.5039752214188811,0.5229437891296501,0.40725618152159315,DNTTIP2,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/56,271/21728,0.5052697217264841,0.5239470071599533,0.4080374638558473,LOXL1,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/56,278/21728,0.5142387819330387,0.532902017051801,0.41501141250931867,SLC2A3,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1/56,280/21728,0.5167719056086955,0.5351802312618549,0.4167856315346924,FNDC3B,1
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,1/56,281/21728,0.518033597761153,0.5357928349418394,0.4172627127060966,LDHA,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/56,281/21728,0.518033597761153,0.5357928349418394,0.4172627127060966,SLC2A3,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,1/56,288/21728,0.5267753019558417,0.5444820347946935,0.4240296548251357,PPFIBP1,1
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,1/56,292/21728,0.5317004468468639,0.5485090416181518,0.4271657919319796,MCFD2,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,1/56,292/21728,0.5317004468468639,0.5485090416181518,0.4271657919319796,LOXL1,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,1/56,292/21728,0.5317004468468639,0.5485090416181518,0.4271657919319796,PSMD5,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,1/56,296/21728,0.5365752386544158,0.5528246176600585,0.43052665988074734,GBE1,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1/56,296/21728,0.5365752386544158,0.5528246176600585,0.43052665988074734,PKD2,1
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,1/56,298/21728,0.5389939103244998,0.5549589585375887,0.4321888337776686,SLC35D1,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/56,299/21728,0.5401985925933672,0.555841408981206,0.43287606518861577,AKAP12,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/56,308/21728,0.5509025259906388,0.5664907646681875,0.44116953003684267,PSMD5,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/56,309/21728,0.5520766370338008,0.5673332536099278,0.4418256403808594,NRIP1,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/56,313/21728,0.5567430081420571,0.5717611239686251,0.44527396047192885,MOXD1,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/56,314/21728,0.5579021205186178,0.5725837552691078,0.44591460615737105,PRKAR1A,1
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1/56,315/21728,0.5590582558156645,0.5734022777737315,0.4465520520103515,DUSP5,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,1/56,322/21728,0.5670684729792312,0.581245184803712,0.452659921413246,ACTR3,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,1/56,323/21728,0.5682010603618888,0.5820329888011916,0.45327344442369233,NRIP1,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1/56,329/21728,0.5749357273095822,0.5881780089366743,0.45805903990789354,PRKAR1A,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/56,329/21728,0.5749357273095822,0.5881780089366743,0.45805903990789354,PSMD5,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/56,334/21728,0.5804690562784627,0.5934590927041316,0.46217182230274695,PRKAR1A,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/56,335/21728,0.5815672021533997,0.5942018889733458,0.46275029436520726,FEM1B,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/56,336/21728,0.5826625247673113,0.5945611851326935,0.46303010566602576,FNDC3B,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/56,336/21728,0.5826625247673113,0.5945611851326935,0.46303010566602576,NRBF2,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1/56,345/21728,0.592394551657887,0.604106433737858,0.47046371818694976,STBD1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/56,347/21728,0.59452676398166,0.6058943885319786,0.4718561348430471,TBC1D19,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1/56,350/21728,0.5977045580010166,0.6087449606647297,0.47407609260154393,STBD1,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,1/56,361/21728,0.6091485696555622,0.6200054505914984,0.4828454942561091,MCFD2,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/56,364/21728,0.612213770853853,0.6227288928723351,0.484966446310505,BIRC3,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/56,366/21728,0.6142441092163242,0.6243969044099824,0.4862654540120532,PERP,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/56,367/21728,0.6152553595619794,0.6250275221979702,0.4867565641421933,PPP1R15A,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1/56,371/21728,0.6192743891576369,0.6287109512781343,0.4896251310766814,SH3GLB1,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/56,374/21728,0.6222615743760986,0.6313428029361559,0.4916747545330782,PSMD5,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/56,377/21728,0.6252257373447643,0.6339479733762068,0.4937035992916972,MCFD2,1
BENPORATH_ES_1,BENPORATH_ES_1,1/56,379/21728,0.6271891419451164,0.6355357655071238,0.4949401340277985,USO1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/56,382/21728,0.6301153210378089,0.6380965157311312,0.49693438537897267,PPP1R15A,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/56,384/21728,0.6320535629159854,0.6396542070270004,0.49814747830087325,DUSP5,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,1/56,386/21728,0.6339818285993942,0.6411998380331635,0.49935117895607933,PCYT1A,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,1/56,388/21728,0.6359001685069624,0.6427334825806782,0.5005455448424623,SLC33A1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,1/56,395/21728,0.6425369147682141,0.6490312866167873,0.5054501247935613,TPM1,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/56,399/21728,0.646275844203523,0.6523958806069655,0.5080703905454331,LDHA,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/56,403/21728,0.6499763570151986,0.655717473102399,0.5106571677562544,WWTR1,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/56,410/21728,0.656360978149545,0.6617409861671641,0.5153481364245781,LDHA,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/56,423/21728,0.6679161047381683,0.6729665100670014,0.5240903073692522,PCYT1A,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/56,425/21728,0.6696596102834549,0.6742983103546879,0.5251274817481951,RECQL,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/56,427/21728,0.6713941246993829,0.6756193866546968,0.5261563045406711,PRKAR1A,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/56,433/21728,0.6765441753189904,0.6799460316373762,0.5295257927171694,NRIP1,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/56,433/21728,0.6765441753189904,0.6799460316373762,0.5295257927171694,PDLIM4,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/56,445/21728,0.6866075915460147,0.6896265947751743,0.5370647849768153,FNDC3B,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/56,452/21728,0.692335232559983,0.6949428982193426,0.5412049956179733,EHBP1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/56,453/21728,0.6931450289021825,0.695319260485941,0.5414980975970957,NRIP1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/56,454/21728,0.6939527317638267,0.6956930520942688,0.541789197608716,FEM1B,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/56,463/21728,0.7011287233334321,0.7024466344675175,0.5470487268852725,NRIP1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/56,476/21728,0.711203160162769,0.7120938341266546,0.5545617364614941,BIRC3,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/56,485/21728,0.7179816126173577,0.7184309127504098,0.5594969025270629,MOXD1,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,1/56,497/21728,0.7267769928243843,0.7267769928243843,0.5659966311255369,PKD2,1
